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ABSTRACT 
 
This abstract was written J. A. Thorley and also appears on the Rappoport laboratory 
website. This statement is confirmed by supervisor J. Z. Rappoport.  
 
Many viruses exploit and in some cases, promote host cell endocytic pathways for 
infection. These pathways include caveolar and clathrin-mediated endocytosis, as 
well as caveolin- and clathrin-independent pathways, such as macropinocytosis. The 
entry mechanisms of many viruses are not clear cut, with more than one pathway 
implicated in some cases. Hepatitis C virus (HCV) is a hepatotropic virus associated 
with liver disease, fibrosis, cirrhosis and hepatocellular carcinoma. There are four 
well-established co-receptors or “entry factors” for HCV, namely, the tetraspanin 
CD81, scavenger receptor BI (SR-BI) (which have been shown to directly bind the 
virus) and the tight junction proteins Claudin 1 (CLDN1) and Occludin (internalisation 
of which is required for viral entry). Clathrin-dependent endocytosis of HCV has been 
demonstrated in hepatoma cell lines and has also been shown to be the route of 
entry for co-receptor CD81. 
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However, clathrin-dependent endocytosis of HCV has been demonstrated in 
hepatoma cell lines, which do not express detectable levels of caveolin 1, a protein 
required for caveolar endocytosis. Due to this fact, the potential role of caveolae in 
HCV entry has largely been ignored, despite the fact that hepatocytes in the liver 
have been shown to express caveolin 1. Data in this thesis demonstrate that SkHep1 
(SRBI+ CLDN1) cells offer a model cell line for HCV entry studies as they express 
caveolin 1, take up the caveolar cargo cholera toxin B, and can be infected with 
pseudotype virus. Using Dynasore, a small molecule inhibitor of dynamin, we have 
demonstrated that HCV entry shows a marked dependence on dynamin in these 
cells. In addition, using siRNA knockdown of caveolin 1 and adaptor protein 2 
complex (AP2), we have demonstrated a strong dependency on AP2. However, 
knockdown of caveolin 1 had no significant effect on viral entry. 
Recently it has become apparent that the epidermal growth factor receptor (EGFR) 
is required for viral entry into hepatoma cells and that stimulation with EGF results in 
increased entry and infection. We demonstrate that EGF stimulation of hepatoma 
cell lines results in the ruffling and blebbing of the plasma membrane typical of 
macropinocytosis, an increase in the uptake of fluid phase markers and loss of 
EGFR from the cell surface when compared with unstimulated cells. EGF stimulation 
also promoted filopodia formation and elongation, offering another potential 
mechanism for the role of EGFR in HCV entry. However, TIRF microscopy revealed 
that the formation of clathrin-coated pits is also upregulated in response to EGF 
treatment, and a proportion of overexpressed EGFR-GFP relocalises to clathrin 
punctae on the cell surface, suggesting that both pathways could contribute to the 
EGF-induced promotion of viral entry. Knockdown of PAK1 and AP2 has been 
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achieved and will allow for the contribution of each pathway to this effect to be 
determined in future work. 
Localisation and trafficking of EGFR and the HCV co-receptor CD81 were assayed 
by live-cell confocal microscopy, revealing that internalisation and degradation of 
both receptors was promoted by EGF stimulation. Furthermore, the two proteins 
colocalise on the cell surface at early timepoints following EGF stimulation, 
suggesting that they internalise together. This is the first evidence of an association 
between CD81 and EGFR on the cell surface. Super-resolution imaging of CD81 by 
structured illumination microscopy (SIM) showed fewer clusters of CD81 in the 
plasma membrane after EGF stimulation, corroborating the rapid internalisation and 
degradation of the CD81 in response to EGF treatment.  
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1.1 Hepatitis C virus (HCV) 
 
1.1.1 Historical and clinical perspectives 
HCV is a hepatotropic virus associated with chronic liver disease, fibrosis, cirrhosis 
and hepatocellular carcinoma (HCC). HCV has a narrow host range, infecting only 
humans and chimpanzees (Kolykhalov et al 1997, Yanagi et al 1997). Although 
primarily leading to liver disease, hepatitis C has been shown to affect several other 
areas of the body, including the digestive tract, the immune system and the brain 
(Lauer and Walker 2001). Recent evidence suggests the virus is able to infect B-
lymphocytes, dendritic cells and endothelial cells (Fletcher et al 2012). 
It is estimated that around 180 million individuals are infected worldwide (WHO 
epidemiological record 2009), making the virus a global health concern. The 
prevalence varies widely from country to country, and is highest in South America, 
Africa and Asia (Shepard et al 2006, WHO epidemiological record 2009). HCV 
infection remains the leading cause of liver transplant in the USA and Europe (Adam 
et al 2003, Wiesner et al 2003). 
HCV was first discovered in the 1975, when it became clear that a virus other than 
Hepatitis A and B was causing liver disease (Feinstone et al 1975). This aetiological 
agent became known as non-A non-B hepatitis (NANBH), but was not identified for 
over a decade later due to its inability to propagate efficiently in cell culture. Hepatitis 
C virus was identified as the aetiological agent of NANBH in 1989 (Choo et al 1989, 
Kuo et al 1989) and was first viewed by electron microscopy in 1995 (Li et al 1995). 
This makes HCV a relatively newly identified virus and thus many aspects of 
infection and the viral life cycle are still poorly understood.  
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The virus is blood-borne and as such is transmitted from person to person by the use 
of unscreened blood products (the primary route of transmission in the developing 
world), the sharing of needles between intravenous drug users (the primary route of 
transmission in developed countries), sexual exposure and vertical transmission 
from mother to child. There are seven genetically heterogeneous major genotypes of 
HCV (differing by around 35% in their nucleotide sequence), numbered 1-7, which 
predominate in different areas of the world (Kuiken et al 2009).  
HCV infection is typically initially asymptomatic, with around 85% of cases failing to 
clear the virus without clinical intervention (Rustgi 2007, WHO epidemiological 
record 2009). Persistent infection frequently leads to chronic hepatitis which can 
result in fibrosis, cirrhosis and HCC. Liver inflammation in response to infection is 
thought to be the leading cause of HCV-induced liver damage, however, there is 
evidence that some viral proteins additionally contribute directly to the oncogenic 
transformation of hepatocytes (Koike et al 2007).  
The standard therapy regime for HCV has traditionally consisted of the non-specific 
antivirals, PEGylated interferon-α and ribavirin taken in combination. This treatment 
has had limited success and is effective in only around 55% of patients (Zeuzem et 
al 2004), depending on viral genotype (around 50% for genotype 1 and 80% for 
genotypes 2 and 3). The current standard of care for genotype 1-infected patients 
comprises the new protease inhibitors Telaprevir and Boceprevir (Kiser et al 2012). 
There is currently no vaccine or preventative treatment for HCV.  
A better understanding of key steps in the viral life cycle would help to identify better 
antiviral targets and aid in the development of potential treatments for HCV. 
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1.1.2 The HCV virion  
Hepatitis C virus (HCV) is an enveloped, single-stranded RNA virus of the flaviviridae 
family (Choo et al 1989). The HCV particle comprises a single stranded positive-
sense RNA, which is surrounded by a capsid (formed from the core protein) and an 
envelope that is derived from the host cell lipid bilayer and contains the viral 
glycoproteins E1 and E2 (Bartosch and Cosset  2006), shown in Figure 1.1. HCV 
virions are 50-60 nm in diameter (Li et al 1995).  
 
 
 
 
The HCV genome encodes a large polyprotein of around 3000 amino acid residues 
in length. Following translation, the polyprotein is processed by both viral and host 
cell proteases to generate the viral structural and non-structural proteins as well as a 
small ion channel, p7. Although p7 is not involved in viral replication, it is required for 
Figure 1.1: The HCV virion. The HCV virion consists of a single-
stranded RNA genome of positive polarity (+ssRNA) surrounded 
by an icosahedral capsid and viral envelope from which protrude 
the viral glycoproteins E1 and E2. 
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the production of infectious HCV particles, which suggests that it may be involved in 
the assembly or release of nascent virions (Sakai et al 2004, Jones et al 2007, 
Steinman et al 2007). 
Three N-terminal structural proteins (Core, E1 and E2) are generated. Core makes 
up the viral capsid and E1 and E2 are envelope glycoproteins which play critical 
roles in receptor binding and membrane fusion (Keck et al 2004, Op De Beeck et al 
2004, Helle et al 2008). The six C-terminal non-structural proteins generated are 
known as NS2, NS3, NS4A, NS4B, NS5A and NS5B. NS3-5B make up the viral 
replication complex and were shown to be required and sufficient for viral RNA 
replication (Bartenschlager et al 2000, Bartenschlager et al 2003).  
 
1.1.3  The viral life cycle 
HCV particles circulate in the blood along with very low- and/or low-density 
lipoproteins (VLDLs and LDLs) which are carriers of cholesterol and trigylcerides 
(Andre et al 2002, Nielsen et al 2008). The first step in the viral life cycle is 
attachment to the hepatocyte cell surface. This is thought to be mediated by 
attachment molecules such as the glycosaminoglycan heparin sulphate and the low 
density lipoprotein receptor (LDLR) (Barth et al 2003, Koutsoudakis et al 2006, 
Agnello et al 1999, Monazahian et al 1999, Wunschmann et al 2000, Molina et al 
2007).  
Following attachment, HCV is brought into contact with multiple host cell co-
receptors (which will be discussed in more detail in section 1.4) via the envelope 
glycoproteins E1 and E2, followed by endocytosis of viral particles in a receptor-
mediated manner (Blanchard et al 2006). Following endocytosis, it is thought that 
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endosomal acidification results in fusion of the viral and endosomal membranes, 
uncoating and release of viral RNA (Tscherne et al 2006, Lavillette et al 2006, 
Sharma et al 2011). 
 
 
 
 
 
 
 
 
 
The single strand of viral RNA enclosed within the nucleocapsid acts as both mRNA 
for translation and as a template for RNA replication, as shown in Figure 1.2. Once 
translated, the non-structural proteins induce membrane alterations known as 
‘membranous webs’ and form a membrane-bound replication complex. .  The 
polyprotein containing the structural proteins is cleaved by host cell signal 
peptidases. New viral particles are then assembled from the matured structural 
Figure 1.2: The HCV life cycle. Following attachment, virus particles interact with 
host cell receptors, resulting in endocytosis and cellular entry. Uncoating and 
release of the viral RNA results in translation of the viral polyprotein and RNA 
replication to produce new virions. The polyprotein is processed by both viral and 
cellular proteins and new virions are assembled on the endoplasmic reticulum and 
lipid droplets before release. 
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proteins, and are released from the cell via the host cell secretory pathway (reviewed 
in Ashfaq et al 2011).. Assembly of nascent viral particles is thought to take place 
within the endoplasmic reticulum and on lipid droplets (Miyanari et al 2007), although 
the exact mechanism of viral egress is not well understood. The key steps in the viral 
life-cycle are shown schematically in Figure 1.2.          
 
1.1.4 HCV in cell culture 
Identification of HCV as the causative agent of non-A non-B hepatitis was severely 
impaired by the inability of the virus to propagate in cell culture. The HCV 
pseudoparticle (HCVpp) system was first reported in 2003 and this has enabled the 
study of critical steps in the viral entry process, including binding, attachment and 
internalisation (Bartosch et al 2003, 
Bartosch et al 2009). HCVpp can 
be assembled by displaying 
functional HCV E1/E2 
heterodimers on retroviral and 
lentiviral particles, as shown in 
Figure 1.3. A reporter gene, for 
example, encoding green 
fluorescent protein (GFP) or 
luciferase allows the detection of 
infected cells. HCVpp are an 
ideal system for studying viral 
Figure 1.3: HCV pseudoparticles (HCVpp). 
HCVpp are generated by displaying HCV 
glycoproteins E1 and E2 on retroviral core particles, 
which include a reporter gene, allowing infected 
cells to be detected. 
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entry in isolation from other aspects of the viral life cycle. This system has enabled 
the identification of several HCV co-receptors and entry factors such as Claudin1 
and Occludin (Evans et al 2007, Bartosch et al 2009). 
Additionally, in 2005, three independent groups reported the production of authentic 
HCV particles in cell culture, known as HCVcc (Lindenbach et al 2005, Wakita et al 
2005, Zhong et al 2005). These reports were based on a genotype 2a isolated JFH1, 
that was obtained from a patient in Japan with fulminant hepatitis. HCVcc has 
enabled the study of the entire HCV life cycle in vitro. JFH1 infection of human 
hepatoma cells resulted in release of progeny virus particles which are capable of 
infecting naïve cells and are also infectious in chimpanzees and in a humanized 
mouse model system (Lindenbach et al 2006). Following this, infectious genotype 1a 
particles have also been generated (Yi et al 2006). 
 
1.2 Endocytosis and intracellular trafficking 
 
1.2.1 Endocytosis  
Cellular membranes compartmentalise cellular processes and provide an important 
barrier to extracellular pathogens such as viruses. The plasma membrane is the 
surface through which the cell communicates with the extracellular environment, and 
for this communication to function optimally, the contents of the membrane must be 
tightly regulated. Endocytosis is involved in regulating the contents of the plasma 
membrane by internalising membrane lipids and integral membrane proteins along 
with bound ligands.  
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Endocytosis plays a key role in a variety of apparently disparate cellular processes, 
including mitosis (Tacheva-Grigorova et al 2013), antigen presentation (Burgdorf and 
Kurts 2008) and cell migration (Fletcher and Rappoport 2009), as well as the 
regulation of intracellular signalling pathways (Wiedłocha and Sørensen 2004). 
Importantly, many pathogens including numerous viruses have been shown to 
exploit endogenous host cell endocytic pathways to enter the cell (reviewed in 
Thorley et al 2010). 
 
 
 
 
 
Endocytosis 
Phagocytosis Macropinocytosis Micropinocytosis 
Clathrin-Mediated 
Endocytosis 
Caveolar Endocytosis 
Clathrin- and caveolin-
independent pathways 
Figure 1.4: Endocytic Pathways. Internalisation pathways covered under 
the term ‘endocytosis’ include phagocytosis, macropinocytosis and the 
receptor-mediated pathways. Micropinocytic pathways include the well-
studied clathrin-mediated route and caveolar endocytosis, as well as 
clathrin- and caveolin-independent pathways. 
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The term ‘endocytosis’ encompasses a variety of pathways (outlined in Figure 1.4) 
including macropinocytosis, phagocytosis and micropinocytosis. Macropinocytosis is 
often termed ‘cell drinking’, and generally refers to non-specific uptake of 
extracellular fluid, although there is some evidence that the pathway is more specific 
and tightly regulated than generally assumed (Schmees et al 2012). Phagocytosis is 
often termed ‘cell eating’ and involves the engulfing of solid particles by specialised 
phagocytic cells.  
Micropinocytosis involves formation of small (50-150 nm) diameter vesicles usually 
containing extracellular ligands bound to their cognate cellular receptors, and 
encompasses the well-described clathrin-mediated pathway, the caveolar pathway 
and more recently described pathways acting independently of both clathrin and 
caveolin 1 (Sandvig et al 2011). Micropinocytic pathways are generally considered 
the most important when studying viral entry, as viruses often form specific 
interactions with host cell receptors, mimicking extracellular ligands and often 
inducing their own endocytosis as a result (Grove and Marsh 2011).  
 
1.2.1.1 Clathrin-mediated endocytosis 
Clathrin mediated endocytosis is the most well studied endocytic pathway, and the 
mechanisms by which endocytic cargo is recruited into clathrin-coated pits as well as 
those by which clathrin-coated vesicles are formed are comparatively well 
understood (McMahon and Boucrot et al 2011). During clathrin-mediated 
endocytosis, adaptor and accessory proteins help to package transmembrane 
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receptors and their bound 
ligands into clathrin-coated 
vesicles. In addition to 
endocytosis, clathrin-coated 
vesicles also function in other 
intracellular trafficking 
process, which is mediated by 
different adaptor proteins. 
These adaptor and accessory 
proteins mediate the formation 
of a curved clathrin lattice at 
the site of the membrane to 
be internalised, leading to the 
stabilised deformation of the 
membrane (reviewed in 
Doherty and McMahon 2009). 
During clathrin-mediated endocytosis, the clathrin lattice is linked to PI(4,5)P2 in the 
plasma membrane by the adaptor protein 2 complex (AP2) and accessory proteins 
including Epsins and Eps15 (epidermal growth factor receptor phosphorylation 
substrate 15) (Smythe et al 1992, Chang et al 1993). The Epsin family of proteins 
also help to drive membrane deformation through the insertion of an amphipathic 
helix into the plasma membrane (Ford et al 2002). Eps15 acts as a scaffolding 
protein, helping to cluster AP2 complexes (Schmid et al 2006). In order for 
vesiculation of the membrane to be completed, the large GTPase dynamin forms a 
helical polymer around the vesicle neck, mediating vesicle fission upon GTP 
Plasma membrane
AP2 (adaptor protein 
complex)
Clathrin
Dynamin
Figure (ii): Clathrin-Mediated Endocytosis. A 
clathrin lattice is formed on the internal side of the 
plasma membrane, linked to membrane 
phospholipids by adaptor protein 2 complex (AP2) 
and accessory proteins. Budding of the vesicle from 
the membrane is mediated by the large GTPase
dynamin.
Figure 1.5: Clathrin-mediated endocytosis. A 
clathrin lattice is formed on the internal side of the 
plasma membrane, linked to membrane 
phospholipids via the adaptor protein 2 (AP2) 
complex and accessory proteins. Budding of the 
vesicle is mediated by the large GTPase dynamin. 
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hydrolysis (Hinshaw and Schmid 1995). The proteins involved in clathrin-mediated 
endocytosis are depicted in Figure 1.5.  Following uncoating, the nascent vesicle 
then undergoes intracellular trafficking through the endosomal system (described in 
section 1.2.2.1).  
Many of the proteins involved in the formation of clathrin-coated pits and vesicles 
have been identified, allowing researchers to make use of both specific markers and 
specific inhibitors of the pathway. Transferrin (Tf) is internalised exclusively and 
constitutively via the clathrin-mediated pathway and as such, fluorescent-labelled Tf 
is often used as a marker for this pathway in cells. Specific means of inhibiting 
clathrin-mediated endocytosis include dominant negative constructs such as EH29-
GFP, a GFP-tagged trans-dominant mutant of Eps15 (Benmerah et al 1999). Small 
interfering RNAs (siRNA) targeting clathrin heavy chain or components of the AP2 
complex such as α-adaptin are also commercially available, although both proteins 
are very stable and multiple rounds of transfection are generally required to deplete 
the cell of these proteins. Knockdown of AP2 components is preferable, as this 
complex is only involved in clathrin-mediated endocytosis, whereas clathrin is known 
to play a role in other membrane trafficking events (Hinners and Tooze 2003). Less 
specific chemical inhibitors of clathrin-mediated endocytosis such as the cationic 
amphipathic drug chlorpromazine (CPZ) are also frequently used throughout the 
literature (Wang et al 1993); however, pharmacological inhibitors are known to 
exhibit off-target effects and should be used with careful controls and/or in 
conjunction with more specific inhibitory strategies. 
While traditionally, clathrin-mediated endocytosis is thought to rely on the adaptor 
protein 2 complex (AP2) and accessory proteins such as Eps15, which link the 
clathrin lattice to the plasma membrane/receptor cytosolic tails and cause coated pit 
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formation, there is some, albeit, limited evidence for clathrin-mediated pathways 
which can act independently of AP2 and Eps15. For example, two studies have  
demonstrated a clathrin-mediated but AP2-independent EGFR uptake pathway in 
HeLa cells (Motley et al 2003, Hinrichsen et al 2003) and mouse hepatitis virus has 
also been shown to be dependent on clathrin but not on Eps15 for its entry into cells 
(Pu and Zhang 2008). It is thought that these clathrin-mediated pathways rely on 
other adaptor and accessory proteins, but it is unclear which proteins are involved 
and how this pathway differs from the canonical clathrin-mediated endocytic 
pathway.  
 
1.2.1.2 Clathrin-independent endocytosis 
Although clathrin-mediated endocytosis is an extremely important ubiquitous 
endocytic pathway and accounts for a significant proportion of endocytic events, 
there are an ever increasing number of molecules and receptors shown to undergo 
endocytosis independently of clathrin and its accessory proteins (Kirkham et al 2005, 
Kirkham and Parton 2005, Mayor and Pagano 2007). These clathrin-independent 
mechanisms can be divided into distinct endocytic pathways on the basis of their 
reliance on different proteins, their sensitivity to inhibitory drugs and their ability to 
internalise different ligand markers. Clathrin-independent endocytic pathways include 
caveolar endocytosis (Pelkmans and Helenius 2002), flotillin-dependent endocytosis 
(Glebov et al 2006, Frick et al 2007) and Arf6-dependent endocytosis (D'Souza-
Schorey and Chavrier 2006).   
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1.2.1.2.1 Caveolar endocytosis 
Caveolar endocytosis is the 
most well-described clathrin-
independent pathway and 
involves areas of the 
membrane which are 
enriched in cholesterol and 
glycosphingolipids, known as 
lipid rafts. Caveolin proteins 
insert into the lipid rafts 
stabilising them in the 
membrane (Phuong et al 
2001). There are three 
mammalian caveolin proteins, 
caveolins -1, -2, and -3. 
Caveolin 3 is muscle specific, 
while caveolins -1 and -2 are 
found widely in non-muscle cells. Caveolin 1 is enriched in caveolae and cells which 
do not express this protein are devoid of caveolae even in the presence of caveolin 2 
(Li et al 1996). Overexpression of caveolin 1 in caveolin 1-deficient cells leads to 
formation of morphologically evident caveolae, suggesting that caveolin 1 is both 
necessary and sufficient for caveolae formation (Rothberg et al 1992, Li et al 1996, 
Lipardi et al 1998, Pelkmans and Zerial 2005). However, more recently there is 
evidence that adaptor proteins known as cavins are also involved in caveolar 
endocytosis (Liu and Pilch 2008, Aboulaich et al 2004, Liu et al 2008). These 
Caveolin-1
Plasma membrane
Lipid raf t
Figure (iii): Caveolar Endocytosis. Caveolae 
involve lipid rafts enriched in cholesterol and 
glycosphingolipids. Caveolin1 is both 
necessary and sufficient for caveolar 
endocytosis and inserts into the lipid raft with 
intracellular N- and C- termini.
Figure 1.6: Caveolar Endocytosis. Caveolae involve 
lipid rafts enriched in cholesterol and 
glycosphingolipids. The protein caveolin1 inserts into 
the lipid raft with intracellular N- and C-termini. 
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proteins are thought to be involved in regulation of caveolae and promote membrane 
remodelling as well as exercising their own activity independently of caveolae. As 
such, the relationship between caveolins and cavins is complex and remains poorly 
understood. The importance of cavins in caveolar endocytosis and whether they are 
essential to caveolae function is yet to be fully elucidated.  
Phosphorylation of tyrosine14 of caveolin 1 is critical for caveolar endocytosis and is 
thought to lead to the vesiculation of caveolae (Orlichenko et al 2005). Budding of 
caveolae from the plasma membrane is believed to be mediated by the large 
GTPase dynamin (Henley et al 1998, Oh et al 1998), although some evidence 
suggests that caveolae are able to bud in the absence of dynamin (Liu et al 2008). A 
schematic of caveolar endocytosis is shown in Figure 1.6. 
 Ligands such as cholera toxin B subunit (CTB) (Orlandi and Fishman 1998, Wolf et 
al 1998) and Simian Virus 40 (SV40) (Pelkmans et al 2001, Pelkmans et al 2002) 
have been described to enter cells via caveolar endocytosis and as such, 
fluorescent- labelled CTB and SV40 are frequently experimentally used as markers 
for the pathway. Inhibitors of the caveolar pathway include drugs such as nystatin, 
fillipin, methyl- beta cyclodextrin, and indomethacin, all of which complex membrane 
cholesterol, leading to changes in the membrane composition, and subsequent 
flattening of caveolae (Lajoie and Nabi 2010). However, extraction of membrane 
cholesterol can also inhibit other forms of endocytosis (Rodal et al 1999), and both 
CTB (Torgersen et al 2001) and SV40 (Damm et al 2005) have been shown to enter 
cells independently of caveolae in some circumstances.  As the involvement of a 
specific set of proteins in caveolar endocytosis is less clear cut, inhibition or 
knockdown of caveolin 1 is currently the most dependable means of inhibiting the 
pathway without eliciting undesired off-target effects. Therefore, the most specific 
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mechanisms of inhibition include overexpression of dominant negative caveolin 1 
constructs such as Cav1Y14F-GFP (Orlichenko et al 2005), and siRNA targeted 
against caveolin 1 (Sottile and Chandler 2004, Moriyama et al 2007). 
While the clathrin-mediated pathway is ubiquitous, caveolae have only been 
demonstrated in a limited number of cell types (Parton and Simons 2007). Most 
notably, neurons and leukocytes do not have caveolae. Nevertheless, caveolar entry 
pathways have been described for a selected number of viruses including SV40 and 
human coronavirus 229E (Anderson et al 1996, Nomura at al 2004, Kawase et al 
2009), highlighting the physiological importance of the pathway.  Finally, while some 
integral membrane proteins such as certain integrins have been shown to undergo 
caveolar endocytosis (Caswell and Norman 2006), to date no endogenous receptor-
ligand complexes have been shown to enter cells via this pathway. 
 
1.2.1.3 Macropinocytosis 
Macropinocytosis is an archaic form of endocytic pathway by which cells are able to 
indiscriminately internalise large volumes of extracellular fluid into endocytic 
vacuoles known as macropinosomes.  Macropinosomes were first described by 
Lewis in 1931 (Lewis 1931) as large, heterogeneous organelles of over 2 μm in 
diameter, which form from dynamic extensions of the plasma membrane known as 
ruffles. As such, the process is associated with cell-wide plasma membrane 
reorganisation, which is induced by activation of membrane-associated actin. The 
resulting plasma membrane ruffles can be categorised as planar folds (known as 
lamellipodia), circular ruffles or large plasma membrane extrusions (known as blebs), 
which are shown in Figure 1.7.  As with the micropinocytotic pathways, it is unclear 
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whether these differences represent variations on a theme or distinct processes. It is 
interesting to speculate that this variation results from the different roles of 
macropinocytosis in different cell types and tissues. For example, specialised cell 
types, such as immunological and renal cells may require macropinocytosis for 
degradation, whereas growth-factor stimulated cells may require macropinocytosis 
for the downregulation of signalling and reorganisation of the the plasma membrane 
following the activation of receptor tyrosine kinases.  
 
Figure 1.7: Macropinocytosis. Macropinosomes can be formed by lamellipodial 
extensions, filopodia or membrane blebs folding back and fusing with the plasma 
membrane, resulting in uptake of the extracellular fluid, solutes and substances 
suspended within. 
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During macropinocytosis, the ruffles and blebs that are formed are able to provide 
both the energy and the membrane that are required for the formation of 
macropinosomes. Although most of these ruffles seamlessly rejoin the plasma 
membrane, a few fold back to form fluid-filled cavities that undergo membrane fission 
and form macropinosomes, as shown in Figure 1.7.  
Macropinocytosis is typically stimulated by growth factors, which results in the 
activation of cell-surface receptors, such as receptor tyrosine kinases (Mercer and 
Helenius 2009). The resulting signalling cascade triggers actin polymerisation and 
ruffling of the plasma membrane (Bar-Sagi et al 1986, Ridley et al 1992, Lanzetti et 
al 2004).  
Macropinocytosis has many important physiological roles; for example, 
macrophages and dendritic cells primarily monitor their external environment for 
circulating antigens by constitutively macropinocytosing the extracellular solute 
(Sallusto et al 1995). As these cells are constitutively macropinocytic, they are able 
to internalise up to 100% of their membrane within 30 minutes (Steinman et al 1976). 
Macropinocytosis is also involved in the chemotaxis of neutrophils and macrophages 
(Carpentier et al 1991). In addition to these crucial roles in specialised cell types, 
macropinocytosis is also involved in the downregulation of signalling and 
reorganisation of the plasma membrane in cells that are not constitutively 
macropinocytic (Owen and Evans 1998). This is corroborated by the observation of 
Src family kinases within macropinosomes (Kasahara et al 2007). As large areas of 
the plasma membrane are internalised within macropinosomes, considerable 
reorganisation of the membrane is likely to occur. Moreover, because of the inherent 
dependence on membrane ruffling and lamellipodia formation, macropinocytosis is 
also thought to have a role in cell migration (Swanson and Watts 1995), and 
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consequently in tumour progression and metastasis (Platek et al 2004, Platek et al 
2007).  
As with the micropinocytotic processes, macropinocytosis can be hijacked by 
bacteria and viruses, which are able to induce macropinocytosis independently of 
growth factor activation, resulting in their internalisation within the macropinosome. 
Examples of pathogens that utilise macropinocytosis for cellular entry include 
salmonella and shigella (Alpuche-Aranda et al 1994, Schroeder and Hilbi 2008, 
Francis et al 1993), in addition to ebola Zaire virus (Nanbo et al 2010, Saeed et al 
2010).  
Macropinocytosis is often defined by inhibition with amiloride and its derivative EIPA 
(West et al 1989). These inhibit Na+/H+ exchangers; however, it is unclear how they 
inhibit macropinocytosis (Dowrick et al 1993). As with other pharmacological 
inhibitors, cell-specific effects involving non-macropinocytic endocytic pathways have 
been observed and it is not advisable to rely solely on amiloride inhibition to classify 
a process as macropinocytic (Ivanov 2008). 
Members of the Rho GTPase family (such as Rho, Cdc42 and Rac) (together with 
phosphoinositide 4,5-bisphosphate PI(4,5)P2) initiate the actin polymerisation that is 
required for macropinocytosis, and also activate WASP proteins, which coordinate 
the assembly of the Arp2/3 complex on actin filaments. Ruffles and blebs are 
enriched in proteins that are involved in actin polymerisation, such as WAVE and the 
Arp2/3 complex (Lavoie et al 1993, Bretscher et al 1997, Holt and Koffer 2001, 
Buccione et al 2004, Charras et al 2006, Takenawa et al 2007) and the process is 
thought to be highly actin-dependent. 
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In addition, p21-activated kinases (PAKs) have been shown to be directly involved in 
macropinocytosis; for example, PAK1 associates with both membrane ruffles and 
macropinosomes in fibroblasts (Kerr et al 2009). PAK1 is activated by Rac1 and 
Cdc42 and regulates cytoskeleton dynamics as well as CtBP1/BARS, which is 
required for macropinosomes closure. As such, PAK1 is required throughout 
macropinocytosis, from macropinosome formation to closure (Dharmawardhane et al 
2000, Parrini et al 2005, Liberali et al 2008, Bar-Sagi et al 1987, Galisteo et al 1996, 
Puto et al 2003, Liberali et al 2008). is required for scission of macropinosomes (). 
The role that PAK1 plays in various stages of macropinocytosis is summarised in 
Figure 1.8.  
Protein kinase C (PKC) is also involved in macropinocytosis. Following activation by 
receptor tyrosine kinases or PI3K, PKC associates with the plasma membrane, 
where it plays a role in the formation of macropinosomes (Miyata et al 1989, Amyere 
et al 2000). Phorbol esters (e.g. PMA), which are able to activate PKC, can induce 
macropinocytosis in the absence of growth factors (Keller et al 1990, Ridley et al 
1992).  
In addition to these factors, c-src, which is a non-receptor tyrosine src-family kinase, 
has also been implicated in macropinocytosis (Kasahara et al 2007), in which it is 
thought to enhance the activity of the activated receptor tyrosine kinases (Sandilands 
et al 2004, Donepudi et al 2008), as well as activating Arp2/3 and PI3K (Amyere et al 
2000).  
Different factors are required for the closure of macropinosomes than those that are 
involved in macropinosome formation; these factors include myosins and GTPases 
(Sun et al 2003). Dynamin seems to be required in some cases, and inhibition of 
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dynamin prevents Rac1 from localising to ruffles (Schlunck et al 2004, Liu et al 
2008). Bleb closure in particular is thought to be dynamin-independent, although the 
exact mechanism remains unlear (Mercer and Helenius 2008). 
 
 
Although it is traditionally thought that membrane proteins are internalised by 
macropinocytosis as a result of bulk plasma membrane uptake, there is some 
evidence of a sorting function in macropinocytosis. This is consistent with the fact 
that the process is often stimulated by growth factor stimulation and supported by the 
fact that simultaneous stimulation with platelet-derived growth factor (PDGF) and 
EGF results in macropinocytosis of EGFR in fibroblasts, whereas stimulation with 
Figure 1.8: Growth factor receptor signalling regulates macropinocytosis. 
Activation of receptor tyrosine kinases results in activation of Rac1, a protein involved 
in actin modulation. In turn PAK1 is activated and downstream signalling results in 
actin modulation and macropinosome closure. 
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either ligand alone does not (Schmees et al 2012). This suggests that activated 
receptor tyrosine kinases are selectively sorted into macropinosomes, rather than 
simply being internalised as a result of uniform membrane uptake.  
  
1.2.3 Intracellular trafficking 
 
1.2.3.1 The endosomal pathway 
The endosomal pathway involves trafficking of internalised endocytic vesicles, either 
through compartments of increasing acidity (early and late endosomes), resulting in 
degradation by the lysosome or recycling back to the plasma membrane. Many 
viruses are able to uncoat and fuse with the endosomal membrane under the acidic 
conditions of early and late endosomes, releasing their genetic material and 
escaping lysosomal degradation (Gruenberg and Van der Goot 2006, Kӧrner et al 
2006).  
There are three different types of endocytic compartments: early endosomes, late 
endosomes and recycling endosomes (Mellman 1996). Early endosomes provide an 
environment for the sorting of internalised endocytic cargo before it ultimately 
reaches the degradative lysosome or is recycled back to the cell surface, and are 
therefore often referred to as sorting endosomes (Jovic et al 2010) . The different 
endocytic compartments are distinguished by markers such as Rab proteins, which 
regulate vesicle formation, vesicle movement along microtubules and membrane 
fusion (Stenmark and Olkkhonen 2001). Once vesicles have uncoated following 
endocytosis, they fuse with early endosomes, which mature into late endosomes in a 
Rab5-dependent process (Huotari and Helenius 2011). Activity of the vacuolar 
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membrane proton pump, v-ATPase (vacuolar ATPase), leads to increased acidity 
and maturation of the endosome (Kane 2006, Forgac 2007). Early endosomes 
increase in size during maturation due to homotypic fusion with other early 
endosomes. Molecules within endosomes may become sorted into smaller vesicles 
that bud into the endosomal lumen, resulting in a multi-vesicular appearance which 
has led to late endosomes often being called multivesicular bodies (MVBs).  
 
 
 
Finally, early endosomes lose Rab5 and gain Rab7, allowing them to fuse with 
lysosomes as shown in Figure 1.9. Some pathogens can subvert the endosomal 
maturation process, for example, by preventing acquisition of Rab7 by the late 
Endocytosis
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Figure 1.9: The endosomal system. Internalised endocytic vesicles fuse with the 
early endosome where their contents may recycle back to the plasma membrane in 
Rab4 and Rab11- dependent processes, or traffic through compartments of 
increasing acidity to the lysosome for degradation. 
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endosome, allowing escape from lysosomal degradation (Kӧrner et al 2006, 
Gruenberg and Van der Goot 2006).  
Phagosomes and macropinosomes are thought to mature in a similar manner and 
often fuse with compartments of the endosomal system (Racoosin and Swanson 
1993).  Thus, it can be difficult to clearly delineate all aspects of phagosome, 
macropinosome and endosomal trafficking.  
 
1.2.3.2 Maturation and trafficking of macropinosomes 
 Internalised macropinosomes have been shown to mature in a similar manner to 
endosomes, undergoing acidification and fusion with endosomal compartments 
(West et al 1989, Hewlett et al 1994). Macropinosomes have been shown to rapidly 
acquire the endosomal marker Rab7 before ultimately fusing with the lysosomal 
compartment (Racoosin and Swanson 1993, Kerr et al 2006, Lim et al 2008), 
indicating that macropinosomes traffic down the endosomal pathway towards 
lysosomal degradation, with their cargo meeting a similar fate to that internalised by 
micropinocytosis. However exchange of constituents with the endolysosomal system 
and lack of molecular markers have hampered the definitive molecular dissection of 
macropinosome maturation. Transferrin receptor, which typically traffics to the early 
endosome, has been shown to be lost from macropinosomes as they mature; this 
suggests that sorting of cargo occurs during macropinosome trafficking (Racoosin 
and Swanson 1993).  
Furthermore, the ultimate fate of the macropinosome seems to be cell-type 
dependent. In macrophages and kidney cells, macropinosomes are thought to fuse 
with the endolysosomal system (Racoosin and Swanson et al 1993); however, 
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macropinosomes in human A431 and NIH-3t3 cells seem to be independent of 
endosomal trafficking and ultimately fuse back with the plasma membrane (Hewlett 
et al 1994, Schnatwinkel et al 2004), although they do gain some early endosomal 
markers for fusion with other macropinosomes (Roberts et al 2000, Hamasaki et al 
2004). Thus, there is no real consensus on the trafficking pathway that is followed by 
internalised macropinosomes, and the process seems to be remarkably cell-type-
and context-dependent.  
 
1.3 Viral Entry 
Viruses are obligate intracellular pathogens and entry into the host cell is a critical 
step in the viral life cycle. Cellular membranes present a barrier between the viral 
particle and intracellular site(s) of replication in the cytosol or nucleus. Viral entry 
mechanisms thus present a good therapeutic target, and several viral entry inhibitors 
have been successfully developed or are undergoing clinical trials, most notably 
inhibitors of HIV-1 entry (Lalezari et al 2003, Lin et al 2003, Guo et al 2003, Kuritzkes 
et al 2004, Hicks et al 2005, Clotet et al 2007) and Influenza virus A entry (Voss et al 
2008, Song et al 2009, Yamaya et al 2010).  
Viruses have a proteinaceous capsid that encapsulates their genetic material; in 
enveloped viruses, this is surrounded by a lipid bilayer.  Both enveloped viruses and 
non-enveloped viruses have evolved complex and often poorly defined mechanisms 
to enter cells.  Identification of host cell receptors and their trafficking pathways 
provide tools to study viral entry. Although this generally involves the endocytic 
processes of the host cell, the exact entry mechanisms of many medically important 
viruses, including HCV, have yet to be fully elucidated.  
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The entry of both enveloped and non-enveloped viral particles requires specific 
interactions between host cell molecules, or receptors, and virus-encoded envelope 
or capsid proteins. One key result of this is to bring the virus into close contact with 
the plasma membrane and in some documented cases, to initiate a cascade of 
signalling events important to the viral life cycle (Dangoria et al 1996).  In addition to 
primary receptors critical for virus attachment to the cell surface (e.g. CD4 for HIV), 
important co-receptors have been identified (e.g. chemokine receptors CXCR4 or 
CCR5 for HIV).  It is now becoming apparent that a wide variety of host cell 
molecules are important for virus internalisation in the absence of any direct 
association with the virus particle.  This has led to the notion of “entry factors”, for 
example the tight junction protein occludin appears to play an indirect role in 
Coxsackie B group virus entry (Bergelson et al 1997, Patel et al 2009), while both 
claudin-1 and occludin appear to play an indirect role in HCV entry (Benedictio et al 
2009, Ploss et al 2009).   
Following attachment to the host cell surface, direct virus entry at the plasma 
membrane has been described for many viruses such as HIV and polio virus (Stein 
et al 1987, Dunnebacke et al 1969). Some enveloped viruses can fuse with the 
plasma membrane, releasing the capsid directly into the cytosol. However, in 
contrast to fusion at the plasma membrane, many viruses (such as SV40 and 
Influenza A) utilise intracellular trafficking pathways and fuse with internal 
membranes to release their genomic material into the cytosol (Anderson et al 1996, 
Lakadamyali et al 2004).  
Host cells offer a variety of internalisation mechanisms for virus entry, as described 
in Section 1.2. Receptor trafficking pathways often define particle internalisation 
routes and viruses typically infect the cell by a single defined pathway, although 
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examples have been reported where viruses utilise multiple pathways in diverse cell 
types (Meier et al 2002, Damm et al 2005, Patel et al 2009). It is clear that viral entry 
is not a simple process and that a more complete understanding of cellular endocytic 
pathways will provide us with a better perspective regarding viral entry mechanisms. 
Moreover, the study of viral entry has historically, and continues to be, key to our 
understanding of endocytosis and trafficking pathways within the host cell, for 
example, the study of SV40 endocytosis has provided much of the current 
knowledge regarding caveolar endocytosis (Anderson et al 1996). 
While classical understanding of viral entry is that a virus will enter via one defined 
pathway determined by receptor binding, recent studies indicate that many viruses 
are capable of utilising more than one entry mechanism to cause infection. It has 
long been thought that productive entry of HIV occurs via direct fusion of the viral 
envelope with the host cell plasma membrane. One key piece of evidence for an 
endocytosis-independent mode of entry is the observation that infection is insensitive 
to neutralisation of endosomal pH (Stein et al 1987). Despite this long-standing 
belief, studies employing EM have shown internalised virions in membrane-bound 
vesicles (Grewe et al 1990). Whilst the clathrin-mediated entry pathway for HIV has 
been documented for almost as long as the classical plasma membrane entry 
mechanism, it has only recently been confirmed that this route may offer a 
productive entry pathway for infectious viral particles (Daecke et al 2005).  
In addition, SV40, the first virus to be described to enter via the caveolar pathway 
(Pelkmans et al 2001, Pelkmans et al 2002) has recently been shown enter cells 
lacking detectable caveolae, suggesting that it is capable of entering the cell via 
alternative pathways (Damm et al 2005). SV40 entry via a caveolin-independent 
pathway was also observed in wild-type embryonic fibroblasts with an active 
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caveolar pathway (Damm et al 2005). In all of the aforementioned cells, viruses were 
seen to internalise in small, tight-fitting vesicles similar to those seen in the first EM 
images of SV40 infection. The virus was subsequently transported to pH-neutral 
organelles, which resembled “caveosomes” despite being devoid of both caveolin 1 
and caveolin 2 (Damm et al 2005). Furthermore, expression of SV40 T-antigen 
following viral entry in these cells suggested that this pathway supported productive 
infection.  The fact that this entry mechanism was observed in cells with detectable 
caveolin 1 indicates that this alternative pathway is active even in the presence of 
caveolin 1.  This could represent further evidence of host cell endocytic mechanisms 
acting independently of clathrin and caveolin.  
Other examples of viruses which have been shown to enter via more than one 
mechanism include Adenoviruses 2 and 5 (AdV2/5), Coxsackie B group viruses and 
Influenza A. AdV 2/5  have been shown to enter via clathrin-mediated endocytosis 
and then stimulate macropinocytosis leading to increased viral uptake (Meier et al 
2002). Coxsackie B group viruses which have been shown to enter via a mechanism 
dependent on caveolin 1 and some macropinocytic proteins in Caco-2 cells (Coyne 
et al 2007) enter via a clathrin and caveolin- independent mechanism in HeLa cells 
(Patel et al 2009). Moreover, Influenza A virus, which has classically been described 
to enter via clathrin-mediated endocytosis (Yoshimura et al 1982) has also been 
shown to enter cells in the absence of clathrin-mediated endocytosis (Sieczkarski  et 
al 2002). More recently Influenza A has been shown to enter via a caveolar 
mechanism in MDCK cells (Nunes-Correia et al 2004), while yet another paper 
implicates macropinocytosis as an alternative entry mechanism for Influenza A (de 
Vries et al 2011).   
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Indeed, many viruses have evolved mechanisms to manipulate macropinocytosis to 
promote their own internalisation.  Vaccinia virus is thought to enter host cells via a 
mechanism known as ‘apoptotic mimicry’ (Schmidt et al 2011). The viral envelope 
contains phosphatidylserine, which mimics cellular apoptotic material and results in 
internalisation of the virus by macrophages.  
Some viruses can also stimulate macropinocytosis by directly engaging will cellular 
receptors; for example, binding of Coxsackie virus to its receptor OCLN in tight 
junctions induces uptake of the virus by a pathway that resembles macropinocytosis 
(Coyne et al 2007). In addition, inhibiting macropinocytosis reduces HIV infection 
rates, but it is unclear whether the virus induces macropinocytosis or how this effect 
is mediated (Marechal et al 2001, Liu et al 2002).  
Moreover, different endocytic mechanisms may be used by a virus in different cell 
types. For example, although there is some evidence for macropinocytic uptake of 
HIV into endothelial cells and macrophages (Marechal et al 2001, Liu et al 2002), the 
virus is still able to enter and infect cells that are unable to form macropinosomes, 
ostensibly by an alternative endocytic pathway (Vidricaire and Tremblay 2007). For a 
full review of viral entry mechanisms, see Thorley et al 2010. 
HCV is an enveloped virus. Infection with an enveloped virus requires the fusion of 
the viral envelope with a cellular membrane. In some cases, this can occur at the 
plasma membrane, as reported for HIV, where binding to plasma membrane- 
expressed forms of CD4 and chemokine receptors induce changes in the viral 
envelope glycoprotein that are thought to mediate membrane fusion under neutral 
pH conditions. Fusion of other enveloped viruses occurs within the low pH 
environment of an acidic endosomal compartment. Enveloped viruses typically reach 
the endosomal compartment via trafficking in clathrin-coated vesicles, although 
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caveolar routes of entry have been reported for some enveloped viruses, including 
human coronavirus 229E (Nomura et al 2004, Kawase et al 2009). Enveloped 
viruses have also been shown to enter cells via macropinocytosis where fusion is 
also thought to occur within the low pH environment of an endosomal (or analogous) 
compartment. Indeed, AdV2/5 is thought to stimulate macropinocytosis to escape 
from endosomes following a clathrin-mediated entry mechanism, although the 
mechanism by which this occurs remains somewhat unclear (Meier et al 2002). 
 
1.4. HCV Entry 
1.4.1 HCV receptors and viral tropism 
HCV encodes two envelope glycoproteins, E1 and E2, which play a critical role in 
binding host cell surface receptors and membrane fusion (Keck et al 2004, Op De 
Beeck et al 2004, Helle et al 2008). E1 and E2 are heavily glycosylated and form a 
heterodimer. While the conformation of the two glycoproteins is somewhat co- 
dependent, it is thought that E2 is the primary mediator of interactions with host cell 
receptors. Recombinant forms of HCV E2 were used to identify the host cell binding 
partners tetraspanin CD81 (Pileri et al 1998, Bartosch et al 2003a, Cormier et al 
2004, Flint et al 2006) and scavenger receptor B type I (SRBI) (Scarselli et al 2002, 
Grove et al 2007, Cantanese et al 2010), shown in Figure 1.10. The recent 
development of infectious lentiviral pseudoparticles bearing HCV glycoproteins 
(HCVpp) (Bartosch et al 2003b, Hsu et al 2003, Drummer et al 2003), and native 
HCV capable of replication in cell culture (HCVcc) (Lindenbach et al 2005, Wakita et 
al 2005, Zhong et al 2005) have enabled studies validating the role of CD81 and 
SRBI in HCV entry. Following the development of these experimental systems, the 
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tight junction proteins claudin 1 (CLDN1) and occludin (OCLN) were reported to be 
essential for virus internalization (Evans et al 2007, Zheng et al 2007, Yang et al 
2008, Liu et al 2009, Ploss et al 2009). Claudins -6 and -9 have also been shown to 
act as additional co-receptors (Zheng et al 2007).  
HCVpp bearing diverse glycoproteins of all major HCV genotypes show a marked 
preference for infecting liver-derived cells suggesting that receptor-dependent entry 
events may, at least in part, define hepatotropism (Bartosch et al 2003c, McKeating 
et al 2004).  
Hepatocytes in the liver are highly polarised with bile canaliculi surrounded by tight 
junctions running between adjacent cells at the apical membrane, as shown in 
Figure 1.11. HCV enters the liver via the sinusoidal blood and is likely to encounter 
the basolateral surface of hepatocytes, where the co-receptors SRBI, and CD81 as 
well as the entry factor CLDN1 are expressed (Reynolds et al 2008). 
 
 
 
 
EC1 
Figure 1.10: Cellular co-receptors and entry factors for HCV. The tetraspanin CD81, 
scavenger receptor SRBI, and the tight junction proteins claudin 1 (CLDN1) and occludin 
(OCLN). 
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Claudins are tight junction proteins which are able to form homo -and heterodimers 
with each other (Piontek et al 2008) OCLN and CD81 (Harris et al 2010), and the 
formation of the CD81-CLDN1 interaction is essential for HCV entry (Yang et al 
2008, Qiu et al 2008, Cukierman et al 2009, Harris et al 2010, Krieger et al 2010). No 
direct interaction between CLDN1 and the HCV glycoproteins has to date been 
identified, although recent evidence suggests that CLDN1 may serve to potentiate 
the interaction between CD81 and E2 (Krieger et al 2010). While present in tight 
junctions, CLDN1 is also expressed in the basolateral membrane of polarised 
hepatocytes in the liver (Reynolds et al 2008). 
OCLN is a tight junction protein which has been shown to internalise along with 
CLDN1 in caveolae and clathrin-coated vesicles (Matsuda et al 2004, Shen 2008, 
Stamatovic et al 2009). OCLN is necessary to confer entry into non-permissive cell 
Figure 1.11: Hepatocyte polarity. Hepatocytes in the liver exhibit a complex polarity, 
with the basolateral surface exposed to the sinusoidal blood, while the apical 
membranes form bile caniliculi between adjacent cells, bound by tight junctions 
containing CLDN1 and OCLN. 
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lines, and silencing of OCLN reduced infection of permissive Huh7.5 hepatoma cells 
(Ploss et al 2009, Liu et al 2009). OCLN is localised to tight junctions in polarised 
hepatocytes, which has led some to believe that viral entry must occur at tight 
junctions. However, as with CLDN1, there is little evidence for a direct interaction 
between the virus and OCLN.  
More recently, the epidermal growth factor receptor (EGFR) has been identified as 
an entry factor for HCV, using an siRNA screen (Lupberger et al 2011). The authors 
also show that EGF stimulation of hepatoma Huh7.5 and Huh7.5.1 cells promotes 
HCV entry. Exactly how EGFR acts as an entry factor is unclear, but signalling 
downstream of EGFR may be important for HCV endocytosis. Moreover, as EGF 
stimulation results in EGFR internalisation by different pathways under different 
circumstances (Benmerah et al 1999, Huang et al 2004, Sigismund et al 2005, Zhu 
et al 2005, Orlichenko et al 2005, Roepstorff et al 2009), it is interesting to speculate 
that EGF may upregulate trafficking pathway(s) required for HCV entry and infection, 
particularly for the internalisation of HCV co-receptors and entry factors. This will be 
discussed in greater detail in section 1.4.3. 
 
1.4.1.1 CD81 and tetraspanin-enriched microdomains 
The HCV receptor CD81 is a tetraspanin. Tetraspanins are a highly conserved and 
broadly expressed superfamily of transmembrane proteins, which as the name 
suggests, span the lipid bilayer four times (Wright and Tomlinson 1994). They have 
short intracellular C- and N- terminal tails in addition to a small extracellular loop 
(SEL) and a large extracellular loop (LEL), shown in Figure 1.10, which are involved 
in mediating hetero-and homo-typic interactions.  
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There are 33 members of the tetraspanin superfamily expressed in humans and 
members of this protein family tend to form membrane signalling complexes, known 
as tetraspanin-enriched microdomains (TEMs) (Hemler 2005). This is mediated 
through their association with other membrane proteins as well as intracellular 
signalling and cytoskeletal components. Unsurprisingly, tetraspanins are linked to a 
number of physiological functions and pathologies, including diphtheria, malaria, 
cancer and viral infections (Wang et al 2011, Martin et al 2005).  
Specific tetraspanin proteins are associated with specific viruses and appear to be 
involved in multiple stages of viral life cycles, from initial cellular attachment to viral 
budding (Martin et al 2005). As such, the relationship of tetraspanins with viruses is a 
particularly complex one. 
Most tetraspanins possess no intrinsic enzymatic activity or signalling motifs and it is 
thought that they act simply by facilitating the interaction of associated proteins 
within TEMs.  The most studied involvement of a tetraspanin in viral infection is that 
of CD81 in HCV entry. CD81 binds specifically to the E2 glycoprotein of HCV 
through its LEL and was the first HCV receptor to be identified (Pileri et al 1998, 
Bartosch et al 2003a, Cormier et al 2004, Flint et al 2006). E2 binds to cells of 
human origin but not to cell lines derived from other species such as mouse, rat, and 
rabbit (Flint et al 1999, Flint et al 2006). Thus, the interaction appears to be 
dependent on the presence of human (h)CD81 and not to require other molecules in 
human cells, as rat cell lines can bind E2 protein when transfected with hCD81. 
Other human tetraspanins are unable to compensate for the absence of hCD81. 
FRET studies between overexpressed fluorescent co-receptors, revealed that CD81 
and CLDN1 formed complexes within the plasma membrane of hepatoma cells 
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(Harris et al, 2008). When CLDN1 is prevented from interacting with CD81, HCV 
entry is inhibited.  
 
1.4.1.2 The HCV co-receptor complex 
As it is unclear exactly how the co-receptors come together to form a complex, 
whether they all interact with the virus and/or each other, and whether this requires 
translocation of the virus-receptor complex to the tight junctions, several models 
have been proposed to explain the entry mechanism of HCV.  The Coxsackie B virus 
model is predicated on the fact that both viruses require tight junction proteins for 
entry. However, there is limited evidence for the direct association of HCV with the 
tight junction proteins CLDN1 and OCLN, and both CD81 and SRBI are localised 
uniformly on the plasma membrane.  Therefore, the observation that CD81 and SRBI 
localise at basolateral hepatocellular membranes (Reynolds et al 2008) is consistent 
with particle attachment occurring at this site. Moreover, recent data demonstrate a 
role for CD81-Claudin complexes in HCV entry, and these complexes are known to 
form on the basolateral surface (Harris et al 2008, Harris et al 2010).  
Nevertheless, the involvement of tight junction proteins has raised many questions 
about HCV entry. In particular, does the virus need to locate to tight junctions to 
internalise? Current data demonstrate that HCV E2 engagement of CD81 promotes 
clathrin-mediated endocytosis and there is limited evidence to support a role for 
CD81 induced movement of the virus to tight junctions in polarised hepatoma cells 
(Farquhar, personal communication). Additionally, it is thought that the virus enters 
the liver via the sinusoidal blood where it would encounter the basolateral surface of 
hepatocytes. The basolateral entry model suggests the virus enters at the 
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basolateral surface of the hepatocyte, which is accessible by the sinusoidal blood 
and that there is no role for the tight junctions in viral entry. The independence from 
tight junctions is supported by the fact that CD81-CLDN1 complexes, which have 
been shown to be essential for viral entry are entirely absent from the tight junctions 
of polarised hepatocytes (Harris et al 2010). In addition, reduced polarity, promoted 
by the addition of VEGF has been shown to increase infectivity (Mee at al 2010). 
Interestingly, it has been suggested that the filopodia of hepatocytes extend through 
the sinusoidal membrane where they are able to make contact with T-cells, 
potentially mediating initial contact with the virus (Warren et al 2006). In support of 
this idea, HCV has been shown to initially associate with filopodia in Huh7.5 cells 
before being transported towards the cell body for endocytosis (Coller et al 2009). 
Figure 1.12 shows the current model for HCV co-receptor complex formation on the 
basolateral surface of hepatocytes. 
 
 
Figure 1.12: The HCV Co-Receptor Complex. SRBI and CD81 are known to form 
specific interactions with viral glycoproteins. While CLDN1 is not thought to interact with 
the virus directly, its interaction with CD81 is necessary for viral entry. There is no 
known interaction between tight junction protein OCLN and the virus, however OCLN is 
known to be an important entry factor. 
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1.4.2 HCV endocytosis 
Soon after the development of the HCVpp and HCVcc systems, the use of drugs 
such as Bafilomycin A1 and concanamycin A (which inhibit the vacuolar ATPase, 
dissipating membrane proton gradients) demonstrated the pH-dependence of HCV 
entry, implicating the involvement of receptor-mediated endocytosis and fusion in an 
acidic endosomal compartment (Hsu 2003, Blanchard et al 2006, Tscherne et al 
2006). Furthermore, the use of dominant negative constructs of Eps15 and the large 
GTPase dynamin suggested that HCV entry occurs via clathrin-mediated 
endocytosis (Meertens et al 2006). A recent siRNA study confirmed the involvement 
of several genes involved in clathrin-mediated endocytosis and actin polymerisation 
in the viral entry process and used time-lapse imaging to observe viral entry in live 
unpolarized liver-derived cells (Coller et al 2009). The authors demonstrated 
colocalisatiom between labelled HCV and clathrin, suggesting that virions bind to 
filopodia and traffic towards the cell body, where endocytosis occurs.  
While viral internalisation via clathrin-mediated endocytosis has been confirmed 
using chemical inhibitors and clathrin heavy chain siRNA (Blanchard et al 2006, 
Codran et al 2006, Coller et al 2009), alternative entry mechanisms have not been 
considered in any HCV entry studies. In light of recent evidence for several viruses 
utilising more than one internalisation mechanism, it is becoming increasingly 
important that other entry mechanisms for HCV be considered as additional or 
alternative mechanisms in entry studies. 
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1.4.2.1 Caveolae in hepatocytes and hepatoma cell lines 
While several studies have demonstrated that HCV can enter hepatoma cell lines in 
a clathrin-dependent manner, none of these studies has ruled out entry by clathrin-
independent mechanisms. In particular, a potential role for caveolae in HCV infection 
has largely been overlooked due to a long-standing belief that the hepatoma cell 
lines used to study HCV infection do not express caveolin 1 or have functional 
caveolae (Cokakli et al 2009, Tse et al 2012). However, there is evidence both for 
and against the presence of caveolae in hepatoma cell lines throughout the literature 
(Pohl et al 2002, Botos et al 2007, Zhao et al 2009). Among the most convincing 
pieces of evidence for the presence of caveolae in hepatoma cell lines are electron 
micrographs (for example, Figure 1.13) of HepG2 cells, showing what appear to be 
caveolae (Botos et al, 2007). Moreover, several studies have noted the effects of 
inhibitors of caveolar endocytosis or knockdown of caveolin 1 in hepatoma cell lines 
(Pohl et al 2002; Zhao et al 2009). Most notably, Pohl et al demonstrate inhibition of 
[3H]oleic acid uptake when cells were treated with filipin III, cyclodextrin and caveolin 
1 antisense oligonucleotides, all of which are known to inhibit caveolar endocytosis. 
 However, contrary to these findings, studies have failed to detect caveolin 1 
expression in hepatoma cell lines by western blot (Cokakli et al 2009, Qi et al 2010). 
There is mounting evidence for a pathway both morphologically and functionally 
similar to the caveolar pathway acting independently of caveolin 1 (Damm et al 
2005). In the absence of detectable caveolin 1, it is possible that inhibitors of the 
caveolar pathway may be exhibiting their effects on alternative but similar or related 
pathways. If caveolae or related pathways exist in primary hepatocytes in vivo, this 
could represent a potential route for productive infection. 
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Moreover, in order to 
assess the role that all 
endocytic mechanisms play 
in viral entry, cell lines 
which express the 
necessary endocytic 
proteins and that can be 
shown to have active 
clathrin-mediated and 
caveolar uptake pathways should be used in infection studies. This has not been 
done to date.  
 
1.4.3 Tyrosine kinases in viral entry 
Viruses co-opt host cell proteins as their receptors and utilise these to mediate their 
entry into the host cell. Often this is as a result of virus-binding inducing receptor 
complex formation and signalling cascades. Many viral receptors are tyrosine 
kinases, and in many cases, their kinase activity and subsequent downstream 
signalling is required for the viral entry process. For example, the receptor tyrosine 
kinase Axl has been shown to enhance internalisation of ebola Zaire virus via an 
indirect mechanism. The virus does not bind to Axl directly, but the interaction may 
be mediated by Gas6 (an Axl ligand), which has a similar role in the internalisation of 
other viruses (Shimojima et al 2006, Nanbo et al 2010, Saeed et al 2010, Brindley et 
al 2011, Morizono et al 2011).  
Figure 1.13: Electron micrograph of caveolae in HepG2 
cells. Taken from Botos et al 2007, reprinted with permission 
from Springer publishing. 
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Coxsackie virus B (CVB) requires trafficking to tight junctions for entry into host cells 
and uses tyrosine kinase signalling to achieve this. CVB particles initially attach to 
CD55 (also known as decay-accelerating factor (DAF)) on the apical cell surface. 
Virus binding induces clustering of this receptor, leading to the activation of Abl 
kinase and actin reorganisation. . This allows the virus to translocate to tight 
junctions where it finally binds to the coxsackie and adenovirus receptor (CAR) and 
is endocytosed (Cohen et al 2001, Coyne and Bergelson 2006). CD55 binding also 
induces caveolin 1 phosphorylation, promoting internalisation of the virus by caveolar 
endocytosis (Coyne and Bergelson 2006). 
Influenza A virus binds to sialylated receptor tyrosine kinases, such as EGFR and c-
Met, inducing their clustering and promoting tyrosine kinase and PI3K signalling, 
which may be important for viral entry via either clathrin-dependent or –independent 
pathways (Eierhoff et al 2010).   
 
1.4.3.1. The epidermal growth factor receptor (EGFR) in HCV entry 
Recent studies have identified the epidermal growth factor receptor (EGFR) as an 
additional entry factor for HCV, using a functional RNAi kinase screen (Lupberger et 
al. 2011). However, the mechanism by which EGFR promotes viral internalisation is 
not clear.  The receptor tyrosine kinase promotes CD81-CLDN1 complex formation 
via unknown mechanisms, and it is thought that this effect results in increased 
uptake of the virus (Zona et al 2013). Blocking receptor kinase activity was shown to 
inhibit infection by all of the major HCV genotypes and addition of the ligands EGF 
and TGFα significantly stimulated viral entry and infection (Lupberger et al 2011, 
Diao et al 2012). The internalisation of EGFR has been shown to be required for 
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HCV entry (Diao et al 2012). This means that tyrosine kinase inhibitors could 
potentially possess substantial antiviral properties, and RTK inhibitors could be used 
as a new approach to prevent or treat HCV infection. However, the mechanism of 
action of EGFR and the involvement of downstream signalling in HCV entry is still 
poorly understood.  
Additional recent evidence suggests the GTPase HRas, which is activated 
downstream of EGFR signalling, is a key host signal transducer for EGFR-mediated 
HCV entry (Zona et al 2013). HRas was shown to associate with membrane 
microdomains containing CD81 and CLDN1. Additionally, proteomic analysis 
revealed that HRas associates with tetraspanin CD81, CLDN1, as well as integrin β1 
and Ras-related protein Rap2B in hepatic plasma membranes. HRas signalling is 
thought to be required for the lateral diffusion of CD81, promoting the assembly of 
tetraspanin receptor complexes and has also been implicated in the entry of other 
viruses, including influenza A (Zona et al 2013).  
 
1.4.3.2 Signalling and trafficking of the epidermal growth factor receptor 
(EGFR) 
There are four closely related members of the ErbB family of receptor tyrosine 
kinases, known as EGFR (ErbB1; HER1 in humans), ErbB2 (HER2), ErbB3 (HER3) 
and ErbB4 (HER4). EGFR is the prototypical member of the receptor tyrosine kinase 
family and is a transmembrane receptor for several extracellular protein ligands, 
including epidermal growth factor (EGF) (Atalay et al 2003). It is expressed on the 
plasma membrane and is activated by ligand binding, which is followed by 
dimerisation, trans-phosphorylation, clustering, endocytosis and endocytic trafficking, 
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and the initiation of downstream signalling cascades, as shown in Figure 1.14. Once 
in the acidic endosomal lumen, the EGFR-ligand complex dissociates. EGFR can 
then recycle back to the plasma membrane, allowing further rounds of receptor 
activation or traffic to the lysosome for degradation, leading to desensitisation.   
The EGFR-binding ligands include EGF, heparin-binding EGF-like growth factor (HB-
EGF), transforming growth factor-α (TGF-α), amphiregulin (AR), epiregulin (EPR), 
epigen, betacellulin (BTC) and neuregulins 1-4 (NRG1, NRG2, NRG3, NRG4) and 
recent data suggests that different ligands may promote different routes of receptor 
trafficking (Roepstorff et al 2009).  For example, ligands which do not dissociate 
readily from the receptor within the acidic environment of the endosome (such as 
HB-EGF and BC) have been associated with increased receptor degradation over 
receptor recycling (Roepstorff et al 2009)  Furthermore, the concentration of ligand 
applied can affect receptor trafficking: at low EGF concentrations EGFR primarily 
undergoes clathrin-mediated endocytosis (Benmerah et al 1999, Huang et al 2004), 
while at high EGF concentrations EGFR has been reported to undergo clathrin-
independent endocytosis (Sigismund et al 2005, Zhu et al 2005, Orlichenko et al 
2005). 
EGFR undergoes transition upon ligand binding from an inactive monomer to an 
active homo- or hetero-dimer (with another member of the ErbB family of receptor 
tyrosine kinases) (Ferguson et al 2003). This dimerisation stimulates the intrinsic 
tyrosine kinase activity of EGFR, and as such, several tyrosine autophosphorylation 
events occur in the intracellular C-terminal domain of the receptor (Downward et al 
1984). Autophosphorylation then results in downstream signalling through several  
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proteins, which interact with phosphorylated tyrosine residues through their SH2 
domains. Several signal transduction cascades may then be activated, including the 
MAPK pathway, the Akt and JNK pathways (Lynch et al 2004, Oda et al 2005). 
These pathways modulate many important cellular processes such as, cell 
proliferation, cell migration and adhesion (Vermeer et al 2003).  
EGFR is sometimes aberrantly activated by over-expression or mutation. Mutations 
that lead to upregulation of EGFR signalling have been implicated in several 
cancers, including lung cancer (Khazaie et al 1993, Kuan et al 2001, Arteaga 2002). 
As such, small molecule kinase inhibitors such as Erlotinib are often used to treat 
cancer (Raymond et al 2000) and can also be used in laboratory conditions (Moyer 
Figure 1.14: Signalling through the epidermal growth factor receptor (EGFR). 
Upon ligand binding, receptor dimerisation occurs, resulting in autophosphorylation. 
This initiates signalling cascades leading to cell proliferation, migration and invasion. 
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et al 1997, Wood et al 2004, Huether et al 2005) to inhibit the kinase activity, and 
thus the downstream signalling of EGFR. 
 
1.5 Imaging receptor trafficking 
 
1.5.1 Fluorescence microscopy  
The British scientist Sir George G. Stokes first described the phenomenon of 
fluorescence in 1852 when he observed the mineral fluorspar emitting red light when 
illuminated by ultraviolet (UV) light.  Stokes noted that fluorescence emission always 
occurred at longer wavelengths (lower energy), than that of the excitation light; this is 
known as Stokes shift. 
In fluorescence microscopy, high energy, short wavelength (for example, UV or blue) 
light is used to illuminate the sample. This results in the transition of the fluorescent 
molecules into an excited state. Vibrational energy is lost when the fluorophore 
returns to the ground state and, as such, lower energy, longer wavelength (eg. green 
or red) light is emitted. For example, excitation using UV light, invisible to the naked 
eye, results in the emission of visible blue fluorescence light from a label such as 
DAPI. This is because vibrational energy is lost when electrons relax from the 
excited state back to the ground state. This difference in absorption and emission 
wavelength is known as the ‘Stokes shift’ of a fluorophore and is shown in Figure 
1.15. If the Stokes shift of a fluorescent molecule is great enough, the excitation and 
emission light can be effectively separated by a fluorescence microscope. 
Fluorescence microscopy is currently one of the most powerful and versatile 
techniques available for biological studies. Its discovery and utilization has had a 
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major impact on biological research, enabling researchers to visualize cellular 
processes with high temporal and spatial resolution. Fluorescence microscopes 
range from relatively simple widefield (epi-fluorescence) systems to so called super-
resolution microscopes offering novel solutions to overcome the diffraction limit of 
visible light, allowing us to visualise cellular structures in greater detail than ever 
before.  
Fluorophore-labelled molecules can be very bright and readily distinguishable from 
other background signals making high contrast images easy to obtain. With the 
development of genetically encoded fluorescent proteins, such as green fluorescent 
protein (GFP) it has become possible to image protein expression, localisation and 
activity in living cells (Prendergast and Mann 1978).  
 
 
 
 
Figure 1.15: Stokes shift. The emission spectrum of a 
fluorophore is shifted to longer wavelengths when 
compared to the absorption spectrum as a result of energy 
loss. 
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1.5.2 Epifluorescence microscopy 
 
 
In a conventional widefield, or epi-fluorescence microscope, the entire sample is 
illuminated by the excitation light (e.g. from a mercury or xenon source). The light 
can then be collected from the whole depth of the sample and viewed by eye or 
detected by an image capture device (Figure 1.16). 
The dichroic mirror is used to reflect light shorter than a certain wavelength and allow 
light of longer wavelengths to pass through, effectively separating the excitation and 
emission light paths. As the entire sample is illuminated with excitation light, as 
shown in Figure 1.17, this results in the detection of out-of-focus fluorescence 
emitted by the sample outside of the region of interest, which can lead to high levels 
Figure 1.16: Configuration of an epi-fluorescence microscope. The excitation light is 
filtered to limit excitation light to one colour but is then used to illuminate the entire 
sample. Emission light of other wavelengths can also be filtered. 
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of background fluorescence in the observed image. This can be particularly 
problematic for specimens with a thickness greater than ~2 µm. Nevertheless, epi-
fluorescence microscopy offers an overall view of the fluorescence within the sample 
and so represents particularly useful tool when wishing to quantify the total 
fluorescence of individual cells, for example when quantifying the extent to which a 
fluorescent molecule has been internalised by the cell (Ntziachristos 2006). As the 
signal-to-noise ratio in epi-fluorescence microscopy is low, a variety of techniques 
have been developed to reduce contamination by out-of-focus fluorescence and 
image a single plane of focus within the sample; these are discussed in the following 
sections.  
 
 
Figure 1.17: Epi-fluorescence microscopy Illumination. Excitation light of a 
chosen wavelength illuminated the whole sample, resulting in excitation of all 
fluorescent molecules within the sample. 
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1.5.3 Total internal reflection fluorescence (TIRF) microscopy 
Various techniques are employed in fluorescence microscopy to restrict the 
fluorescence detected to a thin section of the sample. This is because eliminating 
out-of-focus fluorescence can dramatically improve signal-to-noise over widefield 
microscopy. Total internal reflection fluorescence (TIRF) microscopy is predicated on 
the fact that an induced evanescent wave can excite fluorophores within a small 
volume (~100 nm) above the coverslip (Mattheyses et al 2010). This is achieved by 
illuminating the sample at an angle greater than the critical angle (defined by Snell’s 
Law), such that all light, as the name ‘total internal reflection’ suggests is reflected 
back without penetrating the sample.  
 
Figure 1.18: TIRF illumination. When the sample is illuminated at an angle greater 
than the critical angle, all of the incident light is reflected. However, an evanescent 
wave is generated, which decays exponentially with distance from the coverslip, in 
practice exciting fluorophores within around 100 nm of the coverslip. 
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Although no light propagates into the sample when it is incident at angles greater 
than the critical angle, the reflected light generates a highly restricted “standing” 
electromagnetic wave adjacent to the interface with the coverslip. This evanescent 
wave decays exponentially in intensity with distance from the coverslip, and as such 
extends only ~100 nm into the sample, as shown in Figure 1.18. Because of the 
exponential decay in intensity, the excitation of fluorophores is rest ricted to the 
plasma membrane and the membrane-proximal cytosol of adherent cells. As such, 
TIRF microscopy is an ideal experimental setup for the visualisation of events taking 
place in or near to the adherent plasma membrane of cells and has been of key 
importance to studies of membrane trafficking, endocytosis and exocytosis  
(Mattheyses et al 2010). 
 
1.5.4 Confocal microscopy 
Confocal microscopy, like TIRF microscopy involves imaging a shallow depth of field 
by elimination of out-of-focus light. However, confocal microscopy involves imaging 
user-defined optical sections within the cell and allows for the collection of serial 
“stacks” of images from different adjacent plane in thick samples (Webb 1996). 
Whereas in a wide-field (e.g. epi- or TIRF) microscope, the entire field of view is 
illuminated, ,   illumination in confocal microscopy is achieved by scanning one or 
more focused beams of light across the sample. Diffraction-limited laser lines are 
used to provide the excitation light and mirrors used to scan the lasers across the 
sample. Light emitted by the fluorescent molecules within the sample passes through 
the dichroic mirror and the confocal pinhole is used to eliminate out-of-focus light, as 
shown in Figure 1.19. As the focal point of the objective lens forms an image where 
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the pinhole is, these are known as ‘conjugate points’. The pinhole is conjugate to the 
focal point of the lens, hence the term confocal. 
 
 
Figure 1.19: Optical configuration of a confocal 
microscope. A pinhole is used to exclude out-of-focus 
light, allowing optical sectioning of the sample. 
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1.5.5 Super-resolution microscopy 
Optical microscopes have an inherent limitation in spatial resolution because of the 
wave nature of light. In light microscopy, resolution is fundamentally limited by the 
properties of light diffraction which were first described by Ernst Abbe in 1873. This 
prevents the resolution of structures smaller than approximately half the wavelength 
of light and as such causes sharp point-like objects to appear blurry under a 
microscope.  
Resolution can be estimated by measuring the full-width at half maximum (FWHM) 
value of the point-spread function (PSF) which essentially describes how blurry a 
fluorescent point-like object (such as a fluorescent bead) will appear when it is 
diffracted through a microscope (Huang et al 2009). Importantly resolution does not 
refer to the ability of a microscope to detect small structures; rather it denotes the 
ability to distinguish adjacent objects as separate structures rather than a single 
object (Figure 1.20).  However, due to the same limitations the true size of objects 
smaller than the PSF cannot be readily determined.  As many structures in biological 
samples are smaller and/or closer together than the PSF, images from fluorescent 
microscopes do not always provide a true representation of the sample being 
visualised.   
Practically speaking, the physical basis for the resolution limit of the light microscope 
depends on two main factors, the wavelength of light (λ) and the numerical aperture 
(NA) of the objective lens. Visible light ranges between the ultra-violet (< 400 nm) 
and the infrared (> 800 nm), and the NA of an objective refers to its light collecting 
ability.  Most commercial objective lenses have a NA around 1, and the practical 
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upper limit for a NA is approximately 1.5.  Thus applying a simplified equation based 
upon Abbe’s work (d = λ / 2 NA), with 500 nm light and an NA of 1, gives d = 250 
nm.  This equation was later refined by Lord Rayleigh in 1896 to give the Rayleigh 
criterion, defined as the shortest distance at which two point emitters can be 
distinguished as separate objects: R = 0.61 λ / NA.  The Rayleigh criterion is a 
commonly used measure of the width of the PSF, and is shown in Figure 1.20. 
Typically, this means that the effect of light diffraction limits the resolution of an 
optical microscope to approximately half the wavelength of the light used; this is 
usually around 250 nm laterally and 500 nm axially, and therefore many fine cellular 
structures cannot be resolved (Huang et al 2009).  
  
Figure 1.20: The Rayleigh criterion. The Rayleigh criterion is defined as the closest 
distance between two point sources for them to still be discernible as separate objects 
under an optical microscope. In practice this is around 250 nm. 
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As the de Broglie wavelength of an electron is much shorter than visible light, 
electron microscopy has a much higher resolution than optical microscopy and has 
long been relied upon to visualise cellular structures smaller and/or closer together 
than the 250 nm diffraction limit. However, fixation, dehydration and thin sectioning 
are required during sample preparation for electron microscopy, making it technically 
challenging, often introducing artefacts and rendering it of no use for live-cell 
imaging. Therefore microscopic techniques that combine the non-destructive nature 
of optical microscopy and the nanometer resolution of electron microscopy have 
been the focus of much research and development in recent years. 
Recent advances in fluorescence microscopy have resulted in the development of a 
series of different “super-resolution” techniques for breaking the diffraction barrier 
inherent in light microscopy.  The diffraction barrier has been broken by creating 
situations to which Abbe’s law does not apply, such as by switching fluorophores 
between bright and dark states. Super-resolution microscopy has improved optical 
resolution from around 250 nm to around 10 nm in the best cases. This super-
resolution technology is built around conventional fluorescence microscopes 
equipped with lasers and sensitive cameras – equipment already in use for wide-field 
fluorescence imaging. 
However, super-resolution microscopes are not based on one single technology, and  
a number of independently developed super-resolution techniques have been 
reported. These include structured illumination microscopy (SIM), stimulated 
emission depletion (STED) microscopy, photoactivation localisation microscopy 
(PALM) and stochastic optical reconstruction microscopy (STORM).  Each of these 
techniques is not only predicated on a different method for overcoming the diffraction 
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limit but has inherent advantages and limitations when applied to different biological 
questions.  
 
1.5.5.1 Single molecule localisation microscopy (SMLM)  
Single molecule localization microscopy (SMLM) techniques such as photoactivation 
localisation microscopy (PALM) and stochastic optical reconstruction microscopy 
(STORM) differ from all other fluorescence imaging techniques in that an image is 
built up, as the name suggests, literally molecule-by-molecule.  
The S L  techniques work on the principle that although the   250 nm limit of 
resolution in light microscopy prevents the separation of two objects at distances of 
less than 250 nm, the centres of individual objects can be determined with 
nanometre precision (Gelles et al 1988, Yildiz et al 2003).  As discussed previously, 
alike objects closer together than the 250 nm diffraction limit of light microscopy 
cannot be distinguished as separate objects (Figure 1.19). However, by inhibiting 
the fluorescence emission of the majority of the labels at any one time, only single 
isolated molecules within a PSF are allowed to fluoresce at any one time. By 
stochastically switching on and off different single isolated molecules in subsequent 
camera recordings, a final image with sub-diffraction sized spatial resolution is 
reconstructed from the summation of individual localised spatial positions. 
Cells can therefore be imaged at nanometre resolution by determining the exact 
location of each fluorophore one by one. All SMLM techniques rely on this temporal 
separation of fluorescence emission, which is be achieved either by switching 
between a dark and fluorescent state or by consecutive binding of individual 
fluorophores to the structure. This is achieved by the application of photoconvertible 
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or photoactivatable dyes and proteins. The emission wavelength of photoconvertible 
dyes or fluorescent proteins can be optically converted from one wavelength to 
another or fluorescence can be turned on and off in the case of photoactivatable 
proteins. This principle has been published by two independent groups who named 
the technique photoactivation localization microscopy (PALM) and stochastic optical 
reconstruction microscopy (STORM), respectively (Betzig et al 2006, Rust et al 
2006). PALM (and fPALM (Hess et al 2006)) make use of photoactivatable 
fluorescent proteins to achieve the necessary bright and dark states. 
As in each frame only a few fluorophores are visualised, a large number of images is 
required.  Thus, the iterative nature of PALM means that even with a high speed 
electron multiplier CCD (EM CCD), it can often take several minutes to acquire all 
the information required to reconstruct a single image.  When considering that sub-
diffraction limit localisation is the goal of PALM, this introduces a significant potential 
for artefacts generated by even small amounts of sample drift during acquisition.  For 
this reason, fiducial markers, such as small fluorescent beads, are often added to 
samples to be imaged by PALM, or other SMLM techniques, and a final image 
registration algorithm employed during post-acquisition processing.   
 Many other photoconvertible, photoactivatable, and photoswitchable fluorescent 
proteins have been developed. Photoactivatable FPs can be activated from a dark 
state to a bright state using UV light, and photoswitchable FPs such as Dronpa can 
be cycled between light and dark states with specific illumination wavelengths 
(Habuchi et al 2005).  
Another SMLM method, Stochastic Optical Reconstruction Microscopy (STORM) 
was developed by Xiaowei Zhuang of the Howard Hughes Medical Institute (HHMI) / 
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Harvard University (Rust et al 2006).  In theory and practice there are many 
similarities between PALM and STORM, however, STORM uses chemical 
fluorophores rather than fluorescent proteins.  These fluorophores are usually 
photoswitchable cyanine (Cy) dyes, that are used in pairs, coupled to antibodies that 
bind the protein of interest. One Cy dye will act as the activator and the other as the 
reporter. A simplified version of this technique, known as direct STORM (dSTORM) 
(Heilemann et al 2008) makes use of the intrinsic ‘blinking’ properties of certain 
fluorophores, such as AlexaFluor 647, meaning that only one fluorophore is 
required.In the original version of the STORM technique, pairs of fluorophores are 
employed which can be switched on and off by the different laser lines employed.  
Otherwise the iterative nature of the STORM image acquisition process is quite 
similar to that of PALM and generally speaking microscopes that have been 
developed for PALM can be used for STORM, and vice versa.   
These techniques are often grouped as ‘single molecule techniques’ and are able to 
localize molecules with ~20 nm resolution.  In both techniques, subsets of 
fluorophores are switched on with a brief laser pulse, which is so weak that only a 
few molecules are stochastically switched on at a time, resulting in such a low 
density of activated molecules that overlap within diffraction limited resolution is 
unlikely. Imaging of the ‘on’ fluorophores is performed until all activated molecules 
are bleached and the process repeated until several hundreds of thousands of 
molecules are imaged. This process is summarised in Figure 1.20. From the 
positions of all molecules, an image is reconstructed, generating a 10-20 nm super-
resolution image.  
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1.5.5.1.1 Benefits and limitations of SMLM  
The chemical fluorophores employed in STORM must be linked to proteins of 
interest post-translationally, usually through indirect methods such as immuno-
cytochemistry.  This introduces other potential concerns such as those regarding 
sample preparation, as well as issues such as the distances between the target 
protein and the fluorophore.  Antibodies are nearly 10 nm in length, and considering 
in indirect immuno-fluorescence a primary antibody specific to the antigen protein of 
interest and a fluorophore tagged secondary antibody are employed, this can result 
is a relatively large distance between the fluorophore and target when compared to 
the compact barrel-shaped structure of most fluorescent proteins (GFP has a 
diameter of approximately only 4 nm).  Thus, even if short peptide linkers are placed 
between the protein of interest and the fluorescent protein tag, STORM can 
potentially introduce a significant localisation error.  Furthermore, the requirement of 
Figure 1.21: Generation of a super-resolution image by SMLM. Fluorescent molecules 
are stochastically switched on and off in multiple rounds of activation such that no more 
than one fluorescent molecule within a PSF is allowed to fluoresce at any one time. The 
centres of these molecules are localised to generate a computer-rendered super-resolution 
image. 
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a dual fluorophore probe for conventional STORM adds other technical concerns.  
However, more recently the technique of direct (dSTORM), which is generally 
considered to be photochemically equivalent to the phenomenon of Ground State 
Depletion (GSD), has been gaining prominence.  In this case a single fluorophore 
(usually Alexa-Fluor-647) is shifted between dark and bright states, thus greatly 
simplifying methodological concerns.  
In PALM, a cDNA construct of a chimeric fusion protein directly tagging the protein of 
interest must be introduced into the cell to be imaged.  While fluorescent proteins are 
generally innocuous tags that do not affect target protein structure, function or 
localisation, these are potential concerns.  In addition, possible over-expression 
artefacts much be considered, as in conventional microscopy studies.   
 As no two fluorophores can be in the ‘on’ state within a PSF at any one time, the 
speed of image acquisition with the SMLM techniques is limited. This makes live cell 
imaging with the SMLM techniques extremely challenging, as cells, and the 
structures within them, are likely to move during the time that is required to acquire a 
single super-resolution image, leading to blurring. 
Additionally, as the SMLM techniques build up images literally molecule-by-
molecule, the user must consider how many of these fluorescent molecules are 
missed or even artificially added during image acquisition. In addition, the user must 
decide when to stop the acquisition, by judging when a significant proportion of 
fluorophores are bleached, which can introduce error.  
SMLM also faces the problem that if too many fluorescent molecules are missed 
because a low number of photons are emitted, the resulting image will be incomplete 
and give an incorrect image of localisation rather than simply generating a low 
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quality but accurate image. As such, it is not clear if localisation techniques can 
always be used for accurate protein quantification. In contrast, over-labelling can 
result in images that are improperly rendered due to the presence of partially 
overlapping centroids that cannot be resolved.  Thus, although extremely powerful, 
SMLM is not suitable for all applications, and other techniques which are more rapid 
and/or can be used with all fluorophores have been developed. 
 
1.5.5.1.2 SMLM data processing 
As described above, once the series of sparsely populated individual frames has 
been acquired, techniques such as Gaussian Fitting can be applied to each in series 
to generate a map of fluorophore centroids, although more recently a significantly 
faster “wavelet” approach has also been applied (Kechkar et al 2013).  Thus, when 
summed together these individual processed frames can provide a super-resolution 
image.   
SMLM techniques generate images unlike those we are used to seeing as 
microscopists. Our eyes tend to look for patterns and to focus on the largest and 
brightest structures in a microscopic image. However, STORM and PALM images 
are generated mathematically, and the size and brightness of the ‘dots’ in the image 
represent user-selected parameters. There are currently two mathematical 
approaches to describe the distribution of molecules in two dimensions: Ripley’s K 
function analysis compares the actual distribution relative to a random distribution 
and assigns a degree of ‘non-randomness’ to each molecule to create a cluster map 
(Hsu and Baumgart 2011) whereas pair-correlation analysis determines the 
probability of finding a molecule at a given distance from another molecule compared 
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with the probability expected from a random distribution of molecules (Sengupta at al 
2013). 
 
1.5.5.2 Structured illumination microscopy (SIM) 
Developed collaboratively between the laboratories of John Sedat at UCSF and the 
late Mats Gustafsson at HHMI Janelia Farms, Structured Illumination Microscopy 
(SIM) also relies upon computational approaches to generate a super-resolution 
image from a series of acquisitions. However, as the name suggests, rather than 
relying upon fluorophore effects, SIM utilises a structured pattern of illumination light 
for excitation of the whole field (Gustafsson 2000). When a high spatial frequency 
pattern is projected onto a sample, this generates an interference pattern known as a 
moiré fringe, which is simply an interference pattern created by overlaying two grids 
with different angles or mesh sizes (shown in Figure 1.22).  
 
 
 
If the pattern is moved across the specimen, a characteristic signal variation in the 
fluorescence response can be observed as a function of time and grid position. If 
one of the patterns is an unknown structure (the molecules in the sample being 
Figure 1.22: Generation of Moiré fringes. The overlay of two grids results in a Moiré 
pattern, from which structural information can be calculated, this effect is exploited by SIM 
super-resolution techniques. 
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imaged) and the other pattern is a known pattern (the grid), the moiré fringes that are 
generated by overlapping the two patterns will contain more information about the 
unknown structure than the original pattern, thus offering an improvement in spatial 
resolution. Multiple grid positions and rotations are required to produce several 
images of the same sample that have different moiré patterns (Gustafsson 2000). As 
the illumination pattern is a known entity, it can be mathematically removed from the 
moiré pattern to generate the final super-resolution image.  
 
1.5.5.2.1 SIM data processing 
To produce a super-resolution image from the generated moiré fringes, the signal 
variations between frames must be analysed using a Fourier transform–based 
algorithm (Gustafsson 2000). This algorithm requires that there are high contrast 
elements in the images acquired, meaning that significant levels of out-of-focus 
fluorescence can result in a lack of high contrast data from which to reconstruct a 
true super-resolution image. This issue depends on the thickness of the sample 
being imaged and the localisation of the molecules within the sample. However, this 
can represent a particular problem for over-expressed proteins tagged with 
fluorescent proteins such as GFP, where high levels of out of focus light are often 
observed.  
This effect can be minimised through the utilisation of illumination via total internal 
reflection fluorescence (TIRF) microscopy (Mattheyses et al 2010).  SMLM can also 
utilise TIRF illumination, and the flexibility of either TIRF or epi illumination is one of 
the shared benefits of these two techniques.  However, in the case of SIM, if the 
target protein is not with 200 nm of the coverslip and is surrounded above and below 
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by fluorophores, proper reconstitution of a super-resolution image can be difficult to 
achieve.   
Once generated, the super-resolution nature of a SIM image can be directly 
validated by visualisation of the Fourier transform. Whereas a the Fourier transform 
generated from a diffraction-limited image will be visualised as a circular shape, the 
Fourier transform of a SIM image will contain additional lobes from the extra 
information gained from the different grid positions and rotations used. For example, 
the visualisation of a Fourier transform of a SIM image generated using three grid 
positions and three rotations, will contain 6 lobes surrounding the central one. 
Thus, while artefacts can be difficult to discern in SMLM, in SIM there are clear 
quantitative criteria that can be employed to determine if reconstruction was 
successful.  However, most commercial SIM and SMLM systems provide the ability 
to acquire corresponding conventional non-super-resolution images which can 
permit direct comparisons and serve as a guide to validate that the reconstructions 
generated reasonable localisations.   
 
1.5.5.2.2 Benefits and limitations of SIM 
SIM is arguably one of the most user-friendly of the super-resolution techniques, 
particularly in terms of sample preparation, as any label used in conventional 
fluorescence microscopy can be applied to the technique. In addition, conventional 
excitation routines are applied resulting in less photobleaching than some of the 
other techniques (although multiple images of the same sample must be acquired to 
generate a super-resolution image). SIM is typically a wide-field approach, meaning 
that fast CCD cameras can be used. However, the imaging rate is usually slower 
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than conventional microscopy because of the need to acquire several images in 
order to generate one final image.  
SIM allows resolutions of around 100 nm in x,y, and z when biological material is 
used (Schermelleh et al 2008), and as such is the least powerful super-resolution 
technique regarding gained resolution over conventional fluorescence microscopy. 
This is because, unfortunately, the spatial frequencies that can be created optically 
in SIM are also themselves limited by diffraction. As such SIM is limited to this factor-
of-two improvement as it is still limited by the PSF of conventional microscopy 
(Gustafsson, 2000). 
 
1.5.5.3 Super-resolution techniques: A comparison 
Relative benefits and limitations exist within the different super-resolution microscopy 
techniques available (Table 1.1). While SMLM provides the highest spatial 
resolution, it also takes the longest time to acquire the necessary data, is conducted 
in fixed cells, and is only compatible with certain fluorophores.  SIM can be used with 
any fluorophore and is relatively rapid, making it useful for live-cell imaging studies, 
but does not provide the same resolution gains as SMLM.  Furthermore, SIM can be 
difficult to perform successfully with certain types of samples.  SMLM and SIM share 
the benefits of being wide-field techniques compatible with both epi and TIRF 
illumination, but also share the limitation that image reconstruction via application of 
computational algorithms is required.  As in some deconvolution techniques, direct 
image acquisition is not possible, creating a concern for potential artefacts that 
cannot easily be discerned.   
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Therefore, among the commercially available super-resolution solutions no single 
technique can be said to be optimal for all applications.  Depending upon the specific 
questions being addressed and the constraints of the experimental system, the user 
will must decide which is best.   
 
Modality Resolution Illumination Probes Acquisition 
Time 
Post-
Acquisition 
Processing 
Data Size Other 
Concerns 
Standard 
fluorescence 
microscopy 
250 nm Epi/TIRF/ 
confocal 
Conventional 
fluorescent probes 
    
SIM 100 nm Wide-field 
(epi/TIRF) 
Conventional 
fluorescent probes 
Short 
(seconds) 
Yes (Fourier 
transforms) 
Small (9-
15 frames) 
Out of focus 
signal and 
sample 
thickness 
PALM/fPALM 10-55 nm Wide-field 
(epi/TIRF) 
Photo-activatable 
fluorescent 
proteins (e.g. PA-
GFP) 
Long 
(minutes) 
Yes (centroid 
identification) 
Large 
(many 
frames) 
Over/under 
labelling 
artefacts 
STORM/ 
dSTORM 
10-55 nm Wide-field 
(epi/TIRF) 
Photoswitchable 
dyes (e.g Cy3/5) 
Blinking 
fluorophores (e.g. 
Alexaflour-647) 
Long 
(minutes) 
Yes (centroid 
identification) 
Large 
(many 
frames) 
Over/under 
labelling 
artefacts 
 
 
 
 
 
 
 
Table 1.1: The relative benefits and limitations of super-resolution microscopy 
techniques when compared to conventional fluorescence microscopy. 
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CHAPTER 2 
 
 
 
 
MATERIALS AND METHODS 
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2.1 Plasmid constructs 
Table 2.1: DNA constructs 
 Constructs were purchased from, or kindly donated by: 
Plasmid Source 
Clathrin-dsRed (rat light chain a) 
Prof. Thomas Kirchausen, Harvard Medical 
School, Boston, USA. 
GFP-Clathrin 
Dr Alex Benmerah, Institute Cochin, Paris, 
France. 
pEGFP-N1 
Clontech, BD Biosciences Clontech, Palo 
Alto, USA. 
pECFP-Mem 
Clontech, BD Biosciences Clontech, Palo 
Alto, USA. 
GFP-Occludin 
Prof. Tianyi Wang, Department of Infectious 
Diseases and Microbiology, University of 
Pittsburgh, USA. 
AcGFP-CD81 
McKeating Lab, University of Birmingham, 
UK. 
EGFP-EGFR 
Alexander Sorkin, University of Colorado 
Health Sciences Centre, USA. 
 
81 
 
2.2 Bacterial transformation 
1 μg of the required cDNA construct (Table 2.1) was added to 50 μl  AX Efficiency DH5α 
Competent Cells (Invitrogen) on ice for 30 minutes. The MAX Efficiency DH5α cells were 
heat-shocked at 42ºC for 45 seconds and returned to ice for 2 minutes. 500 μl of Luria Broth 
(LB; SM 1) (Sigma) was then added, and the cells were incubated at 37ºC with agitation for 
1.5 hours. 125 μl of bacterial mix was spread onto an LB agar (Sigma) 13 cm plate (SM 2) 
containing either kanamycin or ampicillin (depending on the bacterial antibiotic resistance 
gene encoded) using a flaming loop. Inverted plates were incubated overnight at 37ºC. For 
each plate, 2 well-separated colonies were picked with a pipette tip and added to 2 ml LB 
broth containing kanamycin (50 μg/ml) or ampicillin (100 μg/ml) in 14 ml dual -position snap 
cap round bottomed tubes (Falcon) and incubated at 37ºC for 6 -8 hours with agitation. 200 
μl of this bacterial mix was added to 100 ml antibiotic-containing LB broth in a conical flask 
and incubated 37ºC for 8 hours with agitation. The flask contents were then centrifuged 
centrifuged at 5000 rpm at 4ºC in 50ml plastic centrifuge tubes (Falcon) using a Heraeus 
Labofuge 400R centrifuge (Thermo Scientific). The resulting pellets were then lysed 
immediately for purification with a Qiagen Plasmid Maxi Kit (Qiagen) following 
manufacturer’s instructions. Purified DNA was dissolved in 1 ml ultrapure water and stored 
at -20ºC. DNA concentration was measured using a U1800 model spectrophotometer 
(Digilab Hitachi) prior to carrying out transfections. 
 
2.3 Cell culture 
Huh6, Huh7.5, HeLa, HepG2, 293T and CHO cells were all cultured in Dulbecco’s  odified 
Eagle’s  edium (D E ; Lonza) with 10% FCS and 1% penicillin/streptomycin (Invitrogen) 
(SM 3). Parental SKHep1 cells were cultured in RPMI 1640 media (Gibco, Invitrogen) with 
10% FCS, 1% penicillin/streptomycin. SKHep1 (SRBI+CLDN1) were cultured in RPMI 1640 
media (Gibco, Invitrogen) with 10% FCS, 1% penicillin/streptomycin and under double 
selection with 100 µg/ml hygromycin and 700 µg/ml G418 (both Gibco, Invitrogen). HepG2-
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CD81 cells were cultured in DMEM (Lonza) with 10% FCS and 1% penicillin/streptomycin 
under selection with zeocin (Gibco, Invitrogen). Primary human hepatocytes were a kind gift 
from Dr Ragai Mitry, Kings College London, UK to Garrick Wilson (McKeating lab), and were 
grown in Williams E growth medium. All cells were grown at 37C with 5% CO2. 
 
2.4 Endocytosis assays (Tf, LDL and CTB uptake) 
Cells were plated onto glass coverslips 24 hours before carrying out endocytosis assays and 
were 70-90% confluent when assays were carried out. Cells were pre-incubated with serum-
free media (SFM) for 10 minutes at 37C and 5% CO2 before incubation  with 1 µg/ml 
Alexafluor555-labelled cholera toxin B subunit (CTB-555; Invitrogen), Alexafluor-568-labelled 
transferrin (1:500 dilution; Invitrogen), or  DiI-LDL (1:50 dilution; Invitrogen) for 5 minutes at 
37C and 5% CO2 (unless otherwise stated). CTB-555 treated cells were then washed with 
room temperature SFM, and LDL and Tf-treated cells with Dulbecco’s phosphate buffered 
saline solution (DPBS; Lonza) at pH5.5 and fixed with 4% paraformaldehyde (PFA; electron 
microscopy sciences) for 5 minutes at room temperature. Coverslips were mounted onto 
glass slides using ProLong Gold antifade reagent (Molecular probes, Invitrogen) and imaged 
24 hours later. Slides were imaged using a Nikon TE300 epifluorescence microscope 
(Nikon) with a 60x oil immersion objective and data analysed using ImageJ 1.42q software 
(National Institute of Health). A student’s T-test was performed to determine statistical 
significance. 
 
2.5 Image analysis using Image J Software 
Epifluorescence images were analysed using ImageJ 1.42q software (National Institute of 
Health). Per experiment 30 cells per treatment or control were circled using the ‘bezier ROI’ 
tool) and fluorescence intensity measured for each cell. Background fluorescence was 
subtracted by drawing a similar sized ROI in a cell-free area of the image. An average 
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fluorescence intensity for each treatment calculated. Results shown are the average of three 
repeats. A student’s T-test was performed to determine statistical significance. 
 
2.6 Preparation of cell lysates 
Two confluent wells of a 6-well plate for each condition were lysed in ice cold Triton X-100 
lysis buffer (SM 5) with added complete mini protease inhibitor cocktail tablet (Roche). Cell 
lysates were kept on ice for 15 minutes with vortexing every 5 minutes before clarifying by 
centrifugation for 15 minutes at 4C and 14000 rpm in a bench top centrifuge (Eppendorf 
5471R). Protein was quantified using the BioRad protein assay (BioRad), according to the 
manufacturer’s instructions (section 2.7). 
 
2.7 Bradford protein quantification assay 
Bovine Serum Albumin (BSA) Standards were made by serial dilutions in distilled H2O, 
giving BSA solutions at 25 μg/ml, 20 μg/ml, 15 μg/ml, 10 μg/ml, 5 μg/ml and 2.5 μg/ml. 
Bradford reagent was diluted 1:5 in distilled H2O and 1 ml added to 10 μl of each BSA 
standard. Absorption at 595 nm was measured in a PU 8720 UV/Vis scanning 
spectrophotometer (Philips) and a standard curve of BSA concentration versus absoprtion 
plotted. Distilled H2O was used as the blank control. 1 ml of diluted Bradford reagent was 
then added to 2 μl of cell lysate and absorption at 595 nm measured as above. Protein 
concentration could then be read of the standard curve. 
 
2.8 Western blot (WB) 
Western bots were performed using the Mini-Protean Tetra Electrophoresis System 
(BioRad). Protein lysates (35 µg) were boiled for 5 minutes in an equal volume of 3x running 
buffer (SM 6) and then separated on a 12% SDS PAGE gel (SM9). To each gel, 10 μl 
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PageRuler Plus Prestained Protein Ladder (Fermentas), was run in one lane. The gels were 
run at 220V for 45 minutes using a PowerPac Basic Power Supply (BioRad) in running buffer 
(SM 7). Protein was then transferred to 0.5μm Immobilon-P PVDF membrane (Millipore) in a 
Mini Trans-Blot Cell (BioRad) filled with transfer buffer (SM 8) at 4C for 1 hour at 400 mA. 
The membrane was blocked for 1 hour using 5% Marvel in TBST (SM 10). The membrane 
was then incubated with primary antibody, dilutions as in table SM table 1 in blocking 
solution (SM 11) overnight at 4C with agitation. Primary antibody was removed by 5 10 
minute washes with 20 ml TBST (SM 9).  The membrane was probed with secondary 
antibody (horseradish peroxidise-conjugated donkey anti-rabbit IgG, unless otherwise 
stated; SM table 2) in blocking solution at a dilution of 1:10,000 for 1 hour at room 
temperature, with agitation. Protein was detected by enhanced chemiluminescence (ECL). 
Detection reagents 1 and 2 from ECL Western Blotting Substrate Kit (Pierce) were mixed in 
a 1:1 ratio, making up a total volume of 1 ml per membrane. The membrane was then 
incubated in ECL reagent for 60 s. The membranes were then inserted into a developing 
cassette; X Ray film (Scientific Laboratory Supplies) was inserted into the developing 
cassette and exposed to the membranes for between 10 s and 5 minutes. Exposed films 
were developed using a CURIX 60 XoGraph machine (AGFA).  
. 
2.9 Immunoprecipitation (IP) 
Immunoprecipitation was carried out using rabbit polyclonal α-caveolin 1 (BD Transduction 
Labs) and rabbit IgG bound to protein G-sepharose beads (Sigma). Antibody coupling to G-
sepharose beads was achieved by mixing 750 μl Triton X-100 lysis buffer (SM 5), 50 μl 
Protein G sepharose (50% slurry in PBS) and 2.5 μg antibody and rotating overnight at 4C. 
Cell lysates were pre-cleared by adding to 20 μl protein G sepharose (50% slurry in PBS), 
vortexing briefly and rotating at 4C for 30 minutes. Antibody-coupled beads were washed 
three times with Triton X-100 lysis buffer, vortexing for 10 s and centrifuging at 4C at 5000 
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rpm for 20 s in a bench top centrifuge (5471R, eppendorf). Dry beads were then placed on 
ice. Cell lysates were centrifuged at maximum speed at 4C for 1 minute to pellet the protein 
G sepharose. Supernatant was then added to the antibody-coupled beads, vortexed briefly 
and then rotated at 4C for 90 minutes. Beads were washed four times in ice-cold Triton X-
100 lysis buffer. For each wash, tubes were kept on ice, vortexing for 10 s and centrifuging 
at 4C at 5000 rpm for 20 s. For the final wash, beads were transferred to new tubes to 
prevent protein sticking to the sides resulting in non-specific bands. Samples were eluted 
into 50 μl non-reducing sample buffer (SM 6) and stored at -20C. Samples were boiled for 5 
min and then separated on a 12% SDS PAGE gel, before western blotting for caveolin 1, as 
described above. 
 
2.10 Flow cytometry 
Following CTB uptake, cells were trypisined and fixed in solution with 4% PFA (electron 
microscopy sciences) for 5 minutes, washed with Dulbecco’s phosphate buffered saline 
solution (DPBS) (Lonza) and then resuspended in DPBS for analysis. Flow cytometry was 
carried out using a BD FACScalibur flow cytometer (Becton Dickinson) and analysed using 
CellQuest Pro software (Tree Star, OR, USA). Appropriate unstained controls were used. 
 
2.11 Transient DNA transfection  
Cells were transfected with 4 µg DNA (table 2.1) and 20 µl lipofectamine 2000 transfection 
reagent (Invitrogen) per well of a 6-well plate, according to the manufacturer’s instructions. 
Cells were transfected 24 hours following plating, and at 70-90% confluency. To transfect 
two wells of a 6-well cell culture plate, 8μg DNA was added to 500 μl serum-free cell culture 
media (SF ; Lonza) and 40 μl lipofectamine 2000 added to another 500 μl SF  in a 
separate 1.5 ml tube (eppendorf) and incubated for 5 minutes at room temperature. The 
DNA/SFM mix was then added to the lipofectamine 2000/SFM mix and incubated for 15 
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minutes at room temperature. 500 μl transfection mix was then added to each well by 
pipetting in a drop-wise manner. Media was changed to DMEM + 10% FCS 2 hours post-
transfection.  
 
2.12 siRNA transfection  
Based upon preliminary studies and previously published work (Motley et al 2003) two 
rounds of transfection are usually necessary to silence expression of AP2 and caveolin 1, as 
they are relatively stable proteins. For transfection of one confluent well of a 6-well plate, 5 l 
Lipofectamine RNAiMAX transfection reagent and 30 pmol siRNA is needed. AP2 custom 
siRNA (Dharmacon) and a caveolin 1 SMARTpool (dharmacon) were used (sequences in 
SM 16). A non-silencing control (ON-TARGETplus Non-trageting siRNA; Dharmacon) was 
used in parallel to all knockdowns. For transfection of 1 well of a 6-well plate, transfection 
reagent is added to 250 µl of serum-free media (SFM), and in a separate tube, siRNA is 
added to another 250 µl SFM. Following 5 minutes incubation at room temperature, the 
transfection reagent and SFM are added to the siRNA, mixed and incubated at room 
temperature for 15 minutes. Transfection mix is then added drop-wise to cells. The two 
rounds of transfection are carried out as follows:  On day 1, cells are plated in a 6-well cell-
culture plate to be 80-90% confluent 24 hours later. On day 2, the first round of transfection 
is carried out, as described above. On day 3, each well of a 6-well plate of transfected cells 
is split 1:2 into 2 wells of a 6-well cell culture plate. On day 4, the second round of 
transfection is carried out, as described above. On day 5, cells are split for lysis on day 6, or 
plated onto coverslips for endocytosis assays to be carried out on day 6. 
 
2.13 Generation of HCVpp  
293-T cells were plated at a density of 8x105 cells per well in a 6-well cell culture plate, pre-
coated with poly-L-Lysine, such that cells were 60-80% confluent 24 hours later. 24 hours 
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following plating, cells were transfected with virus DNA as follows: 1 hour before 
transfection, cell culture media was changed to DMEM containing 3% FCS with no 
antibiotics. For transfection of 1 well of a 6-well cell culture plate, 1.6 µg of DNA, 6 µl Fugene 
transfection reagent, and 100 µl Optimem serum-free media were used. The transfection mix 
was generated by adding the required amount of DNA to 10 µl sterile distilled water (DNAse 
and RNAse free). In a separate tube, 6 µl of Fugene was added to 100 µl Optimem and 
incubated at room temperature for 5 min. The Fugene-Optimem mix was then added to the 
diluted DNA, mixed and incubated at room temperature for 20 min before pipetting drop-wise 
onto cells. Cells were then incubated at 37C and 5% CO2 for 6 hours. The transfection 
mixture was then removed from cells and replaced with fresh media containing 3% FCS. 
Cells were then incubated for 72 hours at 37C and 5% CO2. The supernatant was then 
removed and clarified at 3000 rpm for 5 minutes in a bench top centrifuge (5471R, 
eppendorf) before storage at -80C prior to use. 
  
2.14 HCVpp infection assay 
Target cells (SkHep1 SRBI+CLDN1 or Huh7.5) were plated at a density of 1x104 cells per 
well in a flat bottomed 96-well cell culture plate 24 hours before infection. HCVpp and No 
env control particles were diluted at 1:2 in 3% media, and VSV-Gpp and MLVpp were both 
added at a dilution of 1:500 in 3% media. Cells were incubated at 37C and 5% CO2 for 8 
hours. Virus was then removed, cells rinsed in 3% media, and incubated in fresh 3% media 
for 72 hours before carrying out a luciferase reporter assay to measure infection. Media was 
removed from wells and cells were lysed in Cell culture lysis buffer (Promega), 40 µl per 
well, incubated at 4C for 15 min and analysed for luciferase activity using luciferase 
detection system (Promega E1501). 
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2.15 Treatment with small molecule inhibitors 
Cells were plated onto glass coverslips in a 24-well cell culture plate 24 hours before 
carrying out endocytosis assays and were 70-90% confluent when assays were carried out. 
Cells were pre-incubated with 80 µM Dynasore (Sigma) in serum-free media (DMEM or 
RPMI) for 10 minutes at 37C and 5% CO2, prior to carrying out endocytosis assays, as 
described above. Dynasore is present throughout the endocytosis assay. As Dynsore is 
made up in DMSO, control wells are incubated in the corresponding volume of DMSO.  
Chlorpromazine (Sigma) was added to cells in SFM at a concentration of 1 µM for 30 
minutes prior to carrying out endocytosis assays as described previously and remained 
present throughout the endocytosis assays. 
Lt-LacCer (caveolar inhibitor) and De-LacCer (inactive control) were added to cells at a 
concentration of 10 µM in SFM 30 minutes prior to carrying out endocytosis assays and 
remained present throughout endocytosis assays. 
 
2.16 EGF stimulation of Huh7.5 cells 
Huh7.5 cells were plated in glass-bottomed cell culture dishes and transfected with the 
indicated cDNA constructs 24 hours later. 24 hours following transfection, cells were serum 
starved for 10 minutes at 37C and 5% CO2. EGF (Bachem) was then added at 1 μg/ml 
unless otherwise stated for 10 minutes unless otherwise stated. In live cell imaging studies, 
cells were incubated in serum-free cell imaging media (CIM; SM 12) for 10 minutes while 
cells were selected and EGF added to the dish on the microscope immediately prior to 
beginning the live cell timelapse image acquisition. In this case 20 μl of 100 μg/ml EGF was 
added to a final volume of 2 ml CIM. 
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2.17 Live-cell confocal microscopy 
Huh7.5 cells were plated into glass-bottom cell culture dishes (MatTek corp) 24-hours before 
transfection with constructs listed in table 2.1 using Lipofectamine 2000 transfection reagent 
(Invitrogen) as described previously. Cells were imaged in CIM 24 hours after transfection 
using a 60x oil immersion objective on a Nikon A1 confocal system (Nikon). The microscope 
stage was maintained at 37C by an Okolab incubation chamber (Okolab). Images were 
taken every 1 minute for 60 minutes following the addition of EGF. Excitation of GFP-tagged 
constructs was achieved with the 488 nm line of an Argon Ion laser 457-514 nm, and 
excitation of pECFP-mem was achieved using a Violet Diode laser 400-405 nm. Images 
were acquired with a 12-bit CCD camera (Ixon 1M EMCCD camera) controlled by NIS-
Elements AR version 3.2 software (Nikon). 
 
2.18 TIRF microscopy 
Huh7.5 cells were plated in glass-bottom dishes (MatTek Corp) 24-hours before transfection 
with clathrin-dsRed and EGFR-GFP (table 2.1) using Lipofectamine 2000 transfection 
reagent (Invitrogen) as described previously. Cells were imaged 48 hours after transfection 
using a Nikon A1R TIRF/confocal system (Nikon), with illumination through a 60x TIRF 
objective (CFL Plan Apo 60x NA 1.49, Nikon).  
Single images were captured in each colour at time 0 and after 30 minutes following the 
addition of EGF (Bachem). 
 
2.19 Immunocytochemistry (IC) 
Huh7.5 cells were plated into glass-bottomed cell culture dishes (MatTek) and transfected 24 
hours later as described in section 2.11. Cells were treated with EGF or PBS (control) as 
described in section 2.18. Cells were then washed 3 times in 2 ml 
90 
 
DPBS and fixed with 4% PFA for 5 minutes at room temperature. Cells were then 
permeabilised for 5 minutes in 2 ml permeabilisation buffer (0.1% Triton X-100) and 
permeabilisation buffer removed with 3 washes with 2 ml DPBS at room temperature. Cells 
were then incubated in BSA-GS block buffer (SM 13) for one hour.   
Primary antibodies were diluted as stated in S.M.30 in GS -BSA block buffer and 100 μl 
added to the coverslip. The coverslips were incubated in a humidity chamber at room 
temperature in the dark for 1 hour. Primary antibodies were removed with 3 washes with 
DPBS at room temperature. Secondary antibodies were diluted as stated in SM 30 in GS-
BSA block buffer and 100 μl added to the coverslips for 1 hour at room temperature in a 
humidity chamber. Cells were then washed 3 times with 2 ml DPBS at room temperature.  
  
 
2.20 Structured illumination microscopy (SIM)  
Huh7.5 cells fixed and stained for CD81 by IC with and without EGF stimulation were 
imaged by single-colour 3D SI  at the Nikon Imaging Centre, King’s College London 
(NIC@King’s). Cells were imaged using a Ti-E inverted N-SIM super-resolution system 
(Nikon) through a 100x 1.49 NA oil immersion objective using an Andor Ixon camera 
(Andor). Images were visualised and reconstructed using NIS Elements AR with n-SIM 
module (Nikon). 
 
2.21 Stochastic optical reconstruction microscopy (STORM) 
Huh7.5 cells fixed and stained for CD81 by IC, using alexaflour-647 labelled secondary 
antibodies were imaged by dSTOR  at the Nikon Imaging Centre, King’s College London 
(NIC@King’s). Cells were imaged using a Ti-E inverted N-STORM super-resolution system 
(Nikon), through a 100x 1.49NA oil immersion objective using an Andor Ixon camera 
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(Andor). Images were visualised and reconstructed using NIS Elements AR with n-STORM 
module (Nikon). 
 
2.22 Analysis of SIM data (and clathrin spot data) 
Images were analysed by Jeremy Pike (PSIBS doctoral training centre, University of 
Birmingham). A bandpass filter was used to remove noise from the images. To segment the 
cell boundaries in the SIM images, images were blurred using bandpass and Gaussian 
filtering and the resulting images thresholded to define the cell outline. Otsu thresholding 
with a watershed step was used to segment connected fluorescent spots. 
 
2.23 Statistical Analyses 
Data shown are the means from three independent experiments, unless otherwise indicated. 
Error bars represent standard error. Statistical significance was determined by Student’s T-
tests in all cases except where indicated. * p<0.05,   ** p<0.001,   *** p<0.0001. 
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CHAPTER 3 
 
 
 
RESULTS 
 
 
 
INVESTIGATING A ROLE FOR CAVEOLIN 1 IN HCV ENTRY 
  
93 
 
3.1 Introduction 
While several studies have demonstrated that HCV can enter hepatoma cell lines in 
a clathrin-dependent manner, none of these studies have ruled out entry by clathrin-
independent mechanisms (Blanchard et al 2006, Codran et al 2006, Coller et al 
2009). In particular, any role for caveolae in HCV infection has been overlooked due 
to a long-standing belief that the hepatoma cell lines used to study HCV infection do 
not express caveolin 1, and therefore cannot form functional caveolae.  
In contrast, caveolin 1 is known to be expressed in hepatocytes in the liver, where it 
is thought to play important roles in liver regeneration and lipid metabolism 
(Fernández et al 2006, Mayoral et al 2010, Fernández-Rojo et al 2013). Expression 
of caveolin 1 in hepatocytes is however, relatively low, and it has been reported to 
reside predominantly at intracellular locations rather than at the plasma membrane 
(Mayoral et al 2010, Woudenberg et al 2010).  
The assumption then is that if HCV is able to enter and infect hepatoma cell lines 
which do not express caveolin 1 then this pathway plays no functional role in 
infection in vivo, even if hepatocytes in the liver express caveolin 1. However, there 
is evidence both for and against the presence of caveolae in hepatoma cell lines 
throughout the literature. Among the most convincing pieces of evidence for the 
presence of caveolae in hepatoma cell lines are electron micrographs (for example, 
Figure 1.13) of HepG2 cells, showing flask-shaped invaginations typical of caveolar 
endocytosis (Botos et al, 2007). HepG2 cells are able to develop the complex 
polarity exhibited by hepatocytes within the liver, and are as such, often considered 
to be the most physiological cell line of hepatic origin.  
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the pathway as an additional entry mechanism, or one which promotes infection in 
depolarised/non-polarised cells where caveolin 1 relocalises to the plasma 
membrane (Meyer et al 2013). If functional caveolae or related pathways exist in 
primary hepatocytes in vivo, this could represent a potential route for productive 
infection. 
In order to fully assess the role that different endocytic mechanisms play in viral 
entry, expression of caveolin 1 in HCV-permissive cell lines must be determined and 
the effect of perturbation of this pathway on HCV entry and infection measured in a 
caveolin 1-positive, HCV-permissive cell model. This has not been done to date. 
 
3.2 Chapter aims 
While caveolin 1 is thought to be expressed by hepatocytes within the liver, the 
existence of a caveolar pathway in the hepatoma cell lines used to study HCV entry 
and infection is much debated. While it has been demonstrated that HCV can enter 
hepatoma cell lines via a clathrin-mediated route, clathrin-independent routes of 
entry have not been considered. If clathrin-independent routes of endocytosis are 
active in these cell lines it is possible that they offer alternative or additional routes of 
viral entry, which may contribute to productive HCV infection. Therefore, the aims of 
this chapter are: 
 
1. To assess caveolin 1 expression in hepatocytes, hepatoma, and HCV-
permissive cell lines. 
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In addition, several studies have noted the effects of inhibitors of caveolar 
endocytosis or silencing caveolin 1 expression, which is both necessary and 
sufficient for caveolar endocytosis, in hepatoma cell lines (Pohl et al 2002, Zhao et al 
2009). Most notably, Pohl et al demonstrate inhibition of [3H]oleic acid uptake when 
HepG2 cells were treated with filipin III, cyclodextrin and caveolin1 antisense 
oligonucleotides, all of which are known to inhibit caveolar endocytosis. 
While a recent study detected low caveolin 1 mRNA and protein levels in Huh7 cells 
(Meyer et al 2013), several studies have failed to detect expression of caveolin 1 in 
hepatoma cell lines by western blot (Cokakli et al 2009, Qi et al 2010). Nevertheless, 
there is mounting evidence for a pathway both morphologically and functionally 
similar to the caveolar pathway acting independently of caveolin 1 (Damm et al 
2005). In the absence of detectable caveolin 1, it is possible that inhibitors of the 
caveolar pathway may exert their effects on functionally similar or related pathways.  
Paradoxically, while the polarised HepG2 cell line is thought to be most 
representative of hepatocytes within the liver, these cells are less permissive to HCV 
infection than their non-polarised counterparts. Moreover, evidence suggests that 
loss of polarisation and dedifferentiation following in vitro culture of primary 
hepatocytes results in higher expression levels of caveolin 1, particularly at the 
plasma membrane (Meyer et al 2013). As depolarisation and loss of tight junctions is 
known to promote HCV infection in cell culture (Mee et al 2009), it is important to 
consider the role that the concomitant relocalisation of caveolin 1 may play in 
promoting viral entry.  
While the low level of caveolin 1 in polarised hepatocytes within the liver may limit 
the role that caveolae may play in viral entry in vivo, this does not preclude a role for 
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2. To select a caveolin 1-positive HCV-permissive cell line for use in HCV 
entry studies. 
3.  Using the above entry model, to determine whether HCV can enter cells 
via caveolar endocytosis.  
 
3.3 Results 
 
3.3.1 Caveolin 1 is expressed by primary human hepatocytes but not by 
hepatoma cell lines 
Hepatoma cell lines are typically described as being devoid of caveolae and have 
been shown to be negative for caveolin 1 expression by western blot (Cokakli et al 
2009, Qi et al 2010). However, there is some evidence to the contrary in the 
literature, particularly with respect to HepG2 cells, a hepatoma cell line capable of 
polarisation (Botos et al 2007). Therefore, it was necessary to determine whether 
these cell lines express caveolin 1 and have functional caveolae. Two methods were 
used to ascertain the presence or absence of caveolae in a panel of hepatoma, 
HCV-permissive and positive control cell lines (cell lines known to express caveolin 
1). Firstly the expression of caveolin 1 was assessed by western blot (Figure 3.1 A). 
Utilising HeLa, SKHep1 and CHO cell lysates as positive controls, the expression of 
caveolin 1 was assessed in three human hepatoma cell lines frequently used in the 
study of HCV infection, namely: HepG2-CD81, Huh6 and Huh7.5 cells, in addition to 
primary human hepatocytes (PHH). While strong caveolin 1 expression was detected 
for HeLa, SKHep1 and CHO cells, and, notably, a lower but still detectable level of 
caveolin 1 in PHH, no caveolin 1 expression was detected for any of the three 
hepatoma cell lines studied.  As caveolin 1 levels have been reported to be very low 
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in the liver, it is possible that caveolin 1 expression levels in hepatoma cell lines are 
below the threshold for detection by western blot. Therefore, immunoprecipiation (IP) 
with α-caveolin 1 was carried out in Huh7.5 and HepG2-CD81 cell lysates and the 
western blot repeated, as shown in Figure 3.1 F. However, IP with α-caveolin 1 did 
not result in detection of caveolin 1 in either HepG2-CD81 or Huh7.5 cell lysates by 
western blot.  
To confirm this result, the presence of functional caveolae in the same cell lines was 
assessed by use of a frequently used model cargo for caveolar endocytosis, cholera 
toxin B subunit (CTB). CTB binds to the ganglioside GM1 in the plasma membrane 
and is internalised by caveolar endocytosis, although internalisation via other routes 
has been described in some cases (Torgersen et al 2001, Singh et al 2003). Use of 
an Alexafluor-555 labelled CTB (CTB-555) allowed detection of cells which had 
internalised the cargo by confocal microscopy. Uptake of the clathrin-mediated cargo 
transferrin (Tf) was assessed in the same cell lines as a control. As clathrin-mediated 
endocytosis is ubiquitous, and TfR endocytosis constitutive, Tf would be expected to 
be internalised by all cells. The results of CTB and Tf uptake are summarised in 
Table 3.1. HeLa, SKHep and CHO cells  were all positive for CTB uptake when 
imaged by confocal microscopy, as expected, while HepG2-CD81 and Huh6 cells 
were both negative for uptake of the caveolar marker, exhibiting no fluorescence 
above the background level (Figure 3.1 B-E). Interestingly, a subpopulation of 
Huh7.5 cells was positive for the fluorescent marker despite lacking detectable 
caveolin 1 expression by western blot, as shown in Figure 3.1 D. The percentage of 
Huh7.5 cells which stained positive for the caveolar marker CTB was quantified by 
two methods: confocal microscopy and flow cytometry. 
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Figure 1: Caveolin1 Expression in 
Hepatoma Cell Lines. A: Western blot for 
caveolin1 in HeLa, SkHep and CHO cells as 
a positive control, and three hepatoma cell 
lines, Huh6, Huh7.5 and HepG2-CD81 
cells, as well as primary human hepatocytes 
(PHH). B: CTB uptake in SkHep cells 
(positive control) and the three hepatoma cell 
lines, Huh6, Huh7.5 and HepG2-CD81.
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Figure 9: Culturing HepG2 Cells with 
Supplemental BSA Does Not Increase 
Caveolin1 Expression. A: Western blot for 
Caveolin1 in HepG2 and Huh7.5 cells 
cultured with and without supplemental BSA 
with SkHep cells as a positive control. B: 
Caveolin1 western blot in HepG2 cells and 
Huh7.5 cells cultured with supplemental 
BSA  following immunoprecipitation with 
anti-Cav1.
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Figure 3.1: Expression of caveolin 1 in primary hepatocytes 
and hepatoma cell lines. Caveolin 1 levels of three positive 
control cell lines (HeLa, SkHep and CHO), three hepatoma cell 
lines and primary human hepatocytes (PHH) were measured by 
western blot (A). Uptake of fluorescent CTB by one positive control 
cell line (SkHep1) and three hepatoma cell lines (Huh6, Huh7.5. 
HepG2-CD81) measured by confocal imaging  are shown (B-E).  
Scale bars = 10 μm. Immunoprecipitation with anti-caveolin 1 was 
carried out in HepG2 and Huh7.5 cells and lysates blotted for 
caveolin 1. SkHep1 cells are shown as a contol. FACS sorted  
CTB-positive Huh7.5 cells are shown alongside (F). 
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  Figure 3.2: Uptake of Tf and CTB by hepatoma and control cell lines. 
Representative confocal image of CTB-555 uptake in Huh7.5 cells (A) and 
corresponding brightfield image (B).  Scale bars = 20 μm. Representative 
flow cytometry plot for Huh7.5 cells incubated with CTB-555, with CTB-
positive cells circled (C).  Quantification of CTB uptake in Huh7.5 cells by 
confocal microscopy and flow cytometry (D).  Results are the mean of four 
repeats. Error bars = standard error. 
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By confocal microscopy, cells in a region were counted using the brightfield image 
and the number of fluorescent cells in each region then counted and scored as a 
percentage of the total number of cells. Averages are shown in Figure 3.2 D and a 
representative flow cytometry plot is shown in Figure 3.2 C. By flow cytometry, 4.9% 
of Huh7.5 cells were detected as positive for CTB and by confocal microscopy 
10.8% of cells were detected as being positive for CTB.  There could be several 
explanations for this CTB- positive subpopulation; for example, dying Huh7.5 cells 
may take up CTB through a permeable membrane or the CTB-positive cells could 
represent a contaminant from another cell line, or an Huh7.5 sub-clone, which does 
express caveolin 1. As a control to ensure that CTB was not leaking through the 
permeabilised membranes of dying cells, Huh7.5 cells were stained using Sytox 
green, a dead cell stain which can enter cells with permeabilsed  membranes and 
bind to nucleic acids. Following staining with Sytox green, cells were incubated with 
CTB-555, fixed and imaged by confocal microscopy. As shown in Figure 3.3, cells 
which internalised CTB-555 did not stain positive for Sytox green. As a positive 
control, Huh7.5 cells were permeabilsed with 0.1% Triton X-100 prior to Sytox Green 
staining, shown in Figure 3.3 D. Moreover, to demonstrate that internalised CTB 
enters the cell via an endocytic route rather than directly penetrating the plasma 
membrane, SkHep and Huh7.5 cells were incubated with CTB at 4C to prevent 
endocytosis from occurring. As shown in Figure 3.3 E-F, under these conditions, 
CTB binds the plasma membrane but is not internalised in both SkHep1 control cells 
and in Huh7.5 cells, demonstrating that CTB enters both cell lines via a receptor-
mediated endocytic route. However, it is also possible that not all Huh7.5 cells 
contain GM1 in the plasma membrane, as not all cells are able to bind the ligand.  
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 As other routes for CTB entry 
have been implicated in 
different cell lines (Torgersen et 
al 2001, Singh et al 2003), it 
was important to ensure that 
the CTB uptake observed in 
Huh7.5 cells was occurring via 
a caveolar route. To confirm 
this, Huh7.5 cells were 
transiently transfected with 
caveolin 1-GFP, or clathrin-GFP 
prior to incubation with CTB-555. Cells were then fixed and imaged by confocal 
microscopy. The number of red CTB punctae which were also positive for the GFP-
tagged protein was scored as a percentage of the total number of CTB punctae. A 
negative control involving circling CTB-negative areas of the image, of similar size 
and similar cellular localisation to the CTB-punctae was employed to rule out 
colocalisation being scored as a result of the random alignment of pixels. The 
number of these which randomly colocalised with the GFP-tagged proteins was 
counted and subtracted from the percentage colocalisation. Significant colocalisation 
(p<0.05) was seen with both caveolin 1-GFP and Clathrin-GFP in transfected Huh7.5 
cells, when compared to GFP-transfected control cells (significance was determined 
using a Student’s T-test). However, as shown in Figure 3.4,  the percentage of 
colocalisation of CTB with caveolin 1-GFP was significantly greater than with 
clathrin-GFP, with 78.6% colocalisation observed with caveolin 1-GFP and only 
15.7% colocalisation observed with clathrin-GFP. As it has previously been shown 
Cell Line Tf Uptake CTB Uptake
HeLa + +
SkHep1 + +
Huh6 + -
Huh7.5 + 4.9-10.8%
HepG2-CD81 + -
Table 3.1: Uptake of Tf and CTB by hepatoma 
and control Cell Lines. 
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that cargo entering the cell through caveolae can traffic to early endosomes 
(Pelkmans et al 2004, Parton 2004) and early endosomes can contain clathrin-
coated membrane domains, this colocalisation with clathrin could easily be 
accounted for by CTB which has trafficked to clathrin-positive early endosomes.   
Therefore, we can conclude that a subpopulation of Huh7.5 cells can take up the 
caveolar marker CTB, are not dying cells with permeable membranes and 
internalised CTB in these cells may indicate the presence of caveolae, as 
internalised CTB colocalises with caveolin1-GFP in transiently transfected cells.   
However, in order to utilise these CTB-positive Huh7.5 cells for infection studies, 
they must be isolated so that the whole cell population is CTB-uptake positive and 
caveolin 1 expression shown by western blot. To achieve this, Huh7.5 cells were 
incubated with CTB and then FACS sorted in order to isolate the CTB-positive cells. 
Sorted cells were then cultured for 3 days and lysates were analysed for caveolin 1 
expression by western blot (Figure 3.1 F). However, caveolin 1 expression was still 
not observed. Therefore, it is possible that the internalised CTB visible within Huh7.5 
cells is internalised via a functionally and morphologically similar endocytic pathway 
acting independently of caveolin 1 (as described in Damm et al 2005). 
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Figure 3.3: Huh7.5 cells take up CTB via endocytosis. Sytox 
staining (A)  in Huh7.5 cells incubated with CTB-555 (B). 
Overlay shown in part C. Sytox staining in permeabilised cells is 
shown as a positive control (D).  SkHep1 (E) and Huh7.5 (F) 
cells were incubated with CTB-555 on ice. Images are 
representative of three repeats. 
A
B
A
B C
D
MergeCTB555
SytoxGreen
Sytox Green
20m
A)
B)
Huh7.5
10 μm
A B C D 
E F 
104 
 
 
 
 
  
0
10
20
30
40
50
60
70
80
90
100
Caveolin1-GFP Clathrin-GFP
%
 
C
o
lo
c
a
li
s
a
ti
o
n
***
A B C
FED
G
Figure 3.4: Huh7.5 cells take up CTB via caveolar endocytosis in cells 
transiently transfected with caveolin 1-GFP.  Huh7.5 cells transfected with 
caveolin 1-GFP, incubated with CTB-555 and imaged by confocal microscopy 
(A-C). Huh7.5 cells transfected with clathrin-GFP, incubated with CTB-555 and 
imaged by confocal microscopy (D-F).  Scale bars = 5 μm. Quantification of 
colocalisation between CTB and each endocytic marker is shown as a 
percentage in part G. Data shown are the mean of three independent 
experiments. Error bars = standard error. 
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Summary: 
1. The hepatoma cell lines Huh6, Huh7.5 and HepG2-CD81 do not express 
detectable caveolin 1, whereas, primary human hepatocytes and 
SKHep1 cells do. 
2. A subpopulation of 4.9-10.8% of Huh7.5 cells take up the caveolar 
marker CTB.  Internalised CTB colocalises with over-expressed caveolin 
1 in Huh7.5 cells but FACS sorting of these cells does not result in 
caveolin 1 detection by western blot. 
 
3.3.2 Caveolin 1 is expressed by hepatocytes in vivo 
As shown in Figure 3.1 A, primary human hepatocytes (PHH) express caveolin 1. 
To confirm caveolin 1 expression and observe protein localisation, PHH were grown 
in culture for up to three days and immunocytochemistry (IC) for caveolin 1 carried 
out at day 1, day 2, and day 3 post-plating. As shown in Figure 3.5, cultured PHH 
stained positive for caveolin 1, with punctate cytosolic staining at day one, with some 
relocalisation to the plasma membrane by day 2 and clear plasma membrane 
localisation at day 3. This would suggest that not only is caveolin 1 expressed in 
hepatocytes in vivo but may also be localised to the plasma membrane, where it is 
available for the formation of functional caveolae. In addition, IC for caveolin 1 was 
also carried out on human liver sections (Figure 3.5 A). However, while a low level 
of positive staining can be seen in the hepatocytes, caveolin 1 is expressed to such 
a high level by the liver sinusoidal endothelial cells (LSECs), the possible source of 
SKHep cells (see below), surrounding the hepatocytes in the liver sections that laser 
power and gain had to be reduced accordingly, to prevent saturation of the image. 
This is consistent with the expression level seen by western blot, with endothelial 
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cells expressing caveolin 1 at much higher levels than hepatocytes, however, the 
presence of endothelial cells in the liver sections makes caveolin 1 staining in the 
hepatocytes difficult to visualise clearly. For this reason, cultured primary human 
hepatocytes offer the clearest visualisation of caveolin 1 expression and localisation 
in liver cells. As cultured hepatocytes dedifferentiate and depolarise over time in 
culture, the staining observed at day 1 is likely to be most typical of that in polarised 
hepatocytes in the liver. Interestingly, as loss of polarisation promotes HCV infection, 
cultured primary hepatocytes are most permissive to HCV at days 2 and 3, when 
caveolin 1 is most strongly localised to the plasma membrane.  
As traditional hepatoma cell lines have been shown to be negative for caveolin 1, 
other HCV-permissive cell lines which do express caveolin 1 must be considered for 
HCV infection studies.  
Of the three positive control cells shown to express caveolin 1 by western blot 
(Figure 3.1 A), SkHep1 cells, are the only liver-derived cell line. SkHep1 cells were 
isolated from a hepatocellular carcinoma and originally believed to be of hepatocyte 
origin. However, there is some debate as to whether they may in fact be from an 
endothelial background (Heffelfinger et al 1992). Nevertheless, SkHep1 cells are 
HCV-permissive when transduced to express all HCV entry factors and receptors 
(Dreux et al 2009). They take up CTB, a commonly used marker for caveolar 
endocytosis and endogenously express two of the four HCV receptors/entry factors. 
SkHep1 cells stably transfected to express SRBI and CLDN1, known as SkHep1 
(SRBI+CLDN1) cells (generated and used previously by Ke Hu, McKeating lab) 
therefore offer a good model cell line for infection. 
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Sinusoidal 
endothelial cell 
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B: Day 1 in culture D: Day 3 in cultureC: Day 2 in culture
Anti-Cav1-568
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Figure 3.5: Expression of caveolin 1 in cultured primary human 
hepatocytes and liver sections. Caveolin 1 immunocytochemistry in human 
liver section containing hepatocytes with low caveolin 1 expression and liver 
sinusoidal endothelial cells (LSEC) with strong caveolin 1 expression (A). 
Caveolin 1 immunocytochemistry in primary human hepatocytes after 1 (B), 2 
(C), and 3 (D) days in cell culture. Scale bars = 5 μm.  Performed with help 
from Garrick Wilson and Helen Harris, McKeating lab, University of 
Birmingham, UK.  
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Summary: 
1. Hepatocytes within the liver express caveolin 1. 
2. Cultured primary human hepatocytes express caveolin 1.  
3. Plasma membrane expression of caveolin 1 increases over time in cell 
culture, consistent with dedifferentiation. 
4.  SkHep1 (SRBI+CLDN1) cells express caveolin 1 and are permissive to 
HCV, making them a suitable model for studies of HCV entry. 
 
 
3.4 Specifically inhibiting endocytic pathways in SkHep1 (SRBI+CLDN1) cells.  
 
3.4.1 Small molecule inhibitors 
Small molecule inhibitors offer an attractive means of inhibiting endocytic pathways 
as they exert their effects on the whole cell population and are not dependent on 
transfection efficiency. However, many inhibitory drugs exhibit undesired off-target 
effects and disrupt other endocytic pathways (Ivanov 2008). It is therefore important 
to use specific model cargo such as CTB and Tf to confirm the specificity of the 
inhibitor prior to use in viral entry experiments. 
One widely used small molecule inhibitor of clathrin-mediated endocytosis is 
chlorpromazine (CPZ), which is thought to cause clathrin lattices to assemble on 
endosomal membranes, preventing clathrin-coated pits from forming at the plasma 
membrane (Wang et al 1993). Inhibition of viral entry by CPZ in hepatoma cells is 
one of the key pieces of evidence for the clathrin-mediated entry pathway for HCV 
(Blanchard et al 2006).  However, demonstration of the effects of chlorpromazine 
using endocytic cargo such as Tf has not been carried out in HCV entry studies to 
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date, so it is uncertain if this effect is specific to the clathrin-mediated endocytic 
pathway.  Incubation of SkHep1 (SRBI+CLDN1) cells with CPZ at 1 µM (a 
concentration intermediate between the two concentrations used in Blanchard et al 
2006) exhibited some surprising effects on cargo uptake, unexpectedly increasing Tf 
uptake, and inhibiting CTB uptake, as shown in Figure 3.6. It is therefore clear that 
off-target effects of this drug in SkHep1 (SRBI+CLDN1) cells make unsuitable to take 
forward for use in HCV entry studies.  
More recently, a lactosyl ceramide isomer, L-t-LacCer, has been shown to inhibit 
caveolar endocytosis (Singh et al 2003). The inhibitor is thought to work by 
disrupting cholesterol-rich lipid rafts. However, as both cholesterol and lipid rafts play 
roles in other modes of endocytosis, it is important to confirm that the effects of this 
drug are specific to caveolar endocytosis. In SkHep1 (CLDN1+SRBI) cells, at a 
concentration of 10 µM, L-t-LacCer significantly inhibited uptake of CTB, whereas, 
the inactive control D-e-Lac-Cer had no significant effect, as expected (Figure 3.6). 
However, both Lac-Cer isomers inhibited Tf uptake and therefore do not act 
specifically on the caveolar pathway in this cell line. This is shown in Figure 3.6 K-N.  
Again, it is clear that off-target effects of this inhibitor may be an issue, as with CPZ. 
Dynasore is a small molecule inhibitor of both dynamin I and dynamin II and has 
been shown to act specifically on dynamin (Macia et al 2006). As both the clathrin-
mediated and caveolar pathways are dependent on dynamin II, treatment with 
Dynasore should inhibit uptake of CTB and LDL. As shown in Figure 3.7, a 30 
minute pre-incubation with 80 µM Dynasore is sufficient to inhibit CTB uptake by 
46% and LDL uptake by 32% in SkHep1 (SRBI+CLDN1) cells. Dynasore is therefore 
the only small molecule inhibitor tested which is suitable for use in HCV entry 
studies.
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Figure 3.6: Effect of small molecule endocytosis inhibitors on uptake of 
model cargo in SkHep1 (SRBI+CLDN1). Uptake of a clathrin marker transferrin is 
shown in control cells (A) and chlorpromazine treated cells (B). Quantification of Tf 
uptake is shown in (C). CTB uptake in control (D) and chlorpromazine-treated cells 
(E). Quantification of CTB uptake is shown in (F). CTB uptake in control (G), L-t-
LacCer treated (H) and De-LacCer (I) treated cells. Quantification is shown in (J).  
Tf uptake in control (K), L-t-LacCer  (L) and De-LacCer (M) treated cells is shown.  
Scale bars = 10 μm. Quantification is shown in (N). 90 cells per group were 
quantified from three repeats. Error bars = standard error. 
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Figure 3.7: Dyanasor  inhibits LDL and CTB entry in SkHep1 
(SRBI+CLDN1) cells. LDL uptake in DMSO treated control cells (A) and 
Dynasore-treated cells (B). LDL uptake is quantified in (C). CTB uptake in 
DMSO treated control cells (D) and Dynasore-treated cells (E). Quantification 
of CTB uptake is shown in (F). Scale bars = 20 μm. 90 cells were imaged and 
analysed per group from three independent repeats.  Error bars = standard 
error. 
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Summary: 
 
1. Dynasore significantly inhibits both clathrin-mediated and caveolar 
endocytosis. 
2. Chlorpromazine does not inhibit Tf uptake but does inhibit CTB uptake 
at the concentration used and is therefore not useful for infection 
studies. 
3. Lt-LacCer inhibits CTB uptake but also inhibits Tf uptake and is 
therefore not suitable for infection studies. 
 
 
3.4.2 HCVpp infection is Inhibited by Dynasore 
 As shown in Figure 3.7, treatment with 80 µM Dynasore for 30 minutes inhibited 
endocytosis of CTB by 46% and LDL by 32%. Therefore a significant inhibition of 
HCVpp infection is expected in Dynasore-treated cells. When carrying out HCVpp 
infection assays, murine leukaemia virus pseudoparticles (MLVpp) and vesicular 
stomatitis virus G pseudoparticles (VSV-Gpp) are used as controls. MLV is thought 
to be internalised by caveolar endocytosis (Beer et al 2005) and VSV is thought to 
be internalised exclusively by clathrin-mediated endocytosis (Cureton et al 2009), so 
both controls should also be significantly inhibited by Dynasore. SkHep1 
(CLDN1+SRBI) cells and Huh7.5 cells were pre-treated with 80 μ  Dynasore for 30 
minutes prior to addition of viral pseudoparticles, and was present throughout 
pseudoparticle incubation (8 hours). Luciferase reporter activity of infected cells was 
then assayed 72 hours later.  
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As shown in Figure3.8, HCVpp infection (H77 strain) is markedly inhibited in 
Dynasore-treated cells when compared to the DMSO control. Moreover, this result is 
comparable to that seen in Huh7.5 cells, demonstrating a strong dependency of 
HCVpp entry on dynamin in both cell lines. MLVpp and VSV-Gpp infections also 
showed a strong dynamin-dependency in both cell lines, as predicted, consistent 
with a vital role for dynamin in viral endocytosis by both endocytic pathways. 
 
Summary: 
1. Dynasore significantly inhibits endocytosis of HCVpp (H77) indicating a 
dynamin-dependent entry route. 
2. Dynasore also significantly inhibited endocytosis of control viruses 
MLVpp and VSV-Gpp. 
 
3.4.3 Inhibition of endocytic pathways by siRNA 
Silencing the expression of protein components within endocytic pathways using 
small interfering RNAs (siRNAs) can offer the most specific means of inhibiting 
endocytosis. As clathrin is involved in cellular processes other than endocytosis, 
siRNA against the α-adaptin subunit of the adaptor protein 2 (AP2) complex, which 
links the clathrin coat to cargo and the plasma membrane (Huang and Sorkin 2004), 
has been used alongside a pool of commercially available caveolin 1 siRNAs 
(Dharmacon) (Auciello et al 2013). In each case a non-targeting siRNA sequence 
has been used as the non-silencing control (NSC). As viral infections must take 
place over a 72 hour period, silencing was assayed 72 hours post-transfection with 
the siRNAs. Figure 3.9 A shows the efficiency of both AP2 and caveolin 1 
knockdown achieved by western blot. Two transfection reagents, Lipofectamine 
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2000 and Lipofectamine RNAiMAX, were tested for efficiency of protein silencing 
with both siRNAs. In each case, transfection with Lipofectamine RNAiMAX resulted 
in the greatest reduction in protein expression (data not shown).  
To ascertain specificity of protein silencing, endocytosis assays using model cargo 
were carried out alongside using CTB-555 and LDL-568. Over three repeats, 
consistent and significant inhibition of each pathway was observed, as shown in 
Figure 3.9. In each case, specificity was tested by observing the effects of silencing 
on the other pathway. Transfection with caveolin 1 siRNA resulted in a 58% 
reduction in CTB uptake, while having no significant effect on LDL uptake. AP2 
knockdown inhibited LDL uptake by 46%, and had no significant effect on CTB 
uptake. These results demonstrate that the siRNAs used are potent and highly 
specific means of inhibiting endocytic pathways and are suitable for use in HCVpp 
infection assays. 
    
Summary: 
1. Transfection of caveolin 1 and AP2 siRNA with Lipofectamine RNAiMAX 
results in efficient protein knockdown in SkHep1 (SRBI+CLDN1) cells. 
2. Knockdown of caveolin 1 significantly inhibits CTB uptake but has no 
significant effect on uptake of Tf or LDL, demonstrating specificity. 
3. Knockdown of AP2 significantly inhibits LDL uptake but has no 
significant effect on CTB, demonstrating specificity. 
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Figure 3.9: Knockdown of AP2 and caveolin 1 in SkHep1 (SRBI+CLDN1) 
cells.  Knockdown of AP2 and caveolin 1 shown by western blot (A).  CTB uptake 
in cells transfected with a non-silencing control (NSC) (B), AP2 siRNA (C) and 
caveolin 1 siRNA (D). Quantification of internalised CTB is shown in (E). LDL 
uptake in NSC (F), caveolin 1 knockdown (G) and AP2 knockdown (H) cells is 
shown.  Scale bars = 20 μm. Quantification of internalised LDL is shown in (I).  60 
cells were imaged and analysed per group, from three independent experiments. 
Error bars = standard error. 
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Figure 3.10: Knockdown of AP2 but not caveolin 1 inhibits HCVpp 
infection in SkHep1 (SRBI+CLDN1) cells.  HCV (H77) infection in non-
silenced control (NSC), AP2 knockdown and caveolin 1 knockdown cells (A).  
VSV-Gpp infection in NSC, AP2 knockdown and caveolin 1 knockdown cells 
(B).  MLVpp infection in NSC, AP2 knockdown and caveolin 1 knockdown cells 
(C). Results are means of three independent experiments. Error bars = 
standard error. 
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3.4.4 HCVpp entry is inhibited by AP2 siRNA but not caveolin 1 siRNA 
As mentioned previously, one of the most specific and effective ways to inhibit an 
endocytic pathway is to knock down proteins involved using siRNA. However, 
clathrin is involved in other cellular processes besides endocytosis from the plasma 
membrane, so siRNA targeting clathrin heavy chain could result in off-target effects. 
The adaptor protein 2 complex is exclusively involved in clathrin-mediated 
endocytosis and therefore presents an ideal target for siRNA knockdown. As shown 
in section 3.4.3, efficient and specific knockdown of both AP2 and caveolin 1 protein 
levels was achieved.  
A HCVpp infection assay was then carried out in SkHep1 (CLDN1+SRBI) cells 
transfected with AP2 or caveolin 1 siRNA, using MLVpp and VSV-Gpp as controls. 
Cells were incubated with viral pseudoparticles for 8 hours and luciferase reporter 
activity assayed 72 hours later.  
As shown in Figure 3.10, AP2 knockdown resulted in almost complete abrogation of 
HCVpp entry compared to the non-silencing control (NSC). In contrast, caveolin 1 
knockdown exhibited no discernible effect on HCVpp entry. This demonstrates that 
HCV does not utilise caveolae as an entry mechanism, even when the protein is 
expressed to high levels.  
Interestingly, AP2 knockdown had little effect on VSV-Gpp entry, suggesting that 
VSV entry is not dependent on AP2 as would be expected for a virus thought to have 
a clathrin-dependent entry mechanism (Cureton et al 2009). However, it is possible 
that VSV pseudoparticles enter via a clathrin-dependent but AP2 independent 
mechanism SkHep1 (CLDN1+SRBI) cells (Motley et al 2003).  
119 
 
Additionally, caveolin 1 knockdown significantly inhibited uptake of MLVpp in these 
cells, confirming effective knockdown in this case. Therefore, it is clear that even 
when caveolin 1 is expressed, as is the case in hepatocytes in vivo, HCV does not 
utilise caveolar endocytosis as an additional or alternative entry mechanism to 
clathrin-mediated endocytosis. The almost complete abrogation of HCVpp infection 
seen in AP2-silenced cells would suggest only one AP2-dependent pathway exists 
for HCV infection. 
 
Summary: 
1. AP2 knockdown abrogates HCVpp entry but has little effect on VSV-
Gpp. 
2. Caveolin 1 knockdown does not inhibit HCVpp entry and therefore 
caveolin 1 is not required for HCV entry in SkHep1 (SRBI+CLDN1) cells. 
 
3.5 Discussion 
While hepatocytes within the liver are known to express caveolin 1, there is a long-
standing belief that the hepatoma cell lines used to study HCV entry in vitro, do not. 
The fact that inhibition of clathrin-mediated endocytosis by small molecule inhibitors 
such as chlorpromazine and silencing of clathrin heavy chain abrogate HCV entry in 
hepatoma models substantiates a clathrin-mediated route of entry for the virus 
(Blanchard et al 2006, Codran et al 2006, Coller et al 2009). However, the lack of 
caveolin 1 expression in hepatoma cell lines has resulted in any role this pathway 
may play in in vivo infection being ignored. With increasing numbers of viruses 
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exhibiting altered routes of entry across multiple cell lines, or even utilising more than 
one pathway within the same cell line, it is important to address any potential role 
caveolin 1 may play in HCV infection both in vivo and in vitro.  
To confirm current understanding about caveolin 1 expression in human hepatocytes 
and hepatoma cell lines, caveolin 1 expression was assayed in a panel of hepatoma 
cell lines, as well as in primary human hepatocytes (PHH) (shown in Figure 3.1 A). 
As in the literature (Cokakli et al 2009), low levels of caveolin 1 expression were 
detectable in primary human hepatocytes and no detectable caveolin 1 expression 
seen for the hepatoma cell lines studied, even when caveolin 1 IP was carried out. 
Uptake assays using a common caveolar marker CTB largely confirmed these 
results, with no observable uptake in two of the three hepatoma cell lines 
investigated. However, interestingly, CTB uptake was observed in some Huh7.5 
cells. This population when assayed by flow cytometry and confocal microscopy was 
found to represent 4.9-10.8% of the cell population. However, when these cells were 
isolated by FACS, they still did not test positive for caveolin 1 expression by western 
blot. As there is mounting evidence for (a) pathway(s) functionally similar to caveolae 
but acting independently of caveolin 1, it is possible that this is the pathway utilised 
by the caveolar marker in this instance (Damm et al 2005). When caveolin 1-GFP 
was over-expressed in this cell line it colocalised with internalised CTB. However, 
caveolin 1 expression did not result in CTB uptake in a higher proportion of the cell 
population, suggesting that CTB is taken up by a caveolin 1-independent mechanism 
in these cells. Moreover, staining with a dead cell stain revealed that CTB was not 
simply passing through the permeabilised membranes of dying cells, and the 
membrane staining with CTB on ice shown in Figure 3.3 E and F is consistent with 
an endocytic route of entry for the marker. However, as caveolin 1 expression was 
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still not demonstrable in isolated CTB-positive Huh7.5 cells, another HCV-permissive 
caveolin 1-positive cell line was needed in order to be able to test the functional 
significance of caveolin 1 expression in hepatocytes.  
In initial caveolin 1 western blots, SkHep1 cells were used as a positive control cell 
line, and were shown to express high levels of the protein. SkHep1 cells transduced 
to express the non-endogenously expressed receptors (SRBI and CLDN1) are highly 
permissive for HCV infection (Cureton et al 2009) and so represent an ideal infection 
model for investigating the role of caveolin 1 in HCV infection.  
Means of inhibiting endocytic pathways in this cell line were then tested for their 
specificity before being carried forward for use in infection studies. It is important to 
test inhibitory methods using model endocytic cargo prior to use in infection studies, 
as endocytic trafficking pathways are often interconnected and perturbation of one 
pathway can often result in altered traffic by another. In particular, small molecule 
inhibitors are renowned for exhibiting off-target effects. However, they offer an 
attractive means of pathway inhibition as they exert their effects on the whole cell 
population and as such are not transfection efficiency-dependent. Additionally, 
inhibition of HCV entry by the clathrin inhibitor chlorpromazine (CPZ) is one of the 
key pieces of data suggesting a clathrin-mediated route of entry for HCV (Blanchard 
et al 2006), and its specificity was not demonstrated in this study. When CPZ was 
applied to SkHep1 (SRBI+CLDN1) cells at a concentration of 1 μ , a concentration 
intermediate to the two concentrations used in Blanchard et al 2006, it exhibited 
some surprising results on the uptake of model endocytic cargo Tf and CTB. Not 
only did CPZ inhibit uptake of the caveolar marker, CTB, thus not acting specifically 
upon clathrin-mediated endocytosis, but it also promoted Tf uptake in these cells. 
While it is possible that these effects are cell line-dependent, it is clear that CPZ can 
122 
 
have undesired off-target effects and cannot be solely relied upon in studies of 
endocytosis. Moreover, these results highlight the need to test inhibitors using model 
endocytic cargo before drawing conclusions based on their use. 
More recently, an isomer of lactosyl ceramide has been shown to affect caveolar 
endocytosis. This inhibitor, L-t-LacCer, is thought to exert its effect on the lipid-raft 
nature of caveolae. However, as multiple endocytic mechanisms require cholesterol 
and lipid rafts, perturbation of the composition of the plasma membrane is likely to 
result in multiple pathways being affected. When assayed in SkHep1 (SRBI+CLDN1) 
cells, the inhibitory isomer did markedly and specifically inhibit CTB uptake, exerting 
no effect on the clathrin-mediated endocytic cargo, Tf. Nevertheless, the inactive 
isomer intended for use as a control also inhibited CTB uptake, as well as Tf uptake 
in this cell line. Therefore neither of these small molecule inhibitors was suitable for 
use in infection studies. 
The small molecule inhibitor of dynamin, Dynasore, has been shown to act 
specifically on dynamin in a variety of endocytosis studies (Macia et al 2006, 
Kirchhausen et al 2008). As dynamin is implicated in both clathrin-mediated and 
caveolar endocytosis, it will not distinguish between the two pathways but will be 
able to confirm the dynamin-dependency of HCV uptake shown by previous 
hepatoma cell line studies in this cell line (Farquhar et al 2012). Dynasore effectively 
inhibited uptake of both Tf and CTB in SkHep1 (SRBI+CLDN1) cells. In HCVpp 
infection studies, Dynasore abrogated HCV infection in both SkHep1 (SRBI+CLDN1) 
cells as well as in Huh7.5 cells (the cells used initially to show dynamin-dependency 
of HCV entry). As the virus was unable to enter via dynamin-independent 
mechanisms this both confirms previous results and suggests that even if clathrin-
independent mechanisms of entry can be exploited by the virus, these must also be 
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dynamin-dependent. Dynasore treatment also inhibited uptake of VSV-Gpp and 
MLVpp which were employed as controls and are thought to internalise via clathrin-
mediated endocytosis and caveolar endocytosis, respectively (Beer et al 2005, 
Cureton et al 2009).  
As the other endocytosis inhibitors tested exhibited off-target effects when the 
uptake of model cargo was assayed, a more specific approach to inhibiting clathrin-
mediated and caveolar endocytosis was adopted. siRNA offers one of the most 
specific means of inhibiting endocytic pathways, and well transfection efficiency-
dependent, higher transfection efficiency can be achieved with siRNA than with 
DNA. To implement this approach, a custom AP2 siRNA was used to specifically 
inhibit clathrin-mediated endocytosis. As clathrin coated vesicles play roles in 
trafficking besides endocytosis from the plasma membrane, for example, transport 
from the trans-Golgi network, silencing of clathrin can have off-target effects. 
Therefore inhibition of components of the clathrin-mediated endocytic machinery is 
generally thought to offer a more specific means of inhibition. The AP2 complex is 
involved in connecting the clathrin lattice to phosphoinositides in the plasma 
membrane and serving as a cargo adaptor, and silencing of this protein has been 
shown to specifically inhibit clathrin-mediated endocytosis (Boucrot et al 2010). 
Additionally, a commercially available pool of siRNAs targeted to caveolin 1 was also 
employed (Dharmacon). Both siRNAs were compared to a non-targeting siRNA 
(non-silencing control; NSC). In assays of model cargo uptake, both siRNAs 
exhibited high specificity to their respective pathways and so were carried forward to 
HCVpp infection studies. As HCVpp infections must be carried out over 72 hours for 
measurable infection, it was important to ascertain that silencing is maintained 
throughout the assay. As such, cells were lysed 72 hours following transfection with 
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either AP2 or caveolin 1 siRNA and protein levels detected by western blot. This 
specificity was confirmed by endocytosis assays, as with Dynasore, and significant 
and specific inhibition was observed in each case. In pseudoparticle infections, 
HCVpp entry was markedly inhibited by AP2 silencing but unaffected by caveolin 1 
silencing. This suggests that even in the presence of caveolin 1, HCV enters cells 
strictly via clathrin-mediated endocytosis. The effectiveness of caveolin 1 silencing is 
demonstrated by the inhibition of MLVpp infection and confirmed by western blot. 
Interestingly, VSV-Gpp infection was not significantly inhibited by AP2 knockdown, 
consistent across three independent repeats. As there is some, albeit limited 
evidence for a clathrin-mediated pathway functioning independently of AP2 and/or 
accessory proteins such as Eps15 (Motley et al 2003, Hinrichsen et al 2003, Boucrot 
et al 2010), it is interesting to speculate that this pathway is operational in SkHep1 
cells and that VSV is internalised via this mechanism. Nevertheless, if this pathway 
exists, it is certainly not exploited by HCVpp which shows strong AP2-dependency.  
Additionally, it is thought that due to size constraints, VSV is not internalised via 
vesicles that resemble those involved in the clathrin-mediated endocytosis of Tf or 
LDL, rather VSV internalises in vesicles which are only partially coated in clathrin 
(Cureton et al 2009). While internalisation of these partially coated vesicles is 
thought to be dependent on AP2 (Cureton et al 2009), it is possible that these 
VSVpp internalisation relies on alternative adaptor proteins in this cell line. 
Therefore, the results of this chapter show that caveolin 1 plays no functional role in 
HCV entry in this in vitro model, where high levels of caveolin 1 are expressed. It is 
therefore is unlikely to play a role in HCV entry in vivo, where caveolin 1 levels are 
lower and localisation not enriched at the plasma membrane. This means that the 
increased caveolin 1 levels reported in depolarised cells, while correlating with 
125 
 
increased permissivity to infection, are not likely to be responsible for this change. 
The reason for the discrepancy between caveolin 1 expression in hepatocytes within 
the liver and the hepatoma cell lines used to study HCV infection remains unclear; 
however, it does not seem to be relevant to studies of HCV entry.  
There are reports of caveolin 1 playing a role in hepatocellular carcinoma 
tumourigenesis and metastasis (Cokakli et al 2009, Tse et al 2012), which would 
seem to contradict the loss of caveolin 1 in hepatoma cells in culture. Here, caveolin 
1 expression correlated with increased invasiveness, where over-expression of 
caveolin 1 in HepG2 and Huh7.5 cells promoted a more invasive phenotype (Tse et 
al 2012). This is thought to be a result of the role caveolin 1 plays in regulating the 
internalisation and signalling of cellular receptors such as growth factor receptors 
(Labrecque et al 2003, Pike et al 2005, Galvagni et al 2007). As caveolin 1 is known 
to play a role in liver regeneration and response to partial hepatectomy in mice 
(Fernández et al 2006), its role in hepatocarcinogenesis is perhaps unsurprising.  
 
3.6 Key chapter findings 
 
1. While hepatocytes within the liver express caveolin 1, the hepatoma cell lines 
used to study HCV infection in vitro do not. 
2. When a caveolin 1-positive HCV-permissive cell line, SkHep1(SRBI+CLDN1) 
are used in infection studies, infection is inhibited by Dynasore, a small 
molecule inhibitor of dynamin, and AP2 siRNA, but not caveolin 1 siRNA. 
3. Caveolin 1 is not required for HCV entry in caveolin 1-expressing HCV-
permissive cells. 
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3.7 Conclusions 
Data from this chapter take a systematic approach to the detection of caveolin 1 
expression in human liver, cultured PHH and hepatoma cell lines, and are consistent 
with the majority of disparate published studies on the subject. 
SkHep1 (SRBI+CLDN1) cells were identified as a HCV-permissive caveolin 1-
positive cell line for use in studies of the functional role of caveolin 1 in HCV entry. 
Consistent, efficient and specific knockdown of AP2 and caveolin 1 was 
demonstrated in this cell line and used to show definitively for the first time that 
caveolin 1 is not required for HCV entry, nor are caveolae utilised as an additional or 
alternative entry mechanism.  
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CHAPTER 4 
 
 
 
RESULTS 
 
 
 
CELLULAR EFFECTS OF EGF STIMULATION ON HUH7.5 CELLS 
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4.1 Introduction 
The epidermal growth factor receptor (EGFR) is a member of the ErbB family of 
receptor tyrosine kinases and is known to control a range of physiological processes 
including cell proliferation, migration and differentiation (Lynch et al 2004, Oda et al 
2005). EGFR is highly expressed in the liver (Lockhart and Berlin 2005) and was 
recently implicated as an entry factor for HCV (Lupberger et al 2011). Lupberger et al 
demonstrated through an RNAi kinase screen that silencing of EGFR inhibited 
HCVpp infection of both Huh7.5 and Huh7.5.1 hepatoma cells. Treatment with 
receptor tyrosine kinase inhibitors such as Erlotinib and Dasatinib also inhibited HCV 
entry, demonstrating that EGFR activity is necessary for HCV entry. In addition, 
stimulation of Huh7.5 cells with EGF was shown to promote viral entry. Following on 
from this, it has been shown that the internalisation of activated EGFR is required for 
HCV entry (Diao et al 2012). 
Regulation of EGFR activity is controlled by endocytosis and endocytic trafficking 
(Chung et al 2012). Upon stimulation with ligand, activated growth factor receptors 
undergo endocytosis. Endocytic trafficking controls the duration and intensity of 
growth factor receptor signalling as the balance between EGFR recycling and 
degradation serves to modulate levels of receptor signalling. EGFR is involved in 
signalling through multiple pathways, including MAPK, PI-3K and Src. Internalisation 
of activated receptor into multivesicular bodies terminates the signal (Lynch et al 
2004, Oda et al 2005). Conversely, growth factor receptor activation can cause 
modifications in trafficking pathways. EGF stimulation is known to exhibit effects on a 
number of endocytic pathways. Research has shown that at low physiological 
concentrations of EGF, the receptor internalises primarily via clathrin-mediated 
endocytosis (Benmerah et al 1999, Huang et al 2004), while at higher ligand 
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concentrations (which may be less physiologically relevant), clathrin-independent 
endocytosis may be employed for EGFR as the clathrin-mediated pathway becomes 
saturated with stimulated receptor (Sigismund et al 2005, Zhu et al 2005, Orlichenko 
et al 2006). Moreover, macropinocytosis is promoted in many cell types as a result of 
EGF stimulation and is typically described as a growth factor-dependent process 
(Bryant et al 2007). Therefore, it is possible that the increase in HCV entry shown by 
Lupberger et al occurs as a result of upregulation of one or more endocytic pathways 
following receptor activation, resulting in an increase in viral uptake in a receptor-
dependent or receptor-independent manner. 
There is growing interest in macropinocytosis as a route of viral entry and it has been 
shown to be the exclusive route of entry of some viruses in addition to a growing 
number of publications highlighting macropinocytosis as an alternative infection 
pathway for a wide variety of viruses with established receptor-mediated entry 
mechanisms (reviewed in Mercer and Helenius 2012). Some viruses bind to tyrosine 
kinases in order to initiate signalling events required for viral entry. For example, 
vaccinia virus has been shown to exhibit ‘apoptotic mimicry’, a mechanism by which 
exposed phosphatidyl serine in the viral envelope mimics apoptotic cells and binds to 
the tyrosine kinase Axl, stimulating macropinocytosis and consequent viral 
internalisation (Mercer and Helenius 2008, Mercer and Helenius 2010, Sandgren et 
al 2010, Schmidt et al 2011, Morizono et al 2011).  
Additionally, macropinocytosis is associated with increased filopodia formation, 
where filopodia fold back and fuse with the plasma membrane, encapsulating the 
extracellular fluid and membrane proteins and lipids contained within in nascent 
macropinosomes (Ridley 2006). Filopodia have been implicated in HCV entry, where 
they are thought to penetrate the sinusoidal membrane where they are able to 
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interact with T-lymphocytes and viral particles circulating in the sinusoidal blood, 
perhaps mediating the first contact with the virus (Warren et al 2006). Live cell 
imaging of DiD-labelled HCV particles in Huh7.5 cells expressing CD81-GFP 
showed that viral particles bind to CD81 in filopodia and ‘surf’ towards the cell body 
where endocytosis can occur (Coller et al 2009). Many different viruses associate 
with the microvilli of polarized epithelia as well as the filopodia of nonpolarized cells, 
including MLV and VSV-G, which enter cells via different endocytic mechanisms 
(Helenius et al 1980, Duus et al 2004, Smith and Helenius 2004, Lehmann et al 
2005). Virus particles surfing along filopodia are thought to exploit the inherent ability 
of filopodia to transport ligands towards the cell body and represents another 
example of viruses hijacking host cell machinery in order to achieve efficient infection 
(Lehmann et al 2005). Therefore it is important to consider macropinocytosis and 
filopodial extension as potential HCV entry-promoting effects of EGF stimulation of 
Huh7.5 cells. 
Nevertheless, the established entry mechanism of HCV is clathrin-mediated 
endocytosis (Blanchard et al 2006) and it is thought that virus binding induces 
association of CD81 and CLDN1 and their internalisation by clathrin-mediated 
endocytosis (Harris et al 2008, Farquhar et al 2012). However, the host-virus 
interactions that govern HCV internalisation are still not well understood.  
As EGFR internalization is thought to be critical for HCV entry (Diao et al 2012), 
determining the mechanism of internalisation of the receptor is of critical importance 
in understanding HCV entry. Under physiological concentrations of EGF, EGFR 
typically internalises via clathrin-mediated endocytosis (Benmerah et al 1999, Huang 
et al 2004). As such, the effects of EGF stimulation on clathrin-mediated endocytosis 
must be considered as a potential mechanism for increased viral entry.  
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As EGF stimulation is known to induce multiple cellular effects, depending on the 
concentration, ligand and cell type, it is important to determine the effects of EGF 
stimulation on endocytic pathways in Huh7.5 cells that may contribute to EGF-
promoted HCV entry. 
 
4.2. Chapter Aims 
The epidermal growth factor receptor (EGFR) has recently been implicated as an 
entry factor for HCV and EGF stimulation has been shown to promote HCV entry into 
Huh7.5 cells (Lupberger et al 2011). This stimulation of virus entry could be the 
result of promotion of the established clathrin-mediated route of virus entry as well as 
via EGF-mediated stimulation of other routes of internalisation such as 
macropinocytosis. The aims of this chapter are therefore to delineate the effects of 
EGF stimulation on endocytic pathways in Huh7.5 cells, with particular respect to the 
established viral entry route, clathrin-mediated endocytosis, as well as the growth 
factor-stimulated process of macropinocytosis, and associated filopodial formation 
and extension. 
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4.3 Results 
 
4.3.1 EGF Stimulation Promotes Macropinocytosis in Huh7.5 Cells 
To observe the broad effects of EGF stimulation on hepatoma cell morphology,  
Huh7.5 cells were transiently transfected with CFP-mem (Table 2.1), a construct 
encoding a CFP-tagged farnesylated fluorescent protein which inserts into the 
plasma membrane, allowing movements of the plasma membrane to be imaged in 
real time by live-cell confocal microscopy. A single z-plane in the centre of cells, 
where the plasma membrane was most clearly visible was selected and confocal 
images acquired at this focal plane in multiple x,y positions every minute for 60 
minutes. The most apparent effects of EGF stimulation were a visibly dramatic 
increase in plasma membrane ruffling, lamellipodia and filopodia formation, and 
membrane blebbing, all of which are indicative of macropinocytosis. This is shown in 
Figure 4.1, with yellow arrows highlighting endocytic vacuoles which appear to be 
macropinosomes. The effects of EGF stimulation on ruffling and blebbing in Huh7.5 
cells also appear to be dose-dependent, with a concentration of 20 ng/ml, a 
concentration typically used in studies of EGFR signalling events (e.g. Wang et al 
2002, Ren et al 2011), inducing a modest but noticeable amount of plasma 
membrane ruffling, and the appearance of some visible large endocytic vacuoles, 
possibly macropinosomes even from early timepoints of stimulation, as indicated by 
the yellow arrows (Figure 4.1 A). Similar, but more pronounced effects were seen 
with stimulation with a slightly higher concentration of 100 ng/ml EGF, a 
concentration typically used in studies of EGFR trafficking (e.g. Rappoport and 
Simon 2009, Sousa et al 2011) (Figure 4.1 B). However, much more dramatic 
effects were observed at a high concentration of 1 µg/ml EGF (the concentration 
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used by Lupberger et al 2011 to promote viral entry), and large membrane-bound 
vacuoles which resemble macropinosomes are clearly visible within stimulated cells, 
as indicated by the yellow arrows (Figure 4.1 C). The formation of blebs and 
macropinosomes in cells treated with 1 μg/ml EGF can be more clearly seen in 
Supplementary Video 1 B. While this is an extremely high concentration of EGF 
compared to the majority of published work on EGFR signalling and trafficking, the 
effects can be seen, albeit to a lesser extent, in cells stimulated with the more 
physiological concentrations shown in Figure 4.1 A and B. Therefore, we expect 
these effects to be physiologically relevant. Additionally, as this is the concentration 
shown to promote viral entry by Lupberger et al, these effects are potentially relevant 
to the associated increase in viral entry; therefore this is the concentration of EGF 
used for all further investigations into the EGF-stimulation of Huh7.5 cells, unless 
otherwise stated.  
Internalisation of CFPmem under stimulation with 1 μg/ml EGF was quantified in 
Figure 4.2 to determine if EGF stimulation resulted in bulk membrane uptake, as 
would be expected for macropinocytosis. To achieve this, Huh7.5 cells transiently 
transfected with CFPmem were imaged every 1 minute for 60 minutes in a single 
central plane of focus by confocal microscopy both with and without EGF stimulation 
(Supplementary Video 1 A and B, respectively). Regions of interest (ROIs) were 
then drawn around the plasma membrane and the intracellular area within the 
plasma membrane and fluorescence intensity measured at timepoints at 5 minute 
intervals. Background fluorescence was subtracted from each frame, and data 
normalised to the fluorescence intensity of the ROI at time 0. Without EGF 
stimulation, both plasma membrane fluorescence and intracellular CFP fluorescence 
remained fairly constant throughout the confocal timelapse with little internalisation 
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or photobleaching apparent, as shown in Figure 4.2. In contrast, stimulation with 1 
μg/ml EGF resulted in a drop in plasma membrane CFP fluorescence throughout the 
timelapse. By the 60 minute timepoint, plasma membrane fluorescence was reduced 
to 67.5% of that of unstimulated cells.  As photobleaching is not observed in the 
control (unstimulated) cells, this decrease is likely to be due to internalisation of 
areas of the plasma membrane rather than photobleaching. Correspondingly, EGF 
stimulation results in an increase in internal fluorescence signal throughout the 
timelapse, consistent with bulk internalisation of large areas of the plasma 
membrane.  
To confirm that EGF stimulation promotes macropinocytosis, a dextran uptake assay 
was carried out. 10 kDa dextran is a fluid phase marker, which, due to its size is 
largely internalised by macropinocytosis (although a low level of basal internalisation 
does occur in the absence of stimulation with EGF). As demonstrated by Figure 4.3, 
EGF stimulation results in a substantial increase in dextran uptake in Huh7.5 cells, 
with the fluorescence intensity of dextran-568 within cells stimulated with 1 μg/ml 
EGF for 30 minutes 3.89 times the basal level fluorescence observed in unstimulated 
cells. This corroborates the increase in macropinocytosis seen by live-cell imaging of 
CFPmem-transfected cells in response to EGF treatment.  
As macropinocytosis occurs in response to EGF stimulation, resulting in 
internalisation of both areas of the plasma membrane and extracellular fluid, it is 
possible that this effect of EGF stimulation contributes to the EGF-induced promotion 
of viral entry demonstrated by Lupberger et al. However, macropinocytosis is 
typically thought to be a relatively non-specific internalisation mechanism, with bulk 
uptake of areas of the plasma membrane and the extracellular fluid contained within. 
As such, although HCV may be internalised by EGF-induced macropinocytosis, this 
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route of entry may be receptor-independent and non-specific for HCV. Additionally, 
as the intracellular trafficking of macropinosomes is poorly understood, it is not clear 
whether macropinocytic viral uptake would result in productive HCV infection. 
 
Summary: 
1. EGF stimulation of Huh7.5 cells promotes a dose-dependent increase in 
plasma membrane ruffling, lamellipodia formation and blebbing, 
indicative of macropinocytosis. 
2. EGF stimulation results in bulk plasma membrane internalisation, 
suggesting macropinocytosis. 
3. EGF stimulation promotes dextran uptake in Huh7.5 cells, confirming 
EGF-dependent stimulation of macropinocytosis. 
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4.3.2 EGF Stimulation promotes filopodia formation and elongation in Huh7.5 
cells 
Hepatocytes and hepatoma cells have been shown to be rich in filopodia protruding 
from the cell body (Warren et al 2006, Amy Barnes M.Res thesis). It has been 
suggested that the filopodia of hepatocytes extend through the sinusoidal membrane 
where they are able to make contact with T-cells, suggesting a role for filopodia in 
mediating first contact with the virus (Warren et al 2006).  
Many viruses have been observed in association with the microvilli of polarised 
epithelial cells, as well as with filopodia of non-polarised cells (Helenius et al1980, 
Duus et al 2004, Smith and Helenius 2004, Lehmann et al 2005). Recently, some of 
these, including MLV and VSV-G have been shown to bind to receptors in the 
filopodia membrane and exploit the intrinsic ability of filopodia to transport receptors 
to the cell body for internalisation, in an actin and myosin II- dependent manner 
(Lehmann et al 2005).  
HCV has been shown to initially associate with filopodia in Huh7.5 cells before 
‘surfing’ towards the cell body for endocytosis (Coller et al 2009) and, in support of 
this, the inhibitor of actin polymerisation, Cytochalasin D markedly inhibits HCV entry 
(Codran et al 2006, Coller et al 2009). The HCV receptor CD81 is highly expressed 
within filopodia (Coller et al 2009) and is known to interact directly with viral particles 
(Pileri et al 1998, Zhang et al 2004). Thus, Coller et al propose a mechanism 
whereby viral particles bind to CD81 in filopodia before surfing towards the cell body 
where other viral receptors, entry factors and endocytic proteins are localised and 
viral entry can occur. EGF stimulation is known to induce WAVE- and Arp2/3-
dependent ruffling, resulting in both lamellipodia and filopodia formation, in 
association with macropinocytosis. As results from section 4.3.1 demonstrate that 
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macropinocytosis is significantly upregulated in Huh7.5 cells in response to EGF 
stimulation, and increased ruffling, lamellipodia and filopodia are clearly visible in 
Figure 4.1, this effect could be relevant to viral entry, aiding virus attachment and 
binding in both in vitro and in vivo settings.  
To observe filopodia formation and/or elongation in response to EGF treatment, 
Huh7.5 cells overexpressing CD81-GFP were imaged by confocal microscopy at the 
plane of focus with the highest number of filopodia (close to the adherent plasma 
membrane) every minute for 30 minutes following stimulation with 1 µg/ml EGF. As 
shown in Figure 4.4, the average number of filopodia per µm showed a modest but 
significant increase following 30 minutes of stimulation with EGF. This could 
potentially increase the likelihood of viral particles coming into contact with target 
cells. Interestingly, filopodia visible throughout the timelapse also increased 
significantly in length during the course of the EGF stimulation, from an average of 
1.86 µm to 2.71 µm (a 31.4% average increase). To take both effects into 
consideration, a metric called the ‘filopodial index’ was calculated (filopodial index= 
length x number/area). The filopodial index saw a marked and statistically significant 
increase in response to EGF treatment.  
It is possible that this effect of EGF stimulation is responsible for increased viral 
entry, where in vitro more and longer filopodia would be able to increase virus 
binding and in vivo, where longer filopodia would be able to extend further through 
the sinusoidal membrane, aiding virus attachment.  
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Figure 4.3: Dextran uptake in response to EGF 
stimulation. Huh7.5 cells incubated with fluorescent 10 kDa 
dextran without EGF stimulation (A) or with stimulation with 1 
μg/ml EGF (B) and imaged by confocal microscopy . Scale 
bars = 10 μm. 60 cells were analysed per group, data shown 
are the mean from three independent experiments. Error 
bars = standard error.  
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4.3.3 CD81 is not enriched in filopodia following EGF stimulation 
As shown in Section 4.3.2, filopodia formation and elongation are promoted in 
response to EGF stimulation of Huh7.5 cells. Filopodia have been implicated in HCV 
entry (Codran et al 2006, Coller et al 2009). As such, this effect of EGF stimulation 
may be relevant to the increase in viral entry seen in response to EGF stimulation. 
CD81 is highly expressed in filopodia and is thought to mediate binding of the virus 
to filopodia and its translocation towards the cell body (Coller et al 2009). Previous 
work has shown that CD81 is enriched within filopodia, and the diffusion coefficient 
of CD81 within filopodia is significantly higher than that at the plasma membrane 
(Amy Barnes M.Res thesis). However, the expression of CD81 within filopodia 
following EGF treatment has not been investigated to date.  
Therefore, we investigated whether CD81 was enriched in filopodia following EGF 
stimulation. Huh7.5 cells overexpressing CD81-GFP were imaged by live-cell 
confocal microscopy, with images acquired every five minutes for 1 hour in the plane 
of focus containing the most visible filopodia. A 2 pixel x 2 pixel ROI was drawn 
within filopodia at time zero and after 30 minutes EGF stimulation and fluorescence 
intensity measured. As shown in Figure 4.5, there was no significant difference in 
the CD81-GFP fluorescence intensity within filopodia between EGF-treated and 
untreated cells.  
 
Summary: 
1. EGF stimulation promotes filopodia formation in Huh7.5 cells, resulting 
in increased numbers of filopodia following 30 minutes of stimulation at 
1 µg/ml. 
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2. EGF stimulation results in elongation of filopodia. 
3. Filopodia may play a role in HCV infection by binding to virus and 
allowing it to translocate towards the cell body for internalisation. 
4. Localisation of HCV co-receptor CD81 within filopodia is not enriched by 
EGF stimulation. 
 
4.3.4 EGF Stimulation Promotes Clathrin-Mediated Endocytosis in Huh7.5 Cells 
 Although macropinocytosis is a growth factor-dependent process, EGF stimulation 
is known to exert effects on other endocytic pathways, depending on the cell line and 
concentration used. High concentrations of EGF stimulation, such as that used by 
Lupberger et al to promote HCV entry, are thought to induce uptake of activated 
EGFR by caveolar endocytosis (Sigismund et al 2005, Zhu et al 2005, Orlichenko et 
al 2006). However, as we have already demonstrated that Huh7.5 cells do not 
express caveolin 1 (Figure 3.1A), this pathway can be excluded from our analysis. 
At physiological concentrations, EGF stimulation has been shown to promote 
clathrin-mediated endocytosis, resulting in internalisation of activated EGFR via this 
route (Benmerah et al 1999, Huang et al 2004). As the established route of entry for 
HCV and receptor CD81 is by clathrin-mediated endocytosis, it is important to 
consider the effects EGF stimulation has on this pathway in Huh7.5 cells.  
To investigate the possibility that clathrin-mediated endocytosis is upregulated in 
response to EGF treatment, Huh7.5 cells were transiently transfected with Clathrin-
dsRed (Table 2.1) and the same cells imaged by total internal reflection fluorescence 
microscopy (TIRF) microscopy both before EGF stimulation and after 30 minutes 
stimulation with 1 μg/ml EGF to observe clathrin-coated pit formation on the adherent 
plasma membrane.   
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Figure 4.4: EGF stimulation promotes filopodia formation. Huh7.5 cells 
transiently transfected with CD81-GFP to label the filopodia and imaged by TIRF 
microscopy prior to EGF treatment (A) and following 30 min EGF stimulation at 1 
μg/ml (B).  Quantification of the number of filopodia per unit area is shown in (C), 
quantification of filopodia length is shown in (D) and filopodial index quantification is 
shown in (E). Data shown are the means of three repeats. Error bars = standard 
error. 
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Figure 4.5: CD81 is not enriched in filopodia upon EGF 
stimulation. Huh7.5 cells overexpressing CD81-GFP were 
imaged by confocal microscopy with and without stimulation with 
1 μg/ml EGF for 30 minutes, and CD81 fluorescence intensity 
within filopodia measured. Data shown are the mean of three 
independent experiments. 60 filopodia per group were analysed. 
Error bars = standard error. 
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Using an automatic analysis approach generated by Jeremy Pike (Rappoport lab), 
CD81 cluster density in the adherent plasma membrane was measured with and 
without EGF stimulation. As shown in Figure 4.6, 30 minutes EGF stimulation results 
in an average 17.71% increase in the ‘structure density’ of clathrin punctae in the 
adherent plasma membrane, demonstrating that more clathrin-coated pits are being 
formed under conditions of EGF stimulation. This indicates that clathrin-mediated 
endocytosis is upregulated in response to EGF treatment.  
To observe whether activated EGFR internalises via clathrin-mediated endocytosis, 
Huh7.5 cells were transiently transfected with EGFR-GFP and Clathrin-dsRed 
(Table 2.1) and imaged by TIRF microscopy with and without EGF stimulation in 
order to observe the clustering and colocalisation of the proteins on the adherent 
plasma membrane. As shown in Figure 4.7, prior to addition of EGF, clathrin 
punctae were observable on the adherent plasma membrane but EGFR expression 
was more diffuse throughout the plasma membrane, with little observable receptor 
clustering. Following 30 minutes EGF stimulation, clusters of EGFR become visible 
and these clearly co-localise to a high degree with clathrin punctae, indicating a 
clathrin-mediated entry route for the activated receptor. Therefore, we can conclude 
that EGF stimulation promotes clathrin-coated pit formation in Huh7.5 cells, resulting 
in clathrin-mediated endocytosis of the activated receptor. 
As HCV is known to internalise via clathrin-mediated endocytosis in Huh7.5 cells, 
this effect of EGF stimulation is likely to be relevant to the EGF-stimulated promotion 
of viral entry. Additionally, the internalisation of EGFR has been shown to be 
necessary for HCV entry (Diao et al), therefore this effect is of EGF stimulation is of 
key relevance to HCV entry. 
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However, it is unclear whether HCV and its receptors internalise along with EGFR. 
Therefore, it will be necessary to determine whether viral receptors and entry factors 
colocalise and internalise with EGFR following EGF treatment. 
 
Summary:  
1. EGF stimulation promotes clathrin-coated pit formation in Huh7.5 
cells. 
2. EGF stimulation results in clustering of EGFR on the plasma 
membrane, and clustered EGFR colocalises with clathrin, suggesting 
a clathrin-mediated route of entry for the activated receptor. 
 
4.3.5 Knockdown of PAK1 and AP2 in Huh7.5 cells 
Results from this chapter clearly demonstrate that two endocytic pathways are 
upregulated in response to EGF stimulation of Huh7.5 cells, which could offer a 
mechanism for the EGF-induced increase in viral entry in these cells. The clathrin-
mediated pathway, which is the classical entry route for HCV is stimulated, as well 
as macropinocytosis, which is being shown to be involved in the entry of an 
increasing number of viruses (Mercer and Helenius 2008). In order to delineate the 
effects of each pathway on EGF-stimulated HCV entry, inhibition of each pathway 
must be achieved, as in Chapter 3. As AP2 is involved exclusively in clathrin-
mediated endocytosis and was successfully knocked down in SkHep1 
(SRBI+CLDN1) cells (Figure 3.9), the same siRNA sequence was transfected into 
Huh7.5 cells and a western blot for AP2 carried out.  
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Figure 4.6: EGF stimulates clathrin-coated pit formation. Huh7.5 cells 
transiently transfected with clathrin-dsRed and imaged by TIRF microscopy prior 
to EGF treatment (A) and following 30 min EGF stimulation at 1 μg/ml (B).  
Quantification of the number of clathrin coated pits is shown in (C). Feature 
density analysis was performed by Jeremy Pike, PSIBS doctoral training centre, 
Univeristy of Birmingham, UK. 12 cells per group were analysed and means are 
shown. Error bars = standard error. 
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Figure 4.7: EGFR colocalises with clathrin upon EGF stimulation. Huh7.5 
cells overexpressing EGFR-GFP and Clathrin-dsRed were imaged by TIRF 
microscopy prior to EGF stimulation (A) and after 30 minutes stimulation with 1 
μg/ml EGF. Scale bar= 5 μm.  
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As shown in Figure 4.8 B, successful knockdown of AP2 was achieved, and this 
was confirmed by a Tf uptake assay (Figure 4.8 D). PAK1 has been shown to be 
important for all stages of macropinocytosis, including macropinosomes formation 
and closure, and inhibition of PAK1 has been shown to inhibit macropinocytosis in 
other cell lines, without affecting other endocytic pathways (Dharmawardhane et al 
2000, Parrini et al 2005, Liberali et al 2008). Therefore, a PAK1 siRNA sequence 
(Dharmacon) was transfected into Huh7.5 cells and a western blot carried out to 
assay protein levels. As shown in Figure 4.8 A, PAK1 protein levels in siRNA-
transfected cells are visibly lower than in those transfected with a non-silencing 
control (NSC). The functionality of this knockdown was confirmed by a dextran 
uptake assay. As shown in Figure 4.8 C, dextran uptake was significantly inhibited in 
PAK1 knockdown cells when compared to NSC-transfected cells. This preliminary 
work will allow for the contribution of each endocytic pathway to EGF-stimulated 
HCV entry to be determined in future HCVpp infection assays. 
 
4.4 Discussion 
The epidermal growth factor receptor (EGFR) has recently been identified as an 
entry factor for HCV (Lupberger et al 2011). Lupberger et al show that silencing of 
EGFR and inhibition with kinase inhibitors reduces HCV infection. Additionally, the 
authors show that stimulation of Huh7.5 cells with a high concentration (1 μg/ml) of 
EGF promotes viral entry in Huh7.5 cells. EGFR activation is known to affect 
endocytic trafficking and could therefore promote viral entry by stimulating viral 
endocytosis by one or more endocytic mechanisms in a receptor-dependent or -
independent manner. Therefore, the aim of this chapter was to characterise the 
effects that EGF stimulation has on endocytic pathways in Huh7.5 cells. 
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Figure 4.8: Knockdown of AP2 and PAK1 in Huh7.5 cells. Western blots 
showing knockdown of PAK1 and AP2 in Huh7.5 cells (A & B).  Quantification of 
internalised dextran in Huh7.5 cells transfected with a non-silencing control 
(NSC) or with PAK1 siRNA (C). Quantification of internalised Tf fluorescence in 
Huh7.5 cells transfected with a non-silencing control (NSC) or with AP2 siRNA 
(D). 60 cells per condition were analysed and means are shown. Error bars = 
standard error. 
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To observe the effects of EGF stimulation, Huh7.5 cells were transiently transfected 
with CFPmem to label the plasma membrane and cells imaged by live-cell confocal 
microscopy at increasing EGF concentrations. The concentration used by Lupberger 
et al to promote HCV entry (1 μg/ml) is an extremely high concentration to treat cells 
with so multiple EGF concentrations were initially tested to observe their effects on 
Huh7.5 cells. Firstly, cells were treated with 20 ng/ml EGF, a concentration typically 
used in studies of EGFR signalling (e.g. Wang et al 2002, Ren et al 2011). This led 
to modest but observable ruffling of the plasma membrane, as well as the 
appearance of large intracellular membrane-bound vacuoles, indicative of 
macropinocytosis. These same effects were seen to a greater extent when the EGF 
concentration was increased to 100 ng/ml, a concentration typically used in studies 
of the endocytic trafficking of EGFR (e.g. Rappoport and Simon 2009, Sousa et al 
2011). Finally, the EGF concentration was increased to 1μg/ml as this was the 
concentration used in Lupberger et al 2011 to promote HCV entry. Treatment with 
this concentration led to significant cell-wide plasma membrane ruffling, lamellipodia 
and filopodia formation and membrane blebbing, all of which are indicative of 
macropinocytosis (Figure 4.1). This is an extremely high concentration of EGF; 
however these same effects are visible at lower concentrations, as indicated by the 
yellow arrows, even at early timepoints. As these effects increase in a dose-
dependent manner, and are most prominent at the concentration used by Lupberger 
et al, they may be relevant to the EGF-induced increase in HCV entry. As the effects 
are most apparent at 1 μg/ml, and this is the concentration at which HCV entry has 
been shown to be promoted, this was the concentration used for further 
investigations into the effects of EGF stimulation. This was also the concentration 
used to quantify the bulk membrane internalisation seen upon EGF stimulation 
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(shown in Supplementary Video 1). Quantification of plasma membrane 
fluorescence during 60 minutes EGF stimulation revealed that the plasma membrane 
fluorescence of EGF-treated cells decreased to around 60% of that of untreated cells 
by the 60 minute timepoint (Figure 4.2). Correspondingly, intracellular fluorescence 
increased in response to EGF stimulation, demonstrating that EGF stimulation 
promotes bulk plasma membrane internalisation, indicative of macropinocytosis. To 
confirm induction of macropinocytosis, uptake of the fluid-phase marker 10kDa 
dextran was measured in untreated and EGF-treated cells. As shown in Figure 4.3, 
dextran uptake was significantly upregulated in response to EGF treatment, 
confirming that EGF stimulation promotes macropinocytosis in Huh7.5 cells. 
Therefore, the promotion of HCV entry by EGF stimulation of Huh7.5 cells may be 
due to fluid-phase uptake of viral particles in the surrounding extracellular fluid. 
However, macropinocytosis is thought to be a relatively non-specific process, 
resulting in bulk uptake of the plasma membrane and the extracellular fluid contained 
within. Therefore, both receptor-bound and unbound virus could be internalised non-
specifically via this mechanism. It has been shown that EGF treatment promotes 
pseudoparticle infection not only of HCV in Huh7.5 cells, but also of influenza A, 
VSV, and endogenous feline leukaemia virus (RD114). Treatment with protein 
kinase inhibitors Erlotinib and Dasatinib also reduced infection of these viruses in 
Huh7.5 cells, whereas EGF and kinase inhibitors exhibited no effect on measles 
virus entry into these cells (Lupberger et al 2011).Therefore, it seems that the effects 
of EGF stimulation on Huh7.5 cells are not specific to HCV, however, they do not 
promote infection of all viruses. 
Influenza viruses and VSV are thought to be typically internalised via clathrin-
mediated endocytosis (Lakadamyali et al 2004, Cureton et al 2009), whereas 
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measles virus and RD114 are thought to fuse directly with the plasma membrane in 
a pH-independent manner (Sandrin et al 2002). Therefore, macropinocytosis could 
offer an explanation for the internalisation of viruses with multiple entry pathways in 
response to EGF stimulation. 
However, as endocytic trafficking following macropinocytosis is poorly understood, it 
is unclear if viral particles entering via this pathway would traffic through the same 
compartments as particles internalised via clathrin-mediated endocytosis. As HCV 
infection is pH and Rab5 -dependent, it is thought that fusion occurs within the early 
endosome; therefore traffic through this compartment is crucial for productive 
infection to occur.  
However, more recently evidence has come to light that macropinocytosis operates 
some sorting capacity with different growth factors stimulating internalisation of some 
receptors over others (Schmees et al 2012). Therefore, EGF-induced 
macropinocytosis may operate in a receptor-dependent manner, with internalisation 
of some receptors promoted over that of others. Whether the internalisation of HCV 
receptors and entry factors is promoted by EGF stimulation is something that must 
therefore be determined. 
However, as HCV is thought to internalise via clathrin mediated endocytosis in 
Huh7.5 cells, it was important to ascertain the effects of EGF stimulation on this 
pathway (Blanchard et al 2006). Therefore, clathrin-dsRed transfected cells were 
imaged via TIRF microscopy before and after EGF stimulation and clathrin coated pit 
density in the plasma membrane measured. EGF stimulation increased the density 
of clathrin punctae in the plasma membrane, demonstrating that EGF stimulation 
promotes clathrin-mediated endocytosis in Huh7.5 cells in addition to 
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macropinocytosis (Figure 4.6). Additionally, EGFR was shown to cluster on the cell 
surface in response to EGF stimulation and colocalise with these clathrin punctate, 
indicating that EGF stimulation promotes EGFR internalisation via clathrin-mediated 
endocytosis (Figure 4.7). EGFR endocytosis has been shown to be important for 
HCV entry as the requirement for kinase activation can be bypassed by treatment 
with EGFR antibodies that block both ligand-induced EGFR activation but still induce 
EGFR internalisation (Diao et al 2012). EGFR has been shown to internalise via 
different mechanisms, depending on the concentration of applied ligand, primarily 
internalising via clathrin-mediated endocytosis at physiological concentrations 
(Benmerah et al 1999, Huang et al 2004) and via clathrin-independent mechanisms 
when concentrations are increased and conventional internalisation routes become 
saturated (Sigismund et al 2005, Zhu et al 2005, Orlichenko et al 2006). As the 
concentrations of EGF applied in HCV entry studies (Lupberger et al 2011, Diao et al 
2012) are extremely high, the demonstration of EGFR internalisation via clathrin-
mediated endocytosis under these conditions is of key relevance to HCV entry. 
It remains to be determined, however, whether HCV and HCV receptors internalise 
with EGFR.  It will therefore be interesting to investigate whether HCV receptors 
colocalise with and internalise with activated EGFR in this manner following EGF 
stimulation. 
As both pathways are upregulated in response to EGF stimulation, it is unclear 
whether one or both pathways contribute to the EGF-induced increase in HCV entry. 
Infection of several viral pseudoparticles with different entry mechanisms is 
upregulated in Huh7.5 cells in response to EGF stimulation, including VSV and 
influenza A which internalise via clathrin-mediated endocytosis under normal 
circumstances (Cureton et al 2009, Lakadamyali et al 2004). As EGFR is also 
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internalised via a clathrin-mediated endocytic mechanism in response to stimulation 
with 1 μg/ml EGF in Huh7.5 cells, this is suggestive of the upregulation of clathrin-
mediated endocytosis being responsible for increased infection of viruses with 
established clathrin-mediated entry routes such as HCV.  
Macropinocytosis however, may offer an explanation for the EGF-induced increase 
in entry of viruses with direct fusion entry mechanisms. These viruses are not 
dependent on pH-mediated fusion within intracellular compartments and so would 
not be dependent on trafficking through the endosomal system for fusion and 
productive infection to occur.  
One way to delineate between the effects of the two upregulated endocytic pathways 
on HCV entry would be to knock down components of each pathway, as shown for 
caveolin 1 in Chapter 3. As AP2 is required for clathrin-mediated endocytosis and 
was knocked down successfully in SkHep1 (SRBI+CLDN1) cells, the same 
sequence was used with success in Huh7.5 cells (Figure 4.8 B and D). PAK1 has 
been shown to be crucial to all stages of macropinocytosis (Dharmawardhane et al 
2000, Parrini et al 2005, Liberali et al 2008) and expression of a PAK1 autoinhibitory 
domain or dominant negative PAK1 in NIH-3t3 cells has been shown to dramatically 
inhibit the rate of macropinocytosis stimulated by activated PDGFR 
(Dharmawardhane et al 2000) without any effect on other endocytic processes such 
as clathrin-mediated endocytosis. Therefore, PAK1 siRNA was used to inhibit 
macropinocytosis in Huh7.5 cells (Figure 4.8 A and C). Both siRNAs reduced levels 
of the relevant protein and inhibited dextran and transferrin uptake respectively. 
Future work will involve applying these knockdowns to HCV infection assays to 
determine the contributions of each pathway to EGF-stimulated infection. 
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Nevertheless, one common result of growth factor-stimulated macropinocytosis is an 
increase in filopodia formation. During macropinocytosis, filopodia protruding from 
the plasma membrane can fold back, fusing with the plasma membrane and 
internalising the extracellular fluid and membrane proteins and lipids contained within 
into a nascent macropinosomes (Ridley 2006). Although many viruses are known to 
interact with actin-rich structures such as microvilli and filopodia, the role that these 
associations have in viral entry has been unclear (Helenius et al 1980, Duus et al 
2004, Smith and Helenius 2004, Lehmann et al 2005). There is some evidence that 
virus binding to filopodia induces “surfing” of the virus and bound receptors towards 
the cell body ina process that is dependent on the actin cytoskeleton and myosin II 
(Lehmann et al 2005, Coller et al 2009). Liver-derived cells are rich in filopodia and 
these structures have recently been implicated in HCV attachment and surfing 
towards the cell body for internalisation (Coller et al 2009). In vivo, filopodia are 
thought to extend through the sinusoidal membrane where they mediate the first 
interactions between hepatocytes and viral particles (Warren et al 2006). As EGF-
stimulation results in macropinocytosis and filopodia may play an important role in 
mediated virus contact with target cells, the effects of EGF stimulation on filopodia 
formation and growth were investigated. As CD81 is highly expressed in filopodia 
(Figure 4.4 A and B), CD81-GFP was used as a fluorescent marker for filopodia, 
and both number per unit area and length of filopodia assayed by live cell confocal 
microscopy. Both number of filopodia and the length of filopodia present throughout 
the duration of the timelapse increased significantly following EGF stimulation, 
compared to cells prior to addition of EGF. This corroborates the evidence for EGF-
stimulated macropinocytosis in Huh7.5 cells and also offers an alternative 
mechanism by which infection could be promoted by EGF treatment. The observed 
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effects on filopodia formation and elongation were combined to describe the effects 
on both the de novo formation of filopodia and elongation of existing filopodia into the 
‘filopodial index’, which also increases significantly upon EGF stimulation. Filopodial 
growth as a result of increased macropinocytosis could promote HCV infection by 
increasing hepatoma cell surface area, aiding virus attachment and binding and 
bringing greater numbers of viral particles towards the cell body for internalisation, or 
could promote internalisation through their role in macropinocytosis.  
As CD81 is highly expressed in filopodia and is known to directly interact with the E2 
envelope glycoprotein of HCV, its expression levels within filopodia were assayed 
prior to EGF addition and following 30 minutes stimulation with EGF. Previous work 
has shown that the diffusion coefficient of CD81 within filopodia is significantly higher 
than within the plasma membrane at the cell body, and this significantly increased in 
response to addition of soluble E1E2 (Amy Barnes M.Res thesis). However, there 
was no significant change in the fluorescence intensity of CD81-GFP within filopodia 
upon EGF stimulation, demonstrating that CD81 does not relocalise to these 
structures as a result of EGFR activation, nor does any resultant retrograde 
trafficking of proteins within filopodia result in a decrease in CD81 localisation within 
filopodia.   
Therefore, EGF stimulation exhibits three non-mutually exclusive effects on Huh7.5 
cells which may contribute to an EGF-stimulated increase in HCV entry. These 
include an increase in clathrin-mediated endocytosis, the established entry 
mechanism for HCV, an increase in macropinocytosis, which could promote viral 
uptake in a non-specific or receptor-dependent manner, and a corresponding 
increase in filopodial index, which could promote both virus particle attachment and 
internalisation.  
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Efficient knockdown of components of each pathway has been shown, and future 
work should apply this to infection assays to determine the contribution of each 
pathway to EGF-stimulated HCV infection. 
 
4.5 Key Chapter Findings 
 
1. EGF stimulation promotes clathrin-coated pit formation and the 
clustering of activated EGFR in CCPs. 
2. EGF stimulation promotes membrane ruffling and blebbing, bulk 
membrane uptake and fluid-phase uptake, indicative of 
macropinocytosis in Huh7.5 cells. 
3.  EGF stimulation promotes filopodia formation and elongation in Huh7.5 
cells, which may aid virus attachment and binding as well as 
contributing to macropinocytic uptake. 
 
 
4.6 Conclusions 
 
These results demonstrate that EGF stimulation exhibits multiple effects on Huh7.5, 
which may contribute to the associated promotion of HCV entry and provide novel 
insights into the possible mechanism of action of EGF stimulation in HCV entry and 
the role of EGFR in mediating HCV entry. The established entry route of HCV in 
Huh7.5 cells, clathrin-mediated endocytosis is upregulated in response to EGF 
stimulation and is the route of entry of the activated EGFR. However, 
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macropinocytosis is also upregulated in Huh7.5 cells in response to EGF stimulation, 
resulting in bulk membrane internalisation, which may contribute to the EGF-
dependent increase in HCV entry. Additionally, filopodia formation and elongation 
are promoted in response to EGF stimulation, as is typical of macropinocytosis. As 
filopodia have been implicated in HCV attachment and ‘surfing’ towards the cell body 
for internalisation, this could be relevant to the increase in HCV entry following EGF 
stimulation. As endocytic trafficking is altered in response to EGF stimulation, it will 
be important to study the localisation and trafficking of HCV receptors in response to 
EGF stimulation.  
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CHAPTER 5 
 
 
 
RESULTS 
 
 
 
EFFECTS OF EGF STIMULATION ON EGFR AND CD81 LOCALISATION AND 
TRAFFICKING IN HUH7.5 CELLS 
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5.1 Introduction 
The receptor tyrosine kinase EGFR was recently shown to be an important entry 
factor for HCV (Lupberger et al 2011). Lupberger et al demonstrated that knockdown 
of EGFR and treatment with tyrosine kinase inhibitors inhibited HCVpp infection and 
that stimulation with EGF promotes viral entry in Huh7.5 and Huh7.5.1 hepatoma 
cells. While the authors demonstrate that EGFR ligands can increase HCV entry, the 
exact molecular mechanisms of EGF-stimulated HCV entry still remain unclear. 
The productive entry of HCV is a complex multi-step process dependent on multiple 
receptors and entry factors, the functional and physical interplay between which is 
still poorly understood. Current knowledge of HCV co-receptor interactions suggests 
that CD81 and CLDN1 associations are prompted by virus binding, leading to 
internalisation of the two co-receptors via clathrin-mediated endocytosis (Harris et al 
2008, Farquhar et al 2012).  
EGFR is highly expressed in the liver (Lockhart and Berlin 2005) and is thought to 
influence HCV entry by mediating CD81-CLDN1 co-receptor associations, as siRNA 
targeted against EGFR and Erlotinib treatment reduced fluorescence resonance 
energy transfer (FRET) between the two co-receptors (Lupberger et al 2011). 
Following on from this work, CD81 has been shown to colocalise intracellularly with 
EGFR upon TGFα stimulation by confocal microscopy, leading the authors to 
suggest that the two receptors/entry factors internalise together (Diao et al 2012). 
However, as colocalisation was visualised by confocal microscopy after 15 minutes 
stimulation it is not clear whether the two receptors internalised together or simply 
traffic to the same intracellular compartment. The authors also show that CD81-
mediated virus binding is required for EGFR activation, suggesting a functional as 
well as physical association between the two proteins (Diao et al 2012).  
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Tetraspanins regulate lateral clustering of membrane proteins through their role as 
structural organisers of tetraspanin-enriched microdomains (TEMs) and, 
consequently regulate signalling from a variety of membrane proteins including 
growth factor receptors (Odintsova et al 2000, Odintsova et al 2003, Murayama et al 
2008, Sadej et al 2010). In addition to their purely structural function as organisers of 
partner proteins within TEMs, tetraspanins have also recently been shown to 
regulate various aspects of intracellular trafficking as well as biosynthetic transport of 
tetraspanin-interacting membrane proteins and receptors (reviewed in Berditchevski 
and Odintsova 2007). The tetraspanin CD82 is well known to associate with receptor 
tyrosine kinases of the ErbB family and (Odintsova et al 2000, Odintsova et al 2003) 
increased expression of this tetraspanin in mammary epithelial cells results in 
increased ligand-induced internalisation of EGFR (Odintsova et al 2000).  
CD9, the most closely related tetraspanin to CD81 has also been shown to 
physically and functionally associate with EGFR in cancer cells, including HepG2-
CD9 cells of hepatocyte origin, although this interaction has been much less 
extensively studied than the interaction of EGFR with CD82. Here CD9 is thought to 
be involved in regulating EGF-induced signalling (Murayama et al 2008).  
The HCV co-receptor tetraspanin CD81 interacts directly with the E2 envelope 
glycoprotein of HCV (Pileri et al 1999, Zhang et al 2004, Brazzoli et al 2008) and has 
been shown to internalise via clathrin-mediated endocytosis in response to binding of 
a cross-linking antibody 2s66, as well as in response to virus binding (Farquhar et al 
2012). However, it has been shown that EGF stimulation does not promote the 
internalisation of CD81 treated with a crosslinking antibody (which has been shown 
to induce CD81 internalisation independently of EGF) (Zona et al 2013). Although 
tetraspanins are involved in interactions with a variety of membrane proteins though 
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TEMs, and other tetraspanins have been shown to affect growth factor localisation 
and trafficking, no association between CD81 and EGFR on the cell surface has 
been demonstrated to date. 
Multiple viruses are known to induce intracellular signalling events which are critical 
for various stages of the viral life cycle, including entry into host cells.  The 
interaction between HCV and CD81 has been demonstrated to activate multiple 
downstream signalling pathways, including Rho GTPases, Cdc42, MAPKs, and 
ezrin-radixin-moesin (ERM) proteins (Brazzoli et al 2008, Coffey et al 2009, Farquhar 
et al 2011). In addition, CD81 binding to HCV primes the E1-E2 glycoprotein 
complex for pH-dependent fusion in the early endosome (Sharma et al 2011). All of 
these data suggest that HCV activates multiple intracellular signalling pathways and 
that CD81, in particular, may be important in regulating these. Therefore, study of the 
localisation, clustering and trafficking of HCV receptors and entry factors under EGF 
stimulation will provide important insight into the mechanism of EGF-promoted viral 
entry.  
 
5.2. Chapter Aims 
EGF mediated activation of EGFR results in an increase in HCV entry into Huh7.5 
cells. This effect is thought to be as a result of EGFR-mediated association between 
CD81 and CLDN1 (Lupberger et al 2011) and further evidence suggests that 
following EGF treatment EGFR and CD81 colocalise (Diao et al 2012). The aims of 
this chapter are therefore to determine the effect of EGF-stimulation on EGFR and 
CD81 localisation and trafficking in Huh7.5 cells and to investigate a possible 
association between CD81 and EGFR. 
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5.3 Results 
 
5.3.1 EGF Stimulation Promotes EGFR Internalisation  
HCV entry is dependent on four co-receptors or entry factors: the tetraspanin CD81, 
the scavenger receptor SR-BI, and tight junction proteins CLDN1 and OCLN, in 
addition to the recently identified EGFR. Data from Chapter 4 demonstrate that both 
clathrin-mediated endocytosis and macropinocytosis are stimulated in response to 
EGF treatment of Huh7.5 cells; however, it is not clear how EGF treatment affects 
EGFR localisation and trafficking.  Internalisation of EGFR has been shown to be 
crucial for ligand-induced HCV entry (Diao et al 2012) and data from Chapter 4 
revealed that EGFR localises to clathrin-coated pits on the cell surface under EGF 
stimulation. Therefore, the internalisation of EGFR in response to EGF stimulation 
was confirmed by live cell confocal microscopy. Huh7.5 cells were transiently 
transfected with EGFR-GFP (Table 2.1) and imaged by timelapse confocal imaging 
for 60 min at intervals of 1 min at a single central plane of focus both with and 
without EGF stimulation.  As shown in Figure 5.1 A and C, when plasma membrane 
and intracellular EGFR-GFP fluorescence were quantified with no EGF stimulation, 
little change in total cellular fluorescence can be seen throughout the timelapse. 
However, EGF stimulation results in the formation of membrane ruffles and blebs as 
shown in CFPmem-labelled cells (Figure 4.1), which contain EGFR, as indicated by 
yellow arrows (Figure 5.1), suggestive of macropinocytic uptake of the receptor. The 
decrease in plasma membrane fluorescence was measured by drawing a region of 
interest around the plasma membrane and quantifying the  fluorescence in this 
region of interest over time. A region of interest was also drawn within the plasma 
membrane in order to quantify the intracellular fluorescence. Quantification of 
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plasma membrane fluorescence following EGF stimulation revealed that stimulation 
with 1 μg/ml EGF resulted in a decrease in plasma membrane EGFR, resulting in a 
level of 59.18% of unstimulated fluorescence intensity by the 60 minute time point. 
However, in contrast to  
quantification of CFPmem fluorescence (Figure 4.1), intracellular levels of EGFR-
GFP decrease over time. This is indicative of receptor degradation at longer time 
points of stimulation, which is typical of EGF-induced EGFR internalisation, where 
signalling from the activated receptor is terminated by lysosomal degradation of 
activated receptor (Roepstorff et al 2009).  
 
5.3.2 CD81 internalisation and degradation are promoted by EGF stimulation 
CD81 plays an important role in virus binding by interacting directly with the viral 
glycoprotein E2. CD81 has also been shown to interact with the HCV entry factor 
CLDN1 upon virus binding, and the HCV-receptor complex is thought to internalise 
via clathrin-mediated endocytosis (Farquhar et al 2012). EGF stimulation has been 
shown to promote the formation of CD81-CLDN1 complexes by FRET (Lupberger et 
al 2011). The tetraspanin has also been shown to colocalise in early endosomes with 
EGFR following activation by ligand binding suggesting a possible physical and/or 
functional association between the two proteins (Diao et al 2012). Therefore, 
evidence suggests that CD81 may play a role in EGF-stimulated HCV entry.  
To investigate the internalisation of CD81 in response to EGF treatment, Huh7.5 
cells overexpressing CD81-GFP were imaged by live cell timelapse confocal 
microscopy for 60 minutes both with and without EGF treatment, with image 
acquisition every 5 minutes. The plasma membrane and intracellular fluorescence 
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were quantified by drawing regions of interest around the plasma membrane and 
within the plasma membrane and measuring mean fluorescence in these regions of 
interest over time, in the same way as for CFPmem. Similarly to EGFR-GFP, in 
untreated control cells, both plasma membrane and intracellular CD81-GFP 
fluorescence remain fairly constant throughout the timelapse with little internalisation 
or photobleaching apparent, as shown in Figure 5.2 A and C. In contrast, under 
EGF stimulation, CD81-GFP appears to internalise rapidly, with plasma membrane 
fluorescence visibly decreasing within 30 minutes of EGF addition (Figure 5.2 B).  
It also appears that internalised CD81 localises to large internalised vacuoles 
resembling macropinosomes following EGF stimulation, as indicated by the yellow 
arrows, consistent with the increase in macropinocytosis demonstrated in Section 
4.3.1. Interestingly, intracellular CD81-GFP fluorescence also visibly decreases 
indicating that CD81 is targeted for degradation upon internalisation.  
When quantified in the same manner as EGFR-GFP in Section 5.3.1, CD81-GFP 
fluorescence, both in the plasma membrane and intracellularly, remains constant 
with no significant photobleaching in untreated cells. However, following EGF 
stimulation, CD81-GFP fluorescence in the plasma membrane is seen to decrease 
significantly, dropping to around 53.76% of the plasma membrane fluorescence 
intensity of unstimulated cells by the 60 minute timepoint. Additionally, intracellular 
CD81-GFP fluorescence intensity decreases throughout the EGF stimulation 
timelapse, with similar but delayed kinetics to CD81 internalisation. This suggests 
that CD81 is rapidly degraded upon internalisation, and is not recycled back to the 
plasma membrane, consistent with the images shown in Figure 5.2 B.  
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It is unclear whether this EGF-stimulated CD81 internalisation and degradation is a 
result of the bulk membrane uptake demonstrated in Section 4.3.1, or whether this 
occurs via clathrin-mediated endocytosis as is the established entry mechanism for 
HCV in Huh7.5 cells. It is clear that CD81-GFP is present in large membrane-bound 
intracellular vacuoles, which are likely to be macropinosomes, however, clathrin-
mediated endocytosis has also been shown to be upregulated in response to EGF 
stimulation and CD81 is known to internalise via this pathway in response to HCV 
binding.  As both CD81 and EGFR internalise in response to EGF stimulation, it is 
possible that the receptor and entry factor internalise and traffic together.   
If receptors are internalising together, they should be seen to cluster and localise 
together on the plasma membrane following stimulation and prior to their 
internalisation. Therefore TIRF imaging and cell surface receptor localisation may 
offer the best means to study receptor internalisation.  
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Figure 5.1 Stimulation of EGFR internalisation by EGF. Huh7.5 cells 
overexpressing EGFR-GFP were imaged by confocal microscopy for one 
hour without EGF stimulation (A) and with one hour stimulation with 1μg/ml 
EGF (B). Yellow arrows indicate forming macropinosomes. Scale bar = 20 
μm. Plasma membrane and intracellular fluorescence were quantified and 
shown in part C.  Results shown are the mean of three independent 
experiments. Error bars = standard error. 
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5.3.3 EGFR and CD81 partially colocalise on the cell surface upon EGF 
stimulation 
EGFR is known to cluster upon stimulation, localising to clathrin-coated pits on the 
plasma membrane (Figure 4.7). Tetraspanins such as CD81, through their homo- 
and hetero-typic interactions with membrane proteins act as structural organisers of 
areas of the plasma membrane known as TEMs. Other members of the highly 
conserved tetraspanin superfamily have been shown to interact with EGFR, and 
mediate signalling events, including the closely related CD9 (Murayama et al 2008). 
Evidence suggests that EGFR and CD81 colocalise within early endosomes 
following EGF stimulation (Diao et al 2012). However, this was carried out by 
confocal microscopy; it is therefore possible that the two receptors simply colocalise 
in an intracellular compartment following endocytosis rather than internalising 
together. To investigate whether this colocalisation was the result of the two 
receptors internalising together or of them simply trafficking to the same intracellular 
compartment, Huh7.5 cells transiently transfected with EGFR-GFP were stimulated 
with EGF, fixed and CD81 immunocytochemistry (IC) carried out. As cells were fixed 
for IC, live cell timelapses could not be carried out. Therefore unstimulated cells 
were compared to cells that had been stimulated with EGF for a short (5 min) and 
long (30 min) duration were compared and two EGF concentrations were used (1 
μg/ml and 100 ng/ml). Cells were imaged by both total internal reflection 
fluorescence (TIRF) microscopy to view clustering and localisation in the plasma 
membrane and confocal microscopy, to view the localisation of internalised receptors 
within the cell. As shown in Figure 5.3, when imaged by TIRF microscopy, some 
colocalisation is visible between the two proteins after just 5 minutes stimulation with 
1 μg/ml EGF (and with 100 ng/ml, data not shown). The degree of colocalisation was 
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quantified by identifying CD81-positive structures and scoring the proportion of these 
which were also positive for EGFR-GFP. This is plotted as percentage colocalisation 
in Figure 5.3 C. Significant colocalisation between CD81 and EGFR was observed 
at the five minute timepoint at both EGF concentrations. This is indicative of the 
receptors clustering together rapidly upon EGF stimulation, and colocalisation within 
5 minutes is consistent with the rapid internalisation of both proteins upon EGF 
treatment shown in Figures 5.1 and 5.2. This is the first evidence for an association 
between CD81 and EGFR on the cell surface and is suggestive of the two proteins 
internalising together. Interestingly, by the 30 minute time-point, significant 
colocalisation of the two receptors was still observed, but to a lesser extent, 
suggesting activation and colocalisation and internalisation of the receptors occurs 
rapidly, again consistent with the rapid internalisation observed by live-cell confocal 
microscopy.  
The same samples were then imaged by confocal microscopy, selecting a focal 
plane in the centre of the cell, where the plasma membrane and endocytic vesicles 
were clearly visible. To quantify colocalisation at both timepoints and concentrations, 
an ROI was drawn around the intracellular area of each cell (the area within the 
plasma membrane) and the Pearson’s correlation coefficient for the ROI measured 
using NIS Elements software (Nikon). 
C 
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Figure 5.2: Stimulation of CD81 internalisation by EGF. Huh7.5 cells 
overexpressing CD81-GFP were imaged by confocal microscopy for one hour 
without EGF stimulation (A) and for one hour with stimulation with 1ug/ml EGF (B). 
Quantification of plasma membrane and intracellular CD81 fluorescence over time 
is shown in part C. Scale bar= 20 μm. Data shown are the mean of three 
independent experiments. Error bars = standard error. 
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As shown in Figure 5.4 C, significant colocalisation of EGFR and CD81 was only 
observed at 100 ng/ml EGF at the 5 minute time-point; representative images of this 
are shown in Figure 5.4.B). Again, this corroborates a rapid internalisation of both 
proteins in response to EGF stimulation and is suggestive of the two proteins 
internalising together.  However, the lack of colocalisation in cells stimulated with 1 
μg/ml EGF contradicts data shown in Diao et al, where the two proteins were shown 
to colocalise within EEA1-positive endocytic compartments following EGFR 
activation (Diao et al 2012). However, the authors used TGFα to activate EGFR. 
Stimulation with different ligands has been shown to induce differential trafficking of 
EGFR (Roepstorff et al 2009), which may account for the differences in intracellular 
colocalisation seen here.  
As live-cell imaging demonstrates receptor degradation (Figures 5.1 and 5.2), 
particularly of C81, even at early time points, this could also account for the lack of 
colocalisation seen intracellularly at later time points. Additionally, trafficking of 
EGFR and CD81 to different endocytic compartments would be consistent with the 
observation that while CD81 and EGFR are both seen to internalise rapidly upon 
EGF stimulation, CD81 begins to degrade at much earlier time points than EGFR 
(Figures 5.1 and 5.2, respectively).  
As the majority of plasma membrane colocalisation occurs within 5 minutes of EGF 
addition, it is probable that receptor activation, clustering and internalisation occur 
rapidly upon ligand addition, accounting for internal colocalisation at 5 minutes with a 
low EGF concentration. However, lack of colocalisation visible at the higher EGF 
concentration (1 μg/ml) and longer times of stimulation, mean that the majority of 
intracellular CD81 and EGFR do not localise to the same intracellular compartments.  
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Figure 5.3: CD81 partially colocalises with EGFR on the cell surface 
following EGF stimulation. EGFR-GFP transfected Huh7.5 cells 
immunostained for CD81 with no EGF treatment (A-C) and with 5 min EGF 
treatment (D-F). Scale bars = 5 μm. Quantification of percentage colocalisation 
between CD81 and EGFR  is shown in G. Error bars = standard error.  NT= no 
treatment. Low 5 = treatment with 100 ng/ml EGF, Low 30 = treatment with 100 
ng/ml EGF for 30 minutes, High 5 = treatment with 1 μg/ml EGF for 5 minutes, 
High 30 = treatment with 1 μg/ml EGF for 30 minutes. 9 cells were imaged and 
quantified per group. 
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Figure 5.4: CD81 partially colocalises with EGFR in intracellular compartments 
at 5 minutes stimulation with EGF. EGFR-GFP transfected Huh7.5 cells 
immunostained for CD81 with no EGF treatment (A-C) and with 5 min EGF 
treatment (D-F). Scale bars = 10 μm. Pearson’s correlation coefficient as a measure 
of  colocalisation between CD81 and EGFR is shown in G. Data shown are the 
mean of three independent experiments. N = number of cells analysed per 
condition. Data shown are the mean of three independent experiments. Error bars = 
standard error. NT= no treatment. Low 5 = treatment with 100 ng/ml EGF, Low 30 = 
treatment with 100 ng/ml EGF for 30 minutes, High 5 = treatment with 1 μg/ml EGF 
for 5 minutes, High 30 = treatment with 1 μg/ml EGF for 30 minutes. 9 cells were 
imaged and quantified per group. 
 
175 
 
 
 
 
 
  
Figure 5.5: STORM imaging of CD81. Huh7.5 cells immunostained for 
CD81 with no EGF treatment  imaged via diffraction-limited TIRF microscopy 
(A+D) and STORM (B+E) . Overlay is shown in (C+F). Magnified regions are 
shown in D-E. Scale bars = 5 μm.  
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5.3.4 Super-resolution imaging of CD81 localisation in response to EGF 
stimulation 
Tetraspanins like the HCV co-receptor CD81 tend to form membrane signalling 
complexes, known as tetraspanin-enriched microdomains (TEMs). This is mediated 
through their association with other membrane proteins as well as intracellular 
signalling and cytoskeletal proteins. Tetraspanins possess no intrinsic enzymatic 
activity or signalling motifs and it is thought that they act by facilitating the interaction 
of associated proteins within TEMs. FRET studies between overexpressed 
fluorescent co-receptors, revealed that CD81 and CLDN1 formed complexes within 
the plasma membrane of hepatoma cells (Harris et al, 2008). In addition, data from 
Figure 5.2 demonstrate that CD81 internalisation is significantly upregulated in 
response to EGF stimulation of Huh7.5 cells and colocalises with EGFR on the cell 
surface following EGF stimulation, as shown in Figure 5.3.  Therefore, it is likely that 
CD81 is involved in EGFR-mediated HCV infection. EGFR clusters in response to 
EGF stimulation, concentrating within clathrin-positive structures on the plasma 
membrane (Figure 4.7). As CD81 appears to internalise with EGFR and it is 
therefore likely that it clusters with EGFR within clathrin coated pits prior to 
internalisation following EGF treatment.  
To investigate CD81 clustering in response to EGF stimulation, Huh7.5 cells were 
either treated with 1 μg/ml EGF for 30 minutes or left untreated and CD81 IC carried 
out. As CD81 is highly expressed within the plasma membrane of liver-derived cells, 
clusters of CD81 in the membrane of Huh7.5 cells are densely labelled and not 
easily distinguishable from each other. Therefore, two super-resolution microscopy 
techniques were tested at the Nikon Imaging Centre, King’s College London 
(NIC@King’s): structured illumination microscopy (SIM) and (direct) stochastic 
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optical reconstruction microscopy (dSTORM). dSTORM relies on the intrinsic 
blinking properties of certain fluorophores, such as alexafluor-647. Therefore, an 
alexfluor-647-labelled secondary antibody was used for IC of dSTORM samples. 
However, poor labelling efficiency meant that, although there are centroids fitted for 
most fluorescent punctate detected by TIRF microscopy, the brighter structures 
visible in the corresponding TIRF images don’t appear to have more blinking events 
recorded in the STORM image than less bright structures (Figure 5.5). Additionally, 
while dSTORM images do show blinking events associated with most of the CD81-
positive structures in the corresponding TIRF images, many blinking events were 
also detected in background regions which were not positive for CD81 in the 
corresponding diffraction-limited TIRF images. Therefore, SIM was explored as a 
super-resolution alternative. 
SIM can be applied to conventionally labelled fluorophores and so is not subject to 
the same labelling constraints and issues as dSTORM. However, SIM offers the 
least improvement in gained resolution over diffraction limited optical microscopy. 
Therefore, SIM images were compared to conventional epi-fluorescence images of 
CD81 acquired on the same system. As shown in Figure 5.6, SIM images of labelled 
CD81 offer a considerable improvement in resolution, allowing the analysis of CD81 
structure density to be carried out.  Additionally, the generation of Fourier transforms 
that contain six additional lobes (over a diffraction-limited image) confirms correct 
reconstruction from the nine recorded frames (representative of three grid positions 
and three rotations), as shown in Figure 5.7, demonstrating that true super 
resolution has been achieved.   
Therefore, SIM images, while offering less of an improvement in resolution over 
diffraction-limited techniques, seem to give the most accurate picture of CD81 
178 
 
localisation and clustering and were therefore used for analysis of structure density 
following EGF treatment. Representative SIM images of CD81-labelled Huh7.5 cells 
treated with EGF for 30 minutes (B) or left untreated (A) are shown in Figure 5.7. 
Analysis of CD81 cluster density is shown in Figure 5.7 C.  
 Data shown are the average of three independent experiments; three cells were 
imaged and analysed per repeat. Analysis of feature density revealed that numbers 
of CD81 clusters decrease following 30 minutes EGF stimulation by 16.67 %. This is 
consistent with the rapid internalisation of CD81 observed by live cell confocal 
microscopy (Figure 5.2), in which considerable CD81 endocytosis occurs within 30 
minutes of treatment and corroborates the colocalisation of CD81 with EGFR on the 
cell surface after 5 minutes of EGF stimulation (Figure 5.3).  
While internalised receptor may recycle back to the cell surface to undergo further 
rounds of internalisation, live cell imaging suggests CD81 internalised in response to 
EGF treatment is rapidly degraded upon endocytosis, which is consistent with the 
reduced numbers of CD81-positive structures seen after 30 minutes EGF stimulation 
observed by SIM. Taken together, these data support a rapid internalisation of both 
CD81 and EGFR in response to EGF stimulation, with a least a significant proportion 
residing within the same endocytic structures, followed by trafficking down the 
degradative pathway. 
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Figure 5.6: SIM imaging of CD81 allows separation of clusters. 
Huh7.5 cells immunostained for CD81 with no EGF treatment imaged by 
epi-fluorescence microsopy and magnified inset (A).  A different region of 
the same sample imaged by structured illumination microscopy and 
magnified inset (B).  
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Figure 5.7: EGF stimulation results in fewer CD81 clusters in the plasma 
membrane. Huh7.5 cells immunostained for CD81 with no EGF treatment (A) 
and with 30 min EGF treatment (B) imaged by structured illumination microscopy 
(SIM). The corresponding Fourier transforms confirm proper reconstruction of a 
super-resolution image from the recorded frames. Quantification of feature 
density (a measure of the number of clusters per unit area; carried out by 
Jeremy Pike, PSIBS doctoral training centre) is shown in (C).  Error bars= 
standard error. Scale bars = 5 μm. Data shown are the mean of 9 cells per group 
from 3 independent experiments. Error bars = standard error. 
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5.4 Discussion 
EGFR has been shown to be an important factor in HCV entry (Lupberger et al 
2011). Activation of the growth factor receptor by stimulation with the ligand EGF has 
been shown to promote viral entry. Additional evidence suggests that EGFR and the 
HCV co-receptor CD81 colocalise in intracellular compartments following EGF-
induced internalisation (Diao et al 2012). CD81 can associate laterally with other 
membrane proteins via hetero- and homo-typic interactions within tetraspanin-
enriched microdomains (TEMs). There is evidence that other tetraspanins affect 
growth factor localisation and trafficking through their organisation of TEMs 
(Odintsova et al 2000, Odintsova et al 2003, Murayama et al 20008), however, no 
association between CD81 and EGFR on the cell surface has been demonstrated to 
date. 
While HCV entry is known to rely on multiple co-receptors and entry factors in a 
complex multi-step entry process, the interaction between HCV and CD81 in 
particular is thought to be crucial in mediating the activation of multiple downstream 
signalling pathways involved in viral entry, including Rho GTPases, Cdc42, MAPKs, 
and ezrin-radixin-moesin (ERM) proteins (Brazzoli et al 2008, Coffey et al 2009, 
Farquhar et al 2012). Therefore, the localisation, clustering and internalisation of 
EGFR and CD81 under EGF stimulation were the focus of this chapter. 
Firstly, internalisation of EGFR and CD81 was assessed in Huh7.5 cells both with 
and without EGF stimulation by live cell confocal timelapse microscopy. Results from 
Chapter 4 demonstrate that EGFR localises to clathrin-coated pits (CCPs) on the 
plasma membrane following addition of EGF, indicating internalisation of the 
activated receptor via clathrin-mediated endocytosis. To confirm internalisation of 
EGFR following EGF treatment, Huh7.5 cells were transiently transfected with 
182 
 
EGFR-GFP and imaged by live cell confocal microscopy both with and without EGF 
stimulation. Little internalisation of EGFR or photobleaching was observed in 
untreated cells over a 1 hour timelapse. In contrast, loss of EGFR from the plasma 
membrane was observed upon EGF addition. Intracellular levels of EGFR remained 
relatively constant at early timepoints but also began to drop towards the end of the 
timelapse, in contrast to CFPmem levels seen in Figure 4.1. This is indicative of 
degradation of internalised EGFR, which is consistent with EGF-mediated activation 
of EGFR targeting the receptor for lysosomal degradation over recycling back to the 
plasma membrane.  
As CD81 has been shown to colocalise with EGFR in endosomal compartments 
following TGFα-mediated EGFR activation (Diao et al 2012), internalisation of CD81 
was assessed in the same manner in Huh7.5 cells overexpressing CD81-GFP. 
Again, little photobleaching or CD81 internalisation is visible in untreated cells 
(Figure 5.2 A and C). In contrast, a visible decrease in CD81 fluorescence in the 
plasma membrane occurs upon EGF addition (Figure 5.2 B), which is confirmed by 
quantification (Figure 5.2 C). While this was initially followed by a corresponding rise 
in intracellular fluorescence, intracellular fluorescence also decreased throughout the 
timelapse, suggestive of degradation of internalised CD81 over recycling back to the 
plasma membrane (Figure 5.2 C).  
CD81 and EGFR both internalise rapidly in Huh7.5 cells in response to EGF 
treatment, and have been shown to colocalise in early endosomes following TGFα-
induced EGFR activation (Diao et al 2012). EGFR clusters on the cell surface in 
response to EGF treatment and colocalises with clathrin (Chapter 4). Therefore, a 
possible association between the two proteins on the cell surface was investigated 
both with and without EGF stimulation. 
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Huh7.5 cells transiently transfected with EGFR and labelled for CD81 by IC were 
imaged by TIRF microscopy to visualise localisation on the adherent plasma 
membrane at early (5 min) and later (30 min) timepoints with two concentrations of 
EGF (100 ng/ml and 1 μg/ml). As shown in Figure 5.3, CD81 and EGFR colocalise 
on the plasma membrane within five minutes of EGF stimulation at both high and low 
EGF concentrations. This is indicative of the two receptors internalising together and 
is consistent with published observations of the two proteins colocalising within 
intracellular compartments following ligand-induced internalisation (Diao et al 2012). 
This colocalisation, while still significantly greater than in untreated cells, was 
reduced after 30 minutes EGF stimulation, corroborating the rapid effects of EGF 
treatment seen by live cell confocal imaging. 
 However, when colocalisation was measured in the same samples imaged by 
confocal microscopy in order to observe intracellular colocalisation, EGFR and CD81 
were only seen to colocalise after 5 minutes stimulation with a lower concentration 
(100 ng/ml) of EGF. No significant colocalisation was observed with 1 μg/ml EGF 
stimulation, even at the early 5 minute time point. This contradicts evidence that 
EGFR and CD81 colocalise within early endosomes (Diao et al 2012). However, 
these images were taken in cells where internalisation of EGFR had been stimulated 
with TGFα rather than with EGF. Several ligands are known to bind to and activate 
EGFR, however not all of these target EGFR trafficking down the lysosomal 
pathway; TGFα has been shown to target internalised receptor for recycling whereas 
EGF is known to target EGFR for lysosomal degradation (Roepstorff et al 2009).This 
may account for the difference in levels of colocalisation observed.  
Nevertheless, the fact that colocalisation is observed on the cell surface at both time 
points and with both EGF concentrations demonstrates that the two receptors do 
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internalise together. Therefore, while recently internalised receptors may colocalise 
within the cell, the large numbers of intracellular structures visible where the two 
proteins do not colocalise mean that significant colocalisation is not seen at most 
timepoints and concentrations. Trafficking of EGFR and CD81 to different endocytic 
compartments is consistent with the observation that while CD81 and EGFR are both 
seen to internalise rapidly upon EGF stimulation, CD81 begins to degrade at much 
earlier timepoints than EGFR (Figures 5.1 and 5.2, respectively). Our data indicate 
that EGFR and CD81 do not traffic together once internalised and are rapidly 
trafficked to different intracellular compartments. 
Taken together, these data demonstrate an EGF-dependent colocalisation of CD81 
and EGFR on the cell surface, followed by rapid internalisation of the two proteins. 
While other tetraspanins have been shown to associate with EGFR and influence its 
signalling and trafficking, this is the first evidence for an association between CD81 
and EGFR on the plasma membrane. This is also the first evidence that CD81 and 
EGFR internalise together in response to EGF stimulation and could be of key 
relevance to the role of EGFR in HCV entry, particularly as EGFR internalisation is 
thought to be of key importance to HCV entry. 
EGFR was shown in Chapter 4 to cluster on the cell surface following EGF 
stimulation and to localise to CCPs, the formation of which is also promoted by EGF 
stimulation. The colocalisation of CD81 with EGFR on the cell surface would suggest 
it too localises to CCPs and internalises via clathrin-mediated endocytosis along with 
EGFR following EGF treatment. As CD81 has no endocytic targeting sequence, and 
EGFR is typically internalised via clathrin-mediated endocytosis, it is possible that 
association with EGFR, potentially through TEMs mediates the internalisation of 
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CD81 through this pathway and offers a potential mechanism for the role of EGFR in 
HCV entry. 
As CD81 and EGFR colocalise on the cell surface, and EGFR clusters in response 
to EGF treatment, the clustering of CD81 in response to EGF stimulation was 
investigated. As CD81 labelling on the cell surface is dense, and separate clusters or 
putative microdomains not easily distinguished by diffraction-limited microscopy, two 
super-resolution techniques were tested: (direct) stochastic optical reconstruction 
microscopy (dSTORM) and structured illumination microscopy (SIM). While SIM 
offers the least improvement of the two techniques in terms of resolution, it can be 
carried out using the same fluorescent labels as conventional fluorescence 
microscopy techniques, so the same IC protocol used for the colocalisation 
experiment could be used. dSTORM offers a greater improvement in resolution but 
is reliant on the inherent blinking properties of certain fluorophores such as 
Alexafluor-647, so an Alexafluor-647-labelled secondary antibody was used for IC. 
As dSTORM presented issues with labelling density, SIM images were used for 
analysis of CD81 clustering. Interestingly, analysis of SIM images revealed that after 
30 minutes stimulation with EGF, the ‘feature density’ of CD81 punctae decreased. If 
CD81 localises with EGFR to clathrin-coated pits, an increase in clustering of the 
protein in the plasma membrane would perhaps be expected, however, as live-cell 
imaging and colocalisation experiments show a rapid internalisation of CD81 and 
colocalisation of CD81 with EGFR within 5 minutes of stimulation, this decrease in 
CD81 clustering at 30 minutes of EGF stimulation is consistent with CD81 having 
internalised and been targeted for lysosomal degradation within this time period.  
Taken together, these data suggest that upon EGF stimulation, EGFR activation 
results in upregulation of clathrin-mediated endocytosis, localisation of EGFR to 
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clathrin-coated pits and the rapid internalisation of both EGFR and CD81 together. 
This offers a putative mechanism for the upregulation of viral entry by EGF treatment 
of Huh7.5 cells and for the action of EGFR in viral entry.  
 
5.5 Key Chapter Findings 
 
1. EGF stimulation promotes rapid CD81 and EGFR internalisation and 
degradation. 
2. CD81 and EGFR colocalisation on the cell surface increases from 0.2% 
to 3% following EGF stimulation but colocalisation is lost following 
receptor internalisation. 
3. Super-resolution imaging of CD81 by SIM demonstrates that the density 
of CD81 clusters decreases following EGF stimulation, supporting the 
rapid internalisation and degradation seen by live-cell confocal imaging. 
 
5.6 Conclusions 
 
These results demonstrate that EGF stimulation exhibits multiple effects on viral co-
receptor localisation and trafficking in Huh7.5 cells, which may be relevant to HCV 
entry. Data in this chapter demonstrate that EGFR and CD81 are both rapidly 
internalised in response to EGF treatment, resulting in co-receptor degradation. Dual 
colour TIRF imaging revealed that the two proteins colocalise on the cell surface 
within 5 minutes of EGF treatment, suggesting that they internalise together following 
ligand stimulation. This is the first evidence to date of an association between CD81 
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and EGFR in the plasma membrane. SIM imaging allowed CD81 localisation to be 
seen in more detail than standard diffraction limited techniques. Analysis of SIM 
images with and without EGF stimulation revealed fewer CD81 clusters in the 
plasma membrane following 30 minutes EGF stimulation. This corroborates the rapid 
internalisation and degradation of the receptor in response to EGF stimulation seen 
by live cell imaging, as well as the rapid colocalisation of CD81 with EGFR on the 
cell surface.  Therefore, these results provide novel insights into the effects of EGF 
stimulation on HCV receptor internalisation and trafficking and provide possible 
mechanisms by which EGFR may act in the viral entry process.  
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CHAPTER 6 
 
 
 
FURTHER DISCUSSION AND FUTURE DIRECTIONS 
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6.1 Further Discussion 
Viruses are obligate intracellular pathogens and viral entry is the first and crucial step 
in the viral life cycle, making it a key potential therapeutic target. HCV entry is a 
complex and multi-step process dependent on a number of attachment and entry 
factors and co-receptors, followed by endocytosis and pH-dependent fusion in the 
early endosome. Many aspects of HCV entry remain poorly understood despite 
extensive efforts to understand the process. Indeed, an increasing number of 
important cellular factors required for HCV entry are still being identified, including 
the epidermal growth factor receptor (EGFR) (Lupberger et al 2011), which has been 
the focus of much of this doctoral thesis. HCV entry is dependent on two co-
receptors, the tetraspanin CD81 and the scavenger receptor SR-BI, as well as entry 
factors which include the tight junction proteins CLDN1 and OCLN, as well as the 
recently identified EGFR. However, the precise manner in which members of the 
HCV co-receptor complex interact with each other and the virus and internalise is yet 
to be elucidated. 
Therefore, the focus of this doctoral thesis has been the endocytosis of HCV and its 
cellular receptors, including investigating a role for caveolae in HCV entry and the 
potential mechanisms of EGF-stimulated HCV entry.  
Caveolae have long been overlooked in studies of HCV endocytosis due to a belief 
that the hepatoma cell lines used to study HCV entry and infection do not express 
caveolin 1. However, evidence suggested that hepatocytes in vivo do express 
caveolin 1, and evidence for the expression of caveolin 1 in hepatoma cell lines is 
mixed (Botos et al 2006, Cokakli et al 2009, Pohl et al 2002, Zhao et al 2009). 
Therefore, caveolin 1 expression was assayed in primary human hepatocytes and 
human liver sections, as well as in a panel of hepatoma cell lines. Western blot 
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showed that hepatocytes in vivo express caveolin 1 and this was confirmed by IC of 
human liver sections (Figures 3.1A and 3.5). However, no caveolin 1 was detected 
by western blot or cargo uptake assays for any of the hepatoma cell lines tested 
(Figure 3.1 B-E). As hepatoma cell lines do not express caveolin 1 and hepatocytes 
within the liver do, it was possible that caveolae offer a route for productive infection 
in vivo which had been overlooked by in vitro studies. Therefore, the role of caveolin 
1 in HCV endocytosis was assayed in a HCV-permissive cell line which expresses 
caveolin 1, SkHep1 (SRBI+CLDN1). Clathrin-mediated endocytosis, the established 
HCV entry mechanism, and caveolar endocytosis were inhibited by silencing of AP2 
and caveolin 1 using siRNA, respectively. Inhibition of clathrin-mediated endocytosis 
abrogated HCVpp infection of SkHep1 (SRBI+CLDN1) cells, whereas silencing of 
caveolin 1 had no significant effect. Therefore, although there is a discrepancy 
between the expression of caveolin 1 between the hepatoma cell lines used to study 
HCV infection and hepatocytes within the liver, caveolae play no functional role in 
HCV endocytosis. The reason for loss of caveolin 1 in hepatoma cell lines is unclear; 
however, caveolin 1 is thought to play a role in liver repair and regeneration in vivo. 
Additionally, caveolin 1 expression is associated with poor prognosis in HCC, and 
overexpression of caveolin 1 in HepG2 and Huh7.5 cells results in increased 
migration and invasion (Cokakli et al 2009, Tse et al 2012, Hsu et al 2013). 
The epidermal growth factor receptor, EGFR, has recently been shown to be 
required for HCV entry, and stimulation of Huh7.5 cells with EGF was shown to 
promote HCV entry (Lupberger et al 2011). EGFR can traffic via clathrin-mediated 
endocytosis, as well as growth factor-stimulated macropinocytosis. Upregulation of 
one or more endocytic pathways by activation of EGFR may influence the 
internalisation of bound or extracellular virus. Therefore the effects of EGF treatment 
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on endocytosis and trafficking pathways were investigated. Live-cell confocal 
imaging of Huh7.5 cells treated with EGF revealed that membrane ruffling, 
lamellipodia and filopodia formation and membrane blebbing were induced in a 
dose-dependent response to EGF, all of which are indicative of macropinocytosis 
(Figure 4.1). Furthermore, uptake of dextran, a cargo internalised primarily via 
macropinocytosis, was promoted in response to EGF treatment, confirming that 
macropinocytosis is upregulated in Huh7.5 cells by ligand-induced EGFR activation 
(Figure 4.3). Growth factor-dependent macropinocytosis is the focus of growing 
numbers of publications on viral entry, most notably in the internalisation of influenza 
A and vaccinia virus (Eierhoff et al 2010, Marsh and Eppstein 1987, Mercer and 
Helenius 2008). Stimulation of HeLa cells with EGF has been shown to induce 
macropinocytic uptake of fluorescent-labelled vaccinia virus. Additionally, the non-
receptor tyrosine kinase Axl has been implicated in vaccinia virus entry, and the virus 
is thought to mimic growth factor treatment, by activating the tyrosine kinase, 
resulting in macropinocytosis (Mercer and Helenius 2008, Morizono et al 2011). 
However, macropinocytosis is traditionally associated with a bulk internalisation of 
plasma membrane and encapsulated extracellular fluid, as demonstrated by live-cell 
imaging of CFPmem-transfected Huh7.5 cells under EGF treatment (Figure 4.2). 
This would likely result in a relatively non-specific uptake of virus, which may occur in 
a receptor-independent manner. It has been shown that EGF stimulation of Huh7.5 
cells results in increased uptake of several different viral pseudoparticles, including 
influenza A, VSV and endogenous feline leukaemia virus RD114 (Lupberger et al 
2011). Both influenza A and VSV have been demonstrated to enter cells via clathrin-
dependent mechanisms (Lakadamyali et al 2004, Cureton et al 2009), as with HCV, 
however there is also evidence for macropinocytic uptake of influenza A (de Vries et 
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al 2011). However, RD114 has been shown to enter cells by directly penetrating the 
plasma membrane in a pH-independent manner. As uptake of viruses with multiple 
endocytic mechanisms is promoted by EGF stimulation, macropinocytosis could offer 
a mechanism for this effect. Nevertheless, trafficking of macropinosomes is poorly 
understood and the trafficking of viruses internalised via clathrin-mediated 
endocytosis requires trafficking through the endosomal system for pH-mediated 
fusion, and productive infection to occur. It is therefore unclear whether 
macropinocytosis would offer a route for productive infection of viruses which require 
a pH-mediated endosomal fusion step, such as HCV.  
However, HCV has been shown to internalise exclusively via clathrin-mediated 
endocytosis under normal circumstances. Additionally, EGFR internalisation has 
been shown to be important for HCV entry and, under physiological concentrations, 
EGFR is thought to internalise via clathrin-mediated endocytosis (Sigismund et al 
2008). TIRF imaging revealed that formation of clathrin-coated pits on the plasma 
membrane is promoted by EGF stimulation in Huh7.5 cells and that activated EGFR 
localises to these CCPs (Figures 4.6 and 4.7).  
Therefore, two endocytic pathways are upregulated in response to EGFR activation 
in Huh7.5, which may be relevant for the concomitant increase in HCV entry in EGF-
treated cells. It will be necessary to distinguish between the effects of the 
upregulation of each pathway on HCV entry. Therefore, knockdown of PAK1, a 
protein involved in macropinocytosis, and AP2 was carried out using siRNA in 
Huh7.5 cells and strong knockdown was achieved in both cases. Future work should 
include applying these knockdowns to HCV infection studies to distinguish between 
the contributions of each pathway to the EGF-induced increase in HCV entry (see 
6.2 Future Directions). 
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Internalisation of the HCV co-receptor CD81 with entry factor CLDN1 has been 
shown to be stimulated by virus binding and is thought to occur via clathrin-mediated 
endocytosis (Harris et al 2008, Farquhar et al 2012). As EGF stimulation has been 
shown to promote clathrin-mediated endocytosis (Figure 4.6), the effects of EGF 
stimulation on internalisation and trafficking of CD81 and EGFR were investigated in 
further detail. Live-cell confocal imaging of Huh7.5 cells with and without EGF 
stimulation revealed that both membrane proteins are internalised rapidly and 
degraded in response to EGFR activation (Figures 5.1 and 5.2, respectively). The 
two receptors colocalise on the cell surface within 5 minutes of EGF addition and the 
degree of colocalisation decreases over time (Figure 5.3). This points to a possible 
mechanism for CD81 internalisation alongside the growth factor receptor and offers 
the first observation of the two proteins colocalising on the cell surface. However, 
there is little intracellular colocalisation between the two proteins (Figure 5.4), 
suggesting that internalisation occurs rapidly, followed by trafficking through different 
endocytic compartments, consistent with the differing kinetics of degradation seen. 
This was confirmed by super-resolution imaging of CD81 clustering with and without 
EGF stimulation. Analysis revealed that there are less clusters of CD81 on the cell 
surface after 30 minutes stimulation, corroborating a rapid internalisation of the 
tetraspanin in response to EGF stimulation (Figure 5.7). This evidence highlights 
possible mechanisms by which EGF stimulation may mechanistically promote HCV 
internalisation. Firstly, virus may be internalised as a result of fluid-phase uptake, 
resulting in entry of extracellular or receptor-bound virus into the cell. Secondly, 
upregulation of clathrin-mediated endocytosis may result in increased viral uptake 
through its established internalisation mechanism.  
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Tetraspanins have long been known to regulate the signalling and trafficking of 
growth factor receptors (Murayama et al 2008, Sadej et al 2010). CD82 associates 
with ErbB family receptor tyrosine kinases, and its increased expression in mammary 
epithelial cells significantly increased ligand-induced internalisation of EGFR 
(Odintsova et al 2003). Additionally, CD9, the most closely related tetraspanin to 
CD81 has been shown to physically and functionally associate with EGFR in cancer 
cells, including HepG2-CD9 cells, regulating EGF-induced signalling (Murayama et 
al 2008). Therefore, while it is unclear whether there is a direct interaction between 
CD81 and EGFR in Huh.7 cells, a functional interplay between the two membrane 
proteins within tetraspanin microdomains may play a role in mediating the EGF-
stimulated increase in HCV entry.  
Filopodia formation and growth were also interestingly shown to be promoted in 
response to EGF stimulation (Figure 4.4). Filopodia are thought to play a role in 
mediating first contact with viral particles in vivo (Warren et al 2006), and increasing 
filopodial length and number would increase the chances of virus binding, and 
therefore entry. Interestingly, filopodia have been shown to sense EGF and to 
respond by inducing retrograde transport of activated EGFRs towards the cell body 
for internalisation (Lidke et al 2005). Evidence has suggested that HCV particles bind 
to CD81 in filopodia, where it is highly expressed and to traffic towards the cell body 
for internalisation (Coller et al 2009). It would therefore be interesting to investigate 
the localisation and lateral movement of CD81 and EGFR in filopodia in response to 
EGF stimulation. While evidence from this thesis suggests that CD81 localisation is 
not enriched, or depleted in filopodia (as would be expected if CD81 had been 
transported to the cell body) (Figure 4.5), this was carried out with overexpressed 
CD81, which results in such high expression within the plasma membrane and 
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filopodia that individual clusters of CD81 are not easily distinguishable. Therefore, 
future work looking at CD81 localisation in filopodia should be carried out using IC to 
label CD81 and super-resolution techniques used to be able to visualise clusters of 
CD81 more readily.  
Several other viruses have been shown to activate growth factor receptor signalling, 
thus mimicking the action of growth factors on the cells they infect, including 
Influenza A virus (Monick et al 2005, Eierhoff et al 2010). Evidence suggests that 
HCV may act in the same manner (Diao et al 2012), and as such, could be 
responsible for inducing the effects seen in Chapters 4 and 5, independently of 
EGF. Therefore, it is interesting to speculate that HCV could instigate its own entry 
by promoting endocytic pathways and the internalisation and trafficking of its own 
receptors, as well as promoting virus attachment through filopodial extension. Future 
work should investigate whether HCV-infected cells have increased membrane 
ruffles and blebs or have increased numbers of, or longer filopodia.  
 
6.2 Future Directions 
In summary, results in this thesis demonstrate that EGF stimulation of Huh7.5 cells 
promotes clathrin-mediated endocytosis, colocalisation of CD81 with EGFR and 
EGFR localisation to clathrin-coated pits, resulting in increased internalisation of 
CD81 and EGFR, all of which offer potential mechanisms of EGF-induced HCV 
endocytosis. Tetraspanins have been shown to interact with and influence growth 
factor receptor signalling and trafficking through their association in TEMs. However, 
it remains to be determined whether the two receptors interact directly. Additionally, 
this thesis demonstrates that two endocytic pathways are stimulated by EGF 
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treatment, which could contribute to the EGF-induced promotion in viral entry 
observed by Lupberger et al (Lupberger et al 2011). While the colocalisation of 
activated EGFR with clathrin in the plasma membrane suggests that EGFR and 
CD81 internalise via clathrin-mediated endocytosis, the functional role for 
macropinocytosis in viral entry remains to be assessed. 
 
 
 
 
 
 
This is summarised in Figure 6.1. Preliminary work in this direction has shown that 
PAK1, a protein required for all stages of macropinocytosis can be efficiently 
silenced in Huh7.5 cells by siRNA transfection, and that this reduces dextran uptake. 
AP2, which is required for clathrin-mediated endocytosis was also efficiently knocked 
Figure 6.1: Possible mechanisms for EGF-induced HCV entry. EGF promotes 
the formation of clathrin-coated pits (CCPs) and macropinocytosis in Huh7.5 
cells. Activated EGFR localises to clathrin-coated pits and colocalises with CD81 
on the cell surface, suggesting they internalise together via clathrin-mediated 
endocytosis (CME).  
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down (Figure 4.8). Future work should investigate the effects of these knockdowns 
on HCV entry using HCVpp infection assays.  
Additionally, as CD81 localisation in filopodia was measured in cells overexpressing 
CD81-GFP, this should be further investigated with endogenous protein, and the 
localisation and trafficking of EGFR within filopodia should be investigated alongside, 
to determine whether EGF stimulation promotes retrograde traffic of the two 
receptors towards the cell body. 
Finally, it is possible that HCV mimics EGF stimulation by activating EGFR 
independently of EGF (Diao et al 2012), as has been shown for other viruses 
(Monick et al 2005, Eierhoff et al 2010), stimulating its own internalisation. Therefore, 
the internalisation of receptors, upregulation of endocytic pathways and filopodial 
extension should be studied in HCV-infected cells. 
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SM 1: LB Broth 
20 g of LB Broth (Sigma) was dissolved in 1 L distilled H20 and autoclaved at 121ºC 
for 20 minutes. 
 
SM 2: Pouring LB agar plates 
35 g of LB Agar (Sigma) was dissolved in 1 L distilled H20 and autoclaved at 121ºC 
for 20 minutes. Kanamycin or ampicillin was added to a final concentration of 50 
μg/ml or 100 μg/ml respectively to cooling plates, before setting of the LB agar. In a 
laminar flow hood, 50 ml of the LB agar antibiotic mix was poured into 12 cm plastic 
dishes. Plates were stored inverted at 4ºC before use. 
 
SM 3: Cell culture medium 
500 ml Dulbecco’s  odified Eagle Medium (DMEM; Lonza), or RPMI (Gibco, 
Invitrogen) was added to 50 ml fetal calf serum (FCS) and 5 ml 
Penicillin/Streptomycin (all Lonza) and sterile filtered through a 500ml Corning 0.1 
μ  pore Vacuum Filter System (Corning) to give a final concentration of 10% FCS 
and 1% penicillin/streptomycin. 
 
SM 4: Trypsin 
10X trypsin (Gibco) was aliquoted, frozen then diluted to 1X trypsin in PBS for use.  
 
SM 5: Cell Imaging Media (CIM) 
9.7 g Hanks Balanced Salt (without phenol red and sodium bicarbonate) (Sigma) and 
2.38 g HEPES (Fisher Scientific) were dissolved in 1 L distilled H20. 1 M HCl (Fisher 
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Scientific) was then added dropwise until pH 7.4 was reached using a Basic Denver 
Instrument pH meter (Denver Instruments). The media was then sterile filtered 
through a 500 ml Corning 0.1 μ  pore Vacuum Filter System and stored at 4C prior 
to use. 
 
SM 6: 4% Paraformaldehyde (PFA) 
10 ml 16% Paraformaldehyde (PFA; Electron Microscopy Sciences) was added to 30 
ml PBS for a final concentration of 4% PFA. 
 
SM 7: Permeabilisation buffer 
A 0.1% Triton-X100 solution was made by adding 1 ml Triton-X100 (Sigma) to 99 ml 
DPBS (Lonza), vortexed thoroughly and stored at 4C. 
 
SM 8: GS-BSA Block buffer 
2 ml normal goat serum (Gibco, Invitrogen) and 0.5 g bovine serum albumin (BSA; 
Sigma) were added to 20 ml DPBS (Lonza) to generate a solution of 10% goat 
serum and 5% BSA. 
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SM 9: Acrylamide gel solutions 
 4% Stacking gel 12% Main gel 
Distilled H2O 6.8 ml 6.6 ml 
0.5 M Tris-HCl (pH 6.8) 2.5 ml - 
1.5 M Tris-HCl (pH 8.8) - 5 ml 
Bis-Acrylamide (Protogel) 1.7 ml 8 ml 
10% SDS 100 μl 200 μl 
10% APS 100 μl 200 μl 
TEMED (Fisher Scientific) 10 μl 8 μl 
Total Volume* 10 ml 20 ml 
 
* Makes enough for two gels 
 
0.5 M pH 6.8 Tris-HCl was made as follows: 
60.57 g Tris (Fisher Scientific) dissolved in 1 L distilled H2O. 1 M HCl was added 
dropwise until pH 6.8 was reached, using a Basic Denver Instrument pH meter 
(Denver Instruments) 
 
1.5 M pH 8.8 Tris-HCl was made as follows: 
181.71 g Tris (Fisher Scientific) was dissolved in 1 L distilled H2O. 1 M HCl was 
added dropwise until pH 8.8 was reached, using a Basic Denver Instrument pH  
meter (Denver Instruments). 
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10% Ammonium Persulphate (APS) was made as follows: 
100 mg ammonium persuphate (APS; Sigma) was dissolved in 1 ml distilled H2O. 
10% APS was made fresh for each western blot. 
 
10% Sodium Dodecyl Sulphate (SDS) was made as follows: 
10 g sodium dodecyl sulphate (SDS; Fisher Scientific) was dissolved in 100 ml 
distilled H2O and stored at room temperature. 
 
SM 10: Running buffer 
1X running buffer was made by diluting 100 ml 10X running buffer in 900 ml distilled 
H2O. 10X running buffer was made by dissolving 144g glycine (Fisher Scientific), 
30g Tris (Fisher Scientific) and 4g SDS (Fisher Scientific) in 1 L distilled H2O. 
Running buffer was stored at room temperature. 
 
SM 11: Transfer buffer 
1X transfer buffer was made by diluting 100 ml 10X transfer buffer in 700 ml distilled 
H2O and 200 ml methanol (Fisher Scientific). 10X transfer buffer was made by 
dissolving 144 g glycine (Fisher Scientific) and 30 g Tris in 1 L in distilled H2O. 
 
SM 12: TBST 
1X TBST buffer was made by mixing 100 ml 10X TBS and 1 ml Tween 20 (Sigma) in 
900 ml distilled H2O. Tween 20 was added using a P1000 pipette tip with the tip end 
cut off and ejecting the tip into the solution and mixing for 10 minutes. 10X TBS was 
made by mixing 200ml 1M Tris-HCl pH 7.5, 300 ml 5M NaCl and 500 ml distilled 
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H2O. 1 M pH 7.5 Tris-HCl was made by dissolving 121.14 g Tris (Fisher Scientific) in 
1 L distilled H2O. 1 M HCl was added dropwise until pH 7.5 was reached, using a 
Basic Denver Instrument pH meter (Denver Instruments). 5 M NaCl solution was 
made by dissolving 292.2 g NaCl (Fisher Scientific) 1 L distilled H2O. 
 
SM 13: Blocking Buffer (5% Marvel-TBST) 
A 5% skimmed milk solution (Marvel) was made by dissolving 2.5 g Marvel skimmed 
milk powder in 50 ml TBST (SM 14). 
 
SM 14: Triton-X100 Lysis Buffer 
1 ml 10% Triton-X100 (Sigma) was added to 9 ml DPBS (Lonza) and stored at 4C. 
One Complete mini-cocktail protease inhibitor tablet (Roche) was added immediately 
prior to use and the solution vortexed vigorously to dissolve. 
 
SM 15: 3x Sample buffer 
3x sample buffer was made by mixing 18.8 ml 0.5 M Tris pH 6.8 (Fisher Scientific) 
(as described in SM 10), 6 g sodium dodecyl sulphate (SDS; Sigma), 15 ml beta-
mercaptoethanol (Sigma) and 30 ml glycerol in 100 ml distilled H2O. A small spatula 
of bromophenol blue was added and the solution mixed thoroughly. 3x sample buffer 
was stored at room temperature. 
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SM 16: siRNA sequences 
AP2: siRNA targeted to alpha-adaptin was generated using the sequence 
GAGCAUGUGCACGCUGGCCAdTdT (as used by Huang and Sorkin 2004) by 
Dharmacon RNAi, UK. 
 
Caveolin 1: A SMARTpool of ON-TARGETplus CAV1 siRNAs was purchased from 
Dharmacon, UK. 
 
SM 17: Tables of Antibodies 
 
Table SM 1: Primary Antibodies 
Antibody Dilution Procedure Company Catalogue # 
2s131 (mouse 
α-CD81) 
1:2 IC McKeating lab - 
Rabbit α-
caveolin 1 
1:20,000 WB BD 
Biosciences 
610060 
α-AP2 1:1000 WB Santa Cruz 
biotechnology 
sc-10761 
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Table SM 2: Secondary Antibodies 
Antibody Dilution Procedure Company Catalogue # 
Goat α-rabbit IgG 
horseradish 
peroxidase 
1:10,000 WB Thermo Fisher 
Scientific 
31460 
Sheep α-mouse 
IgG horseradish 
peroxidase 
1:5000 WB GE Healthcare RPN4201 
Donkey α-rabbit-
AlexaFluor-568 
1:200 IC Invitrogen A10042 
Goat α-rabbit-
AlexaFluor-488 
1:200 IC Invitrogen A11008 
Donkey α-
mouse-
AlexaFluor-568 
1:200 IC Invitrogen A10037 
Goat α-mouse-
AlexaFluor-488 
1:200 IC Invitrogen A11001 
Donkey α-
mouse-
AlexaFluor-647 
1:200 IC Invitrogen A-31571 
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APPENDIX II 
 
 
 
 
 
SUPPLEMENTARY VIDEOS 
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Figure Legends for Supplementary Videos 
 
 
Supplementary Video 1A: Huh7.5 cells transfected with CFPmem and imaged 
every 1 minute for 60 minutes by live-cell confocal microscopy. 
https://www.youtube.com/watch?v=CNh9pb5A7wY 
 
Supplementary Video 1B: Huh7.5 cells transfected with CFPmem and treated with 
1 μg/ml EGF, imaged every 1 minute for 60 minutes by live-cell confocal microscopy. 
https://www.youtube.com/watch?v=b37pO18kG1g&feature=youtu.be 
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